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It is estimated that one in three pregnancies ends in miscarriage. Little is understood 
about the underlying protein/receptor interactions responsible for attachment of the 
blastocyst to the uterine epithelial tissue. Even today, in vitro fertilization (IVF) 
sustains only a 30% average success rate. A primary cause of implantation failure in 
IVF is thought to be problems with the initial attachment process. Recent evidence 
suggests that the interaction between L-selectin and its sulfated ligands is the initial 
mechanism responsible for the initial capture of the rolling blastocyst.  Further, 
secondary strengthening attachment processes are thought to be mediated through 
integrin/ligand interactions.  No suitable animal model exists for the study of these 
initial events and research on human tissue is not possible due to ethical constraints.  
In this work, a trophoblast cell model was established and validated for examining 
initial L-selectin mediated attachment events in a hormonally-regulated environment. 
Further studies included the determining the effects of hydrodynamic shear flow on 
L-Selectin regulation in the cell model, and stimulation with dexamethasone, a steroid 
frequently included in the protocol for oocyte retrieval in IVF. For the first time, the 
attachment strengths associated with L-selectin/L-selectin ligand interactions as well 
as integrin/ligand interactions have been quantified in a trophoblast/uterine epithelial 
cell model, providing information that may be relevant to the critical attachment 
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strengths necessary to achieve and maintain successful implantation.   Further insight 
into these complex interactions will enable a more comprehensive understanding of 
the necessary conditions for successful implantation, and may lead to clinically 
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CHAPTER 1.  BACKGROUND 
 
 
It is estimated that one in three pregnancies ends in miscarriage [1]. While numerous 
interactions and genetic factors of both the fetus and the mother may be responsible 
for miscarriage, the critical initial event for pregnancy maintenance is successful 
attachment and continued adherence of the blastocyst to the uterine endometrium. 
Implantation failure is also clinically encountered during in vitro fertilization (IVF) 
treatments. IVF is an increasingly common and widely used infertility treatment. It is 
used to treat nearly all causes of infertility, including ovulatory, tubal, male-related 
and immunologic [2].  Though success rates for IVF treatment have increased 
steadily in recent years [3] the implantation rate remains one of the greatest 
impediments to successful reproductive outcomes in IVF [4].  In 2004 over 88,000 
standard IVF treatment cycles, over 9,000 donor oocyte cycles and over 4,000 
cyropreserved embryo cycles were completed. Despite fertilization rates of up to 
60%, pregnancy rates per transfer of embryos to the uterus in 2004 reached only 
42.5% [4]. 
 IVF is a costly and time-consuming effort for physicians, staff and patients. The 
average self-pay costs for treatments are frequently in excess of $10,000  [3].  
 In addition to costs associated with repeat procedures when implantation fails to 
occur, the high probability of multiple births associated with successful implantation 
is an added insurance burden. The ultimate goal of IVF is the birth of a singleton 
liveborn infant, and the only way to achieve this goal is to move towards a single 
embryo transfer policy [5].  Though research continues in the quest to improve the 
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techniques of  optimum embryo selection,  and embryo transfer, [6]; [7-9], the results 
have not been dramatic. From 1996 through 2004, the singleton live birth rates for 
fresh–non-donor cycles increased 34%, from 17% in 1996 to 23% in 2004 [4].  
Furthermore, even in 2004, 90 % of the IVF cycles still involved the transfer of 2 or 
more embryos, and up to 32% of these resulted in multiple births[4] In 2001, it was 
estimated that the cost per “normal” live birth was $56, 419 [10]. However, neonatal 
care for high risk infants has been reported to be as high as $800, 000 [11].  Infants 
born as multiples are almost always premature and have higher rates of low birth 
weight, cerebral palsy, developmental delays, birth defects and death [12].   Even 
twins, who usually survive, are hospitalized twice as long as singletons and have 
much higher medical costs over the first five years [12].  In a 2004 study, it was 
reported that the total duration of hospital admissions for twins and triplets were 
respectively twice and eight times that for singletons, once duration of life had been 
taken into account.  Inpatient costs were significantly higher for multiple births than 
for singletons, with the cost differences concentrated in the first year of life [12]. 
Thus, the motivation to achieve high success rates with single embryo transfers in 
IVF is very great.  
Many IVF implantation failures are believed to be due to problems with attachment 
of the blastocyst to the endometrium [13].  There are few current clinical 
interventions that directly address this etiology.  Some promising treatments that have 
been reported include:  
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1. Norethindrone (synthetic oral progestin) treatment of women deficient in ανβ3 
integrin increased implantation rates in IVF [14].  
2. Improved pregnancy rates and improved pregnancy outcome following embryo 
culture, prior to transfer, in endometrial culture medium with a GM -CSF 
(Granulocyte Macrophage Colony Stimulating Factor) content greater than 130 
pg/ml [15].  
3.  Improved quality of human embryos with the addition of HB-EGF (Heparin 
Binding Epidermal Growth Factor) in ART cycles [16].  
      With the help of these and other techniques, patients, physicians and staff may 
realize greater success rates for their remarkable efforts. Ultimately, the ideal 
scenario would be a 100% implantation success rate per embryo, which would 
result in reduced out of pocket and insurance costs, reduced physical and 
emotional stress and a much reduced ethical problem with regard to extra 
embryos.  
It is the goal of this work to augment the knowledge base pertaining to the process of     
human implantation.  Specifically, these studies are directed at the molecular 
interactions that are thought to occur in the initial stages of implantation, namely 
apposition and adhesion.   
 
1.1 The Implantation Process 
In order to completely understand  the process of implantation, it is important to be 
familiar with the structure and function of both the uterus and the fertilized egg, at 
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both the physiological level and the molecular level. The uterine wall consists of three 





 The perimetrium, also known as the serosa, is the peritoneal covering on the outside 
of the uterus and it is composed of connective tissue [18].  The central layer is the 
myometrium, the thickest layer of the uterus.  The myometrium consists of three 
poorly defined layers of smooth muscle. The third, inner layer, is the endometrium 
which consists of two layers differing in function and structure [18]. The functional 
layer, also known as the stratum fuctionale or functionalis layer is a thick apical layer 
which lines the lumen of the uterus.  It is hormone responsive, and is covered with a 
simple columnar epithelium consisting of ciliated and non-ciliated cells [19].  The 
second layer of the endometrium is the basal layer, also known as the stratum basale, 
Figure 1:  Three tissue layers of the uterine wall; with enlarged view of 
the endometrial gland [17].  
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or basalis layer.   The functionalis layer represents the upper two thirds of the 
endometrium, and it is the site of tissue proliferation, secretion, and degradation, 
whereas the basalis layer comprises the lower one-third, and serves as a source of 
tissue regeneration [20].  It undergoes continuous morphological changes during the 
monthly cycle. The monthly menstrual cycle is on average, 28 days long. In figure 2 
the phases of the menstrual cycle, the primary hormonal influences, and the 
corresponding progression of ovum as well as uterine development are shown. 
 
 
            Figure 2: Phases of the Menstrual cycle showing hormonal influences,                                     
as well as ovum and uterine tissue development [21]  
  
 
Menstrual cycles are counted from the first day of menstrual bleeding, because the 
onset of menstruation corresponds closely with the hormonal cycle.   Following 
menstruation is the follicular or proliferative phase. During the follicular phase the 
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functionalis layer,  stimulated by gradually increasing amounts of estrogen,  
regenerates as a result of new growth of glands, stroma and endothelial cells. 
Ciliogenesis, the appearance of ciliated cells around the gland openings,  also occurs 
in response to higher estrogen levels [20].  Follicles in the ovary mature, and this 
phase ends with the release of  an ovum or egg in an event called ovulation, which 
usually occurs around day 14. With ovulation, the corpus luteum forms and secretes 
progesterone, which acts on the endometrium to promote active secretion of 
glycoproteins and peptides into the endometrial cavity. The luteal or secretory phase 
begins after ovulation, and comprises days 15 to 28. Under the influence of 
progesterone, the endometrium undergoes changes to prepare for potential 
implantation of an embryo to establish a pregnancy. Pregnancy is most likely to occur 
during a small period of the secretory phase called the “window of implantation” or 
“window of receptivity” which occurs around days 16-19 in the monthly cycle. 
During conversion to the receptive state, the uterine epithelium undergoes not only a 
dramatic functional, but also a morphological transition [13].  Microvilli on the apical 
surface of the luminal endometrial epithelium fuse to form structures known as 
pinopods [22] which are  histologic markers for the window of receptivity.  Though 
their function has not been fully characterized, recent studies suggest that these 
progesterone dependent structures extract fluid from the uterus, and thereby facilitate 
closer contact between the blastocyst and the endometrium [20].  
 For successful implantation to occur, two temporally coordinated developmental 
processes must be achieved:  the blastocyst must be capable of implantation, and the 
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uterus must develop to a receptive condition to support implantation [23]. The 
process begins with fertilization of the egg by the sperm within the Fallopian tube. As 
the growing embryo migrates towards the uterus, its cells keep dividing.  The morula, 
a ball of embryonic cells, continues to divide while in the uterine cavity.  During this 
time, a proteinaceous barrier known as the zona pellucida surrounds the developing 
embryo and its non-adhesive nature is thought to facilitate transport of the developing 
embryo to the uterus [13].  Within 72 to 96 hours of being fertilized, the embryo will 
enter the uterus.  Around day 5, the embryo sheds its zona pellucida and at this point 
is considered “implantation competent” [24].  The embryo is now called a blastocyst, 
and it consists of two well-defined cell populations: the inner cell mass (ICM) and an 
outer cell layer called the trophectoderm.  Approximately 6 days after fertilization, 
the blastocyst and maternal cells, two immunologically different organisms, enter into 
a paracrine dialogue or cross communication which initiates implantation.  This 
process is described in three stages: apposition, adhesion and invasion [25].  During 
stage I,  apposition, the implantation competent blastocyst becomes stationary, 
closely apposed to the uterine endometrium and the inner cell mass freely rotates in 
order to align itself in close proximity to  the uterine endometrial epithelium [24].  In 
stage II, the adhesion phase, direct contact occurs between endometrial epithelium 
(EE) and the trophectoderm (TE). During the adhesion stage, “the association of the 
trophectoderm and the luminal epithelium is sufficiently intimate as to resist 
dislocation of the blastocyst by flushing the uterine lumen” [24].       In stage III, 
epithelial penetration and invasion occurs.  This stage is defined by rapid proliferation 
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and differentiation of the trophoblast cells into an inner cytotrophoblast and an outer 
syncytiotrophoblast. Ultimately, cytotrophoblast cells become integrated into the 
maternal uterine wall creating a distinct two-way relationship between the blastocyst 
and maternal uterine luminal epithelium. Blood vessels of the embryo can interact 
with the maternal circulation which produces the formation of a functional placenta 
and pregnancy. 
One of the fundamental requirements for the successful establishment and 
maintenance of pregnancy is the decidualization of the endometrium. Decidualization 
is defined as the differentiation of the fibroblast-like mesenchymal cells in the 
endometrium to a decidual cell which is morphologically and biochemically distinct 
[26].  Under the influence of progesterone, decidualization involves increased mitosis 
and differentiation of stromal cells. Also associated with decidualization is the 
progesterone-dependent infiltration of specific leukocyte subsets into the endometrial 
stroma, including natural killer cells, T cells, and macrophages [20].  The apical 
glycocalyx (the polysaccharide matrix excreted by epithelial cells forming a coating 
on the surface of epithelial tissue) decreases in both amount and negative charge 
character [25].  
The effect of uterine contractility on the implantation process is a question which 
remains to be fully understood. Throughout the menstrual cycle, hormonally 
controlled wavelike activity patterns are known to occur in the uterus.  These 
peristaltic contractions are initiated in the sub endometrial myometrium [27].  
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Estrogen is known to be the primary utero-stimulant. Estrogen levels peak in the pre-
ovulatory period, with resulting contractions facilitating tubal ovum transport [28].  
They appear to be related to successful pregnancies in both natural and assisted 
reproduction, but the exact role is not yet known.   The relationship between 
contractile frequency and IVF outcomes is controversial, with some researchers 
reporting no correlation [29], and others reporting a negative correlation [30].  
Furthermore, at the precise time of implantation, quiescence is thought to be 
beneficial.   Bulletti states that “when implantation occurs, and the embryo interacts 
with the luminal epithelium surface, the uterus must be relaxed, as this is a 
prerequisite for embryo nidation (implantation) and decidual invasion” [31].   
If pregnancy occurs, hormonal secretions from the placenta  signal the corpus luteum 
to continue progesterone secretion, thereby maintaining the thick lining 
(endometrium) of the uterus, and providing an area rich in blood vessels in which the 
zygote(s) can develop. From this point on, the corpus luteum is called the corpus 
luteum graviditatis. However, if implantation does not occur, the corpus luteum will 
die, causing sharp drops in levels of both progesterone and estrogen. These reductions 
in hormone levels cause the uterus to shed the functionalis layer in menstruation.  
1.2 Molecular Aspects of Implantation  
After fertilization, the events leading to successful implantation of the blastocyst are 
highly regulated by crosstalk between the maternal and fetal tissues involving several 
endocrine, paracrine (signals which  target only cells in the vicinity of the emitting 
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cell) and autocrine (signals which the target cell is the secretory cell itself) factors. 
The most important of these are the ovarian hormones, estrogen and progesterone. 
However, several other groups of molecules, such as cytokines, growth factors and 
cellular adhesion molecules have been found to be very important mediators of 
implantation mechanisms.  
1.2.1 Hormones 
Hormonal regulation of the implantation process has been extensively studied [20]. 
The dialog between embryo and receptive endometrium is under the control of the 
sex steroids, estrogen (estradiol, E2) and progesterone, as well as other hormones, 
such as prolactin, calcitonin, and human chorionic gonadotropin (hCG).  
The major factors that specify uterine receptivity are the ovarian steroids, 
progesterone and/or estrogens [24].  They initiate a cascade of paracrine and 
autocrine signal transduction which, via cell adhesion processes, will lead to the 
attachment and subsequent invasion of the embryo into the endometrium [32].  
Estrogen and progesterone have two receptor subtypes: α and β, A and B, 
respectively. Estrogen receptor, (ER)- α is expressed by endometrial and stromal cells 
during the proliferative phase, but decreases during the secretory phase [33].  
Endometrial expression of (ER)- β is limited to glandular epithelial cells [34]. The 
specific response of a cell to estrogen stimulation depends on the relative abundance 
of the ER subtype, the type of estrogen and the targeted response element [20].  
Similarly, the relative proportions of progesterone receptor (PR)-A and –B within a 
target cell determine if gene activation will occur upon hormonal stimulation because 
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PR-A dominantly represses transcriptional activation by PR-B [35]. PR-A is 
expressed in the stroma and epithelium during the proliferative and secretory phases, 
however, epithelial levels of PR-A gradually decrease during the secretory phase 
[36].  PR-B is present in glandular and stromal nuclei only during the proliferative 
phase [37].  Progesterone receptor (PR) levels are increased by estrogens and growth 
factors, and decrease in response to progesterone [38]. ER- β also seems to down-
regulate PR’s in the luminal epithelium [39]. The down-regulation of PR during the 
window of implantation is a prerequisite for endometrial receptivity [40]. 
In addition to ovarian steroid hormones and local autocrine and paracrine signaling 
within the endometrium, embryo-derived signals seem to be essential for the 
establishment of a receptive endometrium and the initiation of the embryo-maternal 
cross talk.  One of the first known hormonal signals of the embryo during 
implantation is human Chorionic Gonadotrophin (hCG). Its secretion begins no later 
than day 7 in the blastocyst stage which suggests a paracrine role of this hormone 
during the first steps of implantation in addition to its classical endocrine role in 
rescuing the maternal corpus luteum at the onset of pregnancy [41]. 
hCG is a glycoprotein that is synthesized by syncytiotrophoblasts, and principally 
serves to maintain corpus luteum progesterone function until the placenta is able to 
take over at 60 to 70 days’ gestation [20].  The recent discovery of chorionic 
gonadotrophin/lutenizing hormone (CG)/LH receptor in the human uterus as well as 
LH receptor up-regulation during the period of endometrial receptivity has led to 
much interest in the potential direct role of hCG in implantation [42]. In stromal cells, 
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hCG promotes decidualization in the presence of estrogen and progesterone as 
determined by the increased transcription of prolactin, a marker of such 
differentiation. [43].  
Prolactin (PRL) is a peptide hormone secreted in significant part by the anterior 
pituitary.  The endometrium is one of the first extra pituitary sites that have been 
reported to synthesize and secrete PRL [44].  It is synthesized in the secretory phase 
of the menstrual cycle. Endometrial PRL (e-PRL) is similar to hypophyseal (from the 
pituitary gland) PRL in chemical, biological and immunological properties [45].  It 
has been hypothesized that progesterone is essential for the initiation of e-PRL 
synthesis and the maintenance of its production [46].  The effects of PRL are 
mediated by a membrane bound receptor, PRL-R.   The coordinated temporal pattern 
of expression of e-PRL and PRL-R in non-pregnant and pregnant endometrium 
suggests that e-PRL may have an important role in the process of implantation and 
maintenance of pregnancy [45]. Some authors have suggested a role for e-PRL in the 
process of implantation by modification of the immune environment of the 
endometrium or by regulation of the factors within the glandular secretions that may 
control trophoblast proliferation and endometrium invasion [47, 48].  In a recent pilot 
study by Garzia et al, it was found that women with unexplained infertility and 
recurrent miscarriages present a defect in endometrial PRL production. It was 
suggested that e-PRL may be more than a simple marker of decidualization, but rather 
an active cytokine and that the endometrial defect may be associated with an 
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impairment of CD56+ NK killer cell endometrial recruitment ultimately resulting in 
unsuccessful embryo implantation and inadequate placentation [45].   
Calcitonin is a 32 amino acid peptide hormone.   Its most well characterized 
physiological role is to regulate calcium in bone and kidney cells [13].  However, 
recent studies have revealed that calcitonin is transiently expressed in the rat uterine 
epithelium overlapping the window of implantation [49].  Calcitonin was shown to be 
expressed in the human endometrium during the implantation period [50].   
Calcitonin mRNA was found to be expressed in the uterine mucosa during the mid-
secretory phase of the menstrual cycle, with maximal expression occurring between 
days 19–21, which coincides with the implantation window. The same authors 
reported that calcitonin gene expression in the human endometrium is induced by 
progesterone.  Immunoreactivity for calcitonin mRNA was not detected during the 
proliferative and ovulatory phases in human endometrium, suggesting that the 
synthesis of this hormone is increased only during the implantation period [50].   
1.2.2 Cytokines 
Cytokines are small multifunctional glycoproteins that mediate communication 
between cells [51]. Cytokine is a general name: other names include lymphokine 
(cytokines made by lymphocytes), monokine (cytokines made by monocytes), 
chemokine (cytokines with chemotactic activities), and interleukin (cytokines made by 
one leukocyte and acting on other leukocytes). Cytokines may act on the cells that 
secrete them (autocrine action), on nearby cells (paracrine action), or in some instances 
on distant cells (endocrine action). In the human endometrium they play a major role in 
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reparative and inflammatory-like processes which occur every menstrual cycle, but they 
are also implicated in critical reproductive events such as ovulation and implantation 
[52]. The cytokines which have been identified as important to the implantation process 
include leukemia inhibitory factor (LIF), interleukin-1, (IL-1), IL-6, IL-11, Tumor 
Necrosis Factor-α (TNF- α), Colony Stimulating Factor- 1 (CSF-1) [51] and  epidermal 
growth factors (EGF) such as Transforming Growth Factor-β (TGF-β) [53], and 
Heparin-Binding Epidermal Growth Factor (HB-EGF).  Recently, genetic expression of 
IL-8 has been reported to be upregulated in an in-vitro co-culture cell model of human 
endometrial stromal cells and first trimester trophoblast cells, indicating a possibility of 
this protein’s involvement in the implantation process as well [54].  
The  IL-6 family of interleukins, consists of IL-6 itself , IL-11, and LIF (Leukemia 
Inhibitory Factor), all of which are considered to have a role in the implantation 
process. LIF and IL-11 bind to ligand specific receptors, LIFR and IL-11R, 
respectively, and share gp130 (glycoprotein 130) as a signal transduction partner [55]. 
However, studies using IL-11Rα mutant mice have shown that IL-11 is crucial to 
decidualization, but not for the attachment reaction [56]. LIF was originally identified 
by its ability to induce the macrophage differentiation of the myeloid leukemic cell 
line, M1 [57, 58]. LIF is expressed with a molecular weight ranging from 38 to 67 
kDa [52].   LIF has been linked to the implantation process since Bhatt and 
researchers reported  a “dramatic and transient burst of LIF expression in the 
endometrial glands of the mouse uterus which is then reduced once implantation is 
completed” [59].   Studies with mice lacking a functional LIF gene showed that 
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embryos failed to implant, indicating that maternal LIF is essential for successful 
pregnancy. However, implantation failure was partially blocked by administration of 
LIF in the peritoneal cavity of the LIF deficient mice [60].  Thus, in the mouse, it has 
been suggested that endometrial LIF has either a paracrine effect on the embryo, or an 
autocrine effect on the endometrial epithelium to allow implantation [60].  
LIF is also expressed in the human endometrium with patterns suggestive of a role in 
implantation [51].  It is regulated by other cytokines and steroid hormones, 
particularly progesterone.  It has been hypothesized that the embryo, through hCG 
secretion, may actively participate in the control of endometrial LIF expression.  LIF 
treatment of embryos has demonstrated a beneficial effect in the number of embryos 
that progress to the blastocyst stage [61].  Sawai, et al showed that that LIF increased 
hCG production and that the effect of LIF on trophoblast differentiation could be 
blocked by anti-hCG antibodies [62]. The key role of LIF in human implantation has 
been established based on abnormal LIF levels in infertile patients.  Lessey, et al.  
reported that LIF is present during the window of implantation in women, and 
expression may be decreased in the endometrium of some women with infertility 
[63].  Endometrial LIF concentration was found to be lower in infertile women with 
recurrent embryo transfer failure after IVF [64].  Furthermore, Geiss, et al have 
shown, by screening for LIF gene mutations in fertile women and those with 
unexplained infertility, that heterozygosity for a LIF gene mutation could give rise to 
decreased availability or biological activity of LIF in the uterus and cause 
implantation failure [65]. Since LIF and its receptors, LIFR and gp130 exist in both 
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soluble and membrane bound forms, and soluble forms of these two receptors 
antagonize the actions of their ligands, a complexity of the LIF signaling pathway is 
implied [66, 67]. Dey has suggested dual roles for LIF, first in the preparation of the 
uterus, then in the attachment reaction [24].   However, to date, the molecular 
mechanism by which LIF executes its effects on implantation is not fully 
characterized.  
IL-6 was originally identified as a factor inducing immunoglobin production in 
activated B cells.  Within the human endometrium, IL-6 expression  follows a 
regulated temporal pattern with highest levels detected during the luteal phase [68].  
Strong immunoreactivity for IL-6 becomes detectable during the window of 
implantation [52].  The IL-6 receptor was found to be expressed by the blastocyst, the 
trophoblast and the endometrium [69].  
Studies showing the regulation of IL-6 by steroid hormones have given conflicting 
results. Data showing the up and down regulation of endometrial IL-6 secretion by 
estrogen (E2) and progesterone have been published [70, 71], [72] However, no direct 
effect of E2 and/or progesterone treatment on endometrial IL-6 secretion by cultured 
endometrial epithelial cells (EEC’s) could be established [72]. Another study showed 
that E2 mediates the upregulation of IL-6 in immortalized EEC’s, whereas E2 and 
progesterone mediate up-regulation of its receptor [70].   It has therefore been 
speculated that, even if IL-6 is not directly regulated by E2 and progesterone, the 
action of these hormones could be indirect via other mediators that are expressed at 
maximum concentrations in the late secretory phase [68].  Vandermolen, et al have 
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reported that IL-1β, a component of the IL-1 system (see below), stimulates 
endometrial IL-6 protein production in a time- and dose-dependent manner. Human 
endometrial IL-6 may therefore mediate some actions of  IL-1β involving the 
endometrium and trophoblast [73]. 
  IL-1 is a pro-inflammatory cytokine and one of the best characterized members of 
the cytokine family.  IL-1 is produced in and secreted by the endometrium, and has a 
role in implantation.[14].  All components of the IL-1 system (IL-1α, IL-1, cell 
surface receptors IL-1R1, IL-1R2, and a receptor antagonist, IL-1Ra) have been 
examined at the maternal-trophoblast interface during implantation [74].  It is 
distributed in the human endometrium at both the protein and mRNA levels, and it is 
produced by decidualized and pseudo-decidualized stromal cells. [53].  In- vitro,  IL-
1 has been found to exert an influence on expression of the β3 integrin (see section 
1.2.4.1) subunit [75].  Embryo secretion of IL-1β is stimulated by endometrial factors 
[76, 77] demonstrating a clear interaction between the maternal endometrium and 
embryo prior to implantation. In vitro, studies have found that the release of IL-1β by 
cultured cytotrophoblast cells is directly proportional to their invasive capacity [78], 
and that IL-1β  increases the production of matrix metallo- proteinase-2 (MMP-2)  
and -9 by the Jeg-3 trophoblast cell line [79]. It has been found by Arici et al to be a 
potent modulator of LIF expression in endometrial stromal cells in culture [80].   In 
vivo, it is therefore likely that decidual IL-1β may act in a paracrine manner by 
binding to IL-1R1 expressed by trophoblasts and regulating MMP-mediated invasion 
and hCG secretion [74].   
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Colony Stimulating Factor-1, (CSF-1), is a homodimeric protein that modulates 
proliferation, differentiation, and survival of numerous cell types, including 
fibroblasts, monocytes, macrophages and endothelial cells. It is one of the first 
examples of an implantation specific gene [81].  CSF-1 has been shown to be 
expressed by endometrial epithelial and stromal cells and by trophoblast cells, while 
its receptor, c-fms, is expressed on the embryo and placenta [82], [83].  Early studies 
in mice revealed that uterine concentrations of CSF-1 increase approximately 1000-
fold during pregnancy, and there is a concomitant increase in messenger RNA 
(mRNA) in the luminal and glandular epithelium [84]. In humans, CSF-1 protein is 
much higher in the pregnant than the non-pregnant endometrium, and high in the 
placenta during pregnancy [85]. CSF-1 mRNA cannot be detected by Northern blot 
analysis in non-pregnant endometrium and this suggests that its role is not related to 
the early stages of implantation but rather to the processes involved in placentation. 
Furthermore, mice devoid of CSF-1 show impaired preimplantation embryo 
development, but can become pregnant and deliver viable litters [86].   
A related protein, granulocyte macrophage colony stimulating factor (GM-CSF) has 
well characterized effects on survival, proliferation and differentiation of myeloid 
leukocytes and their precursors [87].  Similarly to CSF-1, GM-CSF is synthesized in 
the uterus by endometrial luminal and glandular epithelial cells in both mice and 
humans [88].   In the human endometrium, maximal expression of mRNA for GM-
CSF is seen during the mid secretory phase, coinciding with the window of 
implantation [88].   The exact role of GM-CSF in the has not yet been elucidated, 
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however, a potential role in human implantation is suggested by reports of  improved 
pregnancy outcome following embryo culture prior to transfer in endometrial culture 
medium with a GM-CSF content greater than 130 pg/ml [15].   Roles of the IL-1 
family, IL-6, LIF and CSF-1 in implantation process are shown in Figure 3 [89].  
 
 
Figure 3:  Important factors in the interaction of the blastocyst with the  endometrium 
in the pre-implantation process: Embryonic secretion of IL-1 induces localized 
changes in the uterine epithelium, and the binding of IL-1 to IL-1Rt 1 (Interleukin 1 
Receptor type 1) in the uterine epithelium may up-regulate the expression of αvβ3 
integrins, IL-6 and LIF. Adhesion may be facilitated by the interaction between LIF, 
CSF-1 and corresponding embryonic receptors (Adapted from [89]) 
 
 
TNF- α (Tumor Necrosis Factor-α,  Lymphotoxin B, Cachectin) was first identified in 
its 17 kDa secreted form, but further research showed that a non-cleaved 27 kDa 
precursor also existed in transmembrane form [90].  It was first isolated by Carswell 
et al. in 1975 in an attempt to identify tumor necrosis factors responsible for necrosis 
of the sarcoma “Meth A” [91].  In 1993 it was reported that human embryos secreted 
TNF-α in the medium until the morula stage, but not at the blastocyst stage [92].  
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Pampfer observed  that the developmentally regulated expression of TNF-α receptors 
and its ligand in mouse embryos led to the down regulation of ICM (Inner Cell Mass) 
proliferation [93]. This selective inhibitory effect of TNF-α supports the hypothesis 
that this cytokine could contribute to the causes of many unexplained reproductive 
failures where high levels of TNF-α are present in the reproductive tract [94, 95].  In 
human first trimester villous trophoblast, TNF-alpha binding was found to be 
predominantly detectable on the syncytiotrophoblast and to a lesser extent on the 
cytotrophoblastic cells. Binding was not observed on adjacent embryonic or maternal 
cells. These results further support the idea that TNF- α may modulate early 
embryonic development and (later stages of the) implantation process [96].   TNF-α is 
inhibited by progesterone, which supports the hypothesis that it is not beneficial for 
pre-implantation embryo growth [97]. 
 IL-8 (also known as Neutrophil Chemotactic Factor) is a pro-inflammatory cytokine 
which serves to attract neutrophils to the site of inflammation. During implantation a 
specific subset of leukocytes infiltrate into the endometrium from blood vessels and 
surrounding tissues [98].  Leukocytes also accumulate in the endometrial stroma 
during progesterone mediated decidualization [99].  
 Because the leukocytes do not possess steroid receptors, chemo-attractant cytokines, 
such as IL-8 seem to mediate their steroid dependant recruitment [100].   In the 
apposition phase of implantation, the blastocyst upregulates IL-8 at the protein and 
mRNA levels in endometrial epithelial cells (EEC’s) [101].  Further evidence of this 
was seen in a recently published study by Popovici using comprehensive gene 
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profiling to analyze the effect of trophoblasts on endometrial stromal cells, during 
implantation [54]. In this work, an in-vitro co-culture system of endometrial stromal 
cells and first trimester stromal cells was established.  After 24 hours of co-culture 
contact, cells were separated, and analyzed for changes in gene expression.  The up-
regulated genes included those for inflammatory response, immune response, 
regulators of cell growth and signal transduction and chemotaxis.   IL-8 was found to 
be the most significantly upregulated gene, with a 367 fold increase.   However, the 
pro-inflammatory effects of IL-8 seemed to be regulated [54].  
When pregnancy occurs, the corpus luteum (CL) produces more progesterone, which 
maintains an inhibitory effect on IL-8, and inhibits leukocyte infiltration into the CL. 
This may represent an anti inflammatory effect of progesterone, suppressing the local 
inflammatory response at the time of implantation [102].  Thus, even though the 
process of implantation entails inflammation like events, exaggerated inflammatory 
responses may perturb the integrity of endometrial function and lead to pathological 
conditions, including abortion and complicated pregnancies, such as preeclampsia 
and underdevelopment of the fetus [103].  
1.2.3 Growth Factors 
The expression of various growth factors and their receptors in the uterus in a 
temporal and cell specific manner during the pre-implantation period suggests that 
these factors are important for implantation [24].   Heparin Binding Epidermal 
Growth Factor (HB-EGF), is one of several EGF-like molecules that are expressed in 
during or in close proximity to the window of implantation.  HB-EGF has been found 
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to be expressed by the human endometrium, in secreted as well as membrane bound 
form, immediately before the window of implantation  [104, 105]. Its expression is 
maximal during the late secretory phase (cycle days 20-24).  In mice, during the 
receptive phase, HB-EGF is expressed at the apical surface of the luminal epithelium, 
and as such it has been proposed to be an attachment ligand in human implantation 
[104]. The membrane bound protein binds to the embryonic EGF receptor Erb-4, and 
may facilitate embryo attachment in mice [106]. In fact, cells expressing the 
membrane bound form of HB-EGF adhere to human blastocysts displaying cell 
surface ErbB4 [107].  In humans, addition of HB-EGF improves the quality of 
embryos in ART cycles [16] and may be a paracrine factor that stimulates other 
markers of uterine receptivity in human endometrium [81].  Thus, collective evidence 
suggests that HB-EGF has a significant role in preimplantation embryo development 
and implantation as a paracrine and/or juxtacrine factor [24].  
The transforming growth factor β (TGF β) family comprises at least 42 distinct 
mammalian dimeric proteins that share a similar structure [108].  The TGF β family, 
along with its numerous receptors and signal transducing proteins is a highly complex 
system, and it has been found that disruption of any one member of the family by 
gene targeting in mice has not resulted in disruption of implantation [74].  TGFβ’s 
may play a role in human implantation via their stimulation of fibronectin or vascular 
endothelial growth factor (VEGF)  production  [109, 110] or by promotion of 
adhesion of trophoblast cells to the ECM (extra cellular matrix) [111]. Furthermore, 
TGF β inhibits production and/or secretion of hCG, human placental lactogen, 
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progesterone and estradiol from trophoblast cell lines [112-114]. These in-vitro 
studies may provide some insight into the functional in-vivo actions of TGFβ, where 
the full repertoire of modulators are present, but this remains to be determined [74].  
1.2.4 Cellular Adhesion Molecules (CAM’s) 
 There are four major classes of cell adhesion molecules: integrins, cadherins, 
immunoglobins and selectins.  The classifications are dependent upon the interactions 
which they undergo. Cadherins  are dependent on calcium (Ca2+) ions to function, 
hence their name. Immunoglobulins (antibodies) are proteins produced by plasma 
cells. They are designed to control the body's immune response by binding to 
substances in the body that are recognized as foreign antigens.  Integrins are the 
primary receptors responsible for the attachment of cells to the extracellular matrix 
(ECM), though they also participate in cell-cell adhesive interactions. Selectins are a 
family of cell surface molecules found on both leukocytes and endothelial cells.  All 
selectins are single-chain transmembrane glycoproteins, and they mediate cell to cell 
adhesion through protein-carbohydrate interactions.  Both selectins and integrins are 
considered to play major roles in the apposition and  adhesion stages of  
implantation.  
1.2.4.1 Integrins 
Integrins are involved in many physiologically important processes including 
embryological development, orienting cells in their environment, establishing their 
shape and polarity, haemostasis, thrombosis, wound healing, and immune and non-
immune defense mechanisms [52].  They are  heterodimers containing two distinct 
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chains, called the α (alpha) and β (beta) subunits.  All integrins are made up of a 
combination of each of  these subunits. In mammals, 20 α and 8 β subunits have been 
characterized. The molecular mass of the integrin subunits can vary from 90kDa to 
160kDa. The α and β subunits are transmembrane polypeptides which associate with 
each other noncovalently to form two binding sites: one for the ligand on the outer 
membrane surface and a receptor site on the cytoplasmic side of the membrane. 
Integrins couple the ECM (extra cellular matrix) outside of a cell to the cytoskeletal 
filaments inside the cell Integrins themselves have no enzymatic activity, and 
therefore must rely on accessory proteins for generation of cytoplasmic signals [115].  
They  participate in two types of signaling. Outside-in signaling occurs when the 
binding of the ligand to the integrin activates classical intracellular signal 
transduction pathways to initiate cellular events.   For example, in response to ligand 
binding, integrins aggregate into “focal adhesions sites”, which leads to the 
recruitment of a network of cytoskeletal proteins such as α-actinin, talin and vinclulin 
[116] as well as intracellular signaling complexes; primarily kinases such as focal 
adhesion kinase (FAK), integrin linked kinase (ILK), and mitogen activated protein 
kinase pathway (MAPK) [117].  Inside-out signaling is the mechanism by which a 
cell regulates the affinity state of its integrin receptors [115].  Integrins can exist in 
inactive, partially activated and highly activated states. Inside-out signaling results in  
conformational changes in the external domain of the receptor.  Mutational analysis 
suggests that the cytoplasmic domains of both α and β subunits may play a role in the 
modulation of integrin-ligand binding affinity [118].  
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Which ligand in the ECM that  the integrin can bind to is dictated by the specific α 
and β subunits that it consists of.   Examples of common integrin ligands  are 
fibronectin, vitronectin, collagen, and laminin. The integrin binding domains interact 
with components of the ECM through recognition of an RGD (Argenine-Glycine-
Aspartic acid, Arg-Gly-Asp) tripeptide sequence which was first found in the integrin 
ligand, fibronectin.   This RGD sequence has also been identified in vitronectin, 
fibronectin, and osteopontin [118].  Figure 4 illustrates the interactions of integrin 
subunits with each other, as well as with the ECM [119]. 
 
 








            
      Figure 4:  Interactions of Integrin Subunits (Adapted from[119])  
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Integrins are thought to play a significant role in implantation.  They were first found 
in the endometrium by Lessey, et al. in 1992 [120].  The presence of integrin subunits 
on the human uterine endometrium throughout the menstrual cycle has been 
characterized through immunohistochemistry [120-122]. There are several  integrins 
which are constitutively expressed by the uterine epithelium and these include: α2β1, 
α3β1, α6β1, α6β4, α5β1 [120].  Several integrins, however undergo cycle dependent 
expression during the menstrual cycle. In particular, the integrins which have been 
detected around the window of implantation are: α2β1, α4β1, and  ανβ3 [81]. These 
integrins are receptors for collagen, fibronectin and vitronectin, respectively.  Lessey 
has also reported that expression of these integrins occurs only during the window of 
implantation, on days  20-24 of the menstrual cycle [123].    
Endometrial α4β1 binds to an alternatively spliced form of fibronectin, which is 
secreted by the trophoblast, and it is has been suggested to promote embryo 
attachment [124]. There is substantial evidence that the integrin ανβ3 is directly 
involved in the blastocyst/uterine epithelial adhesion process. This integrin binds to 
the RGD motif in fibronectin, osteopontin, vitronectin and laminin, among others 
[125, 126].  Oncofetal fibronectin is expressed by  human trophoblasts [124], and 
ανβ3 is expressed apically in both mouse and human endometrial epithelium as is 
another αν  partner, β5  which can bind to fibronectin and vitronectin [127].  In mice 
and rabbits, a functional blockade of  αν β3  integrin  reduces implantation sites [128, 
129].   
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In-vitro, immortalized ovine and porcine endometrial luminal epithelial (LE) and 
conceptus trophoblast cells abundantly express αν and  β3  heterodimers at focal 
adhesion sites of cell anchorage to the basal substrate and these show evidence of 
integrin activation via osteopontin binding [130].  αν β3,  as well as osteopontin, have 
been detected by immunohistochemistry on the endometrial luminal epithelial 
surface, which is the location of blastocyst implantation [131].   The αν β3 dimer is 
simultaneously present in the uterine epithelium and in the trophoblast.  It is thought 
that the anchorage of the embryo is made possible through “loop interactions” [132].  
Thus, αν β3 expressed on the trophoblast cells  recognizes endometrial osteopontin, 
and endometrial αν β3 interacts with vitronectin and fibronectin expressed by the 
trophectoderm.  In some women, the aberrant expression of αν β3   is thought to be 
associated with certain infertility conditions, including endometriosis, luteal phase 
defect, hydrosalpinges and unexplained infertility [81].  In a study of 268 normal 
endometrial biopsies judged to be histologically “in phase”, an absence of β3 
expression was found to be closely associated to the diagnosis of endometriosis [123].  
Norethindrone (synthetic oral progestin) treatment of women deficient in ανβ3 
integrin has been reported to result in increased  implantation rates in IVF [14].   
These examples support the hypothesis that ανβ3 is a critical integrin in the 
implantation process, and Lessey has proposed αν β3  as a potential receptor for 
embryonic attachment [81].   
Several studies have focused solely on the integrin subunits involved in implantation. 
Campbell, et al. demonstrated that six integrin subunits, α3,  αν, β1,  β3,  β4,  and  β5 are 
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consistently expressed throughout the pre-implantation period [133].  Integrin 
subunits α1 and α4 are expressed in the endometrial epithelium during the luteal phase 
of the menstrual cycle. The subunit β3 appears at day 20 of the cycle and co-exists 
with subunits α1 and α4 when the embryo is implanted [132]. Evidence has also been 
obtained for the presence of integrin subunits α2, α4, αL, β2 and β7 on a small number 
of oocytes [115]. The αν integrin subunit has been shown to be expressed in human 
embryos throughout early development from the two cell stage and up to the 
blastocyst [134].   In mice, at least three integrin subunits,  α2,  α6A and α7 are newly 
expressed when the blastocyst becomes attachment competent [135]. The α1 integrin 
subunit can only be detected after trophoblast outgrowth, which suggests that its 
expression is in response to contact with the ECM.  
 In mice, embryos carrying the homozygous null mutation for β1 subunit will die 
shortly after implantation, due to degradation of the inner cell mass [136] however, 
the β1-null trophoblast cells invade the uterine stroma, and survive longer than the 
inner cell mass, suggesting that integrins of the β1  family are not required for initial 
implantation [115]. Furthermore, Yoshimura has reported that outgrowth, but not 
attachment, of embryos was inhibited in a dose dependent manner by an antibody that 
recognizes the  β1 subunit,  suggesting that  β1  integrins are important for blastocyst 
development and differentiation following attachment  [137].   
Thus, integrins have been known to be critical to the adhesion process in implantation 
since they were characterized by Lessey in the human endometrium in 1992.  
However, of all the integrins that have been characterized in the human reproductive 
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system, αν β3   clearly stands out as the integrin most likely to be critical in the 
blastocyst  attachment process.   
1.2.4.2. Selectins   
Selectins are type I membrane glycoproteins (carbohydrate binding molecules) which 
primarily mediate the docking of leukocytes to the blood vessel wall and the rolling 
of these cells along the endothelial cell surface [138].  Although selectins have been 
identified as being significant for the initial  adhesion step in this process, their 
activity is known to be lost quickly due to rapid formation then breakage of adhesive 
bonds [139]. The selectins distinguish themselves from other adhesion molecules 
because they mediate cell to cell bonding through protein-carbohydrate interaction.  
In humans, three selectins have been identified and characterized: P-Selectin (named 
due to its initial discovery on blood platelets),  E-Selectin (named due to  its dominant 
presence on vascular endothelium) and L-selectin, (named because it was first 
discovered on blood leukocytes).  
 All three selectins contain many specific structural similarities : an NH2 or amine 
terminal calcium (Ca++) dependant  C-type lectin domain followed by an epidermal 
growth factor-like (EGF) domain,  a series of sequence consensus repeats (CR), a 
trans-membrane domain (TM) and finally a C- terminus  cytoplasmic domain  [138]. 
The three different selectins share an overall homology of 40–60% [140] with highest 
homologies in the lectin and EGF domains between 60% and 70% [140]. The major 
difference between L, E, and P-selectin is found to be the transmembrane and 
  30  
cytoplasmic domains, and this suggests that they are probably regulated differently 
[138].   
As with most proteins synthesized in the rough endoplasmic reticulum (ER), the 
selectins undergo “co-translational glycosylation” by the addition of a preformed 
precursor  oligosaccharide composed of 14 sugars, consisting of   N-
acetylglucosamine, mannose and glucose.  Glycosylation is the  process of adding 
oligosaccharide side chains to the amino acids of a protein. The two major types of 
glycosylation that have been characterized within cells:  N-linked and O-linked 
glycosylation. In N-linked glycosylation the oligosaccharide chain is attached to the 
amide nitrogen of  an asparagine (Asn) residue which occurs  in the tripeptide 
sequence Asn-X-Ser (Serine) or Asn-X-Thr (Threonine) , where X could be any 
amino acid except Pro (Proline). This sequence is known as a glycosylation sequon. 
O-linked glycosylation occurs at a later stage during protein processing, probably in 
the Golgi apparatus, during a process termed “Post-translational modification”, that  
is,  the chemical modification of a protein after its translation. This occurs on the 
hydroxy oxygen of serine or threonine residues. Mucin type O-glycosylation (which 
is important in the production of L-selectin ligands) is initiated by enzymatic addition 
of   N-Acetylgalactosamine(GalNAc) to serine or threonine by specific 
galactosaminyltransferase family of enzymes.  Depending on which saccharide 
groups are subsequently attached to this first GalNAc residue, mucin O-glycans are 
divided into four major subtypes, or core structures.  The core 1 structure is formed 
by addition of galactose to form Gal b1-3GalNAc-aSer/Thr.  The core 2 structure 
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requires the core 1 structure as substrate and is formed by addition of N-
Acetylglucosamine (GlcNAc) to form Galb1-3 (GlcNAcb1-6) GalNAc-aSer/Thr.  
The core 3 structure is formed by the addition of GlcNAc to form GlcNAc b1-
3GalNAc-aSer/Thr.  The core 4 structure requires the core 3 structure as substrate and 
is formed by addition of GlcNAc to form GlcNacb1-3 (GlcNAcb1-6) GalNAc-
aSer/Thr.   
Because the preformed oligosaccharide added to L-selectin  during co-translational 
modification  is transferred to the side chain amine (NH2) group of an asparginine 
amino acid in the protein, it is said to be “N-linked”.  The diversity of the N-linked 
oligosaccharide structures that is seen on the mature glycoproteins is due to a later 
(post-translational) modification of the original precursor. Comparative structures of 
the three selectins are shown in Figure 5, along with proposed sites of glycosylation.  
 
 
Figure 5:  Comparative structures of human selectins where EGF = epidermal 
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Though all three selectins play a major role in the cascade of molecular interactions 
that mediate leukocytes from the blood stream to the vessel wall, only one, L-selectin 
has been identified as a critical player in the capture and adhesion of the human 
blastocyst to the uterine endometrium in the complex process of implantation.  
In 2003, a landmark study by Dr. Fisher’s group showed that human trophoblasts  
expressed  L-selectin, and that the initial attachment of the blastocyst to the uterine 
wall is mediated by oligosaccharide-based L-selectin  ligands.. The ligand-receptor 
system was found to be functional, since trophoblasts could bind to ligand-expressing 
uterine luminal epithelium in tissue sections [141].  This important discovery supports 
what has recently been hypothesized as a clear parallel between the steps involved in 
the  human blastocyst implantation process embryo-endometrial apposition, 
attachment and  invasion, and leukocyte extravasion process: rolling/adhesion and 
invasion of the vascular endothelium [142]. The L-selectin adhesion system, as it 
applies to both of these processes is discussed in detail in the following sections.   
1.2.5  The L-Selectin Adhesion System 
This system is defined as the cellular adhesion  protein,  L-selectin,  and its ligands, 
specifically those ligands which have been identified as important in the implantation 
process and ones which have a high level of O-linked glycosylation containing a 
sulfated sialyl Lewis x epitope.  
1.2.5.1  L-Selectin Structure  
L-selectin (CD62L, LAM-1, gp90MEL, LECAM-1) was originally identified in mice in 
1983, first by its affinity antibody, MEL-14, and then by its involvement in the 
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homing of lymphocytes to high endothelial venules of lymph nodes [143].    This 
protein, along with the other selectins were cloned and sequenced in 1989 [144].  L-
selectin, the smallest molecule of the three selectins, is composed of 372 amino acid  
residues, corresponding to a molecular weight of ~37 kDa. However, the molecular 
weight of L-selectin is expressed in the range of  ~70 and 110 kDa depending on the 
cell type. This could be explained by the fact that the DNA sequence of human L-
selectin encodes a core protein of 37 kDa with eight possible sites for N-linked 
glycosylation. Thus, the observed different molecular weights are most likely 
generated by the glycosylation state [145]. The amino acid sequence for L-selectin 
has been elucidated, as well as the sequences that correspond to each domain 
structure (Figure 6).  
 
  
Figure 6:  Amino acid Sequence of Human L-selectin (UniProtConsortium, 1991)            
with Domain Assignments: (A) corresponds to the Lectin domain, and                                     
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Figure 7 shows 3D filled and ribbon models of the lectin domain of L-selectin, as 
determined by homologous protein modeling (using the modeling program Blast 
[146], and in Figure 8, the, the spatial configuration of the entire L-selectin molecule 




Figure 7:  Proposed structure of lectin domain of L-selectin as depicted by RasMol:       
A:  Filled model showing negatively charged (red), positively charged (blue)  
and sulfur containing (yellow) amino acids 
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.  
Figure 8: Spatial Configuration of the L-selectin Molecule 
 
Kansas has shown that the lectin domain dictates its specificity of adhesion [147].  
However, deletion of the EGF domain of L-selectin completely abolishes its adhesive 
function. This observation was interpreted to mean that the EGF domain is critical to 
the proper configuration of the lectin domain and hence its function,  without being 
directly involved in ligand recognition. The adhesive function of L-selectin was  
found to be variably dependent on the CR domains [147].  
It has also been shown that the cytoplasmic domain can regulate L-selectin shedding 
[148], and, through interactions with the protein calmodulin (CaM),  can induce a 
conformational change in the extracellular domain that renders the cleavage site 
resistant to proteolysis [138].   
1.2.5.2  Function and Regulation of L-Selectin 
L-selectin function is regulated by a variety of mechanisms including gene 
transcription, post-translational modifications, and modifications of the L-selectin 
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topographic distribution by increasing or decreasing its availability at the cell surface 
[52].  Most of this information is derived from observations of vascular endothelial-
leukocyte interactions. L-selectin is involved in the process of lymphocyte 
recirculation as well as in the migration of neutrophils and lymphocytes into inflamed 
tissues. Both up and down regulation of leukocyte L-selectin varies between different 
leukocyte sites and may be influenced by hormonal, cytokine, electrolyte or structural 
factors [144]. Given the recent hypothesized parallel between the steps involved in 
the human blastocyst implantation process of  embryo-endometrial apposition, 
attachment and  invasion, and the leukocyte extravasation process: rolling/adhesion 
and invasion of the vascular endothelium [142] it is instructive to review in detail  the 
knowledge base regarding these interactions. Figure 9 shows the sequential steps 
involved in leukocyte extravasion through the vascular endothelium, with the 
multiple molecular interactions that have been shown to occur.  
 
 
Figure 9:  Sequential steps involved in leukocyte extravasation through                   
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The recruitment of leukocytes from the flowing bloodstream is a rapid process. L-
selectin is constitutively expressed on leukocytes, so the initiation or activation of the 
leukocyte-endothelial contacts is directed by the regulated appearance of its ligands 
(See section 1.2.5.5).   
Following leukocyte activation, interactions between L-selectin and its ligands result 
in the capture or initial “tethering” of the neutrophil, and rolling along the blood 
vessel wall due to the coordinated formation and breakage of  selectin-carbohydrate 
bonds [149].    L-selectin molecules are rapidly redistributed to form a cap at one end 
of the cell membrane during the rolling.   During these events, L-selectin is shed due 
in part to metalloprotease activity which results in rapid accumulation of bioactive L-
selectin in the blood [55].  Autoproteolysis of L-selectin can occur after exposure to 
various inflammatory mediators such as TNF-α, or lipopolysaccharide (an endotoxin) 
but it may also occur from normal rolling interactions with the vessel wall. Since 
metalloprotease inhibitors significantly reduce rolling velocity and cleavage of  L-
selectin, Walchek, et al. suggest that L-selectin is routinely shed from neutrophils 
under normal non-pathalogic conditions [150]. The dynamics of L-selectin rolling 
and shedding are discussed more fully in sections 1.2.5.3 and 1.2.5.4.  
 Cytoplasmic domains of bound and activated L-selectin and its ligand, PSGL-1 are 
linked to signal transduction pathways that lead to integrin activation [151].  
Chemokines induce the high affinity conformation of leukocyte integrins that bind to 
the integrin receptors,  ICAM-1 (CD54) and  VCAM-1.  Upon firm adhesion, 
mediated by the integrin-ligand interactions, the endothelial cells develop a 3-
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dimensional docking structure that prevents the detachment of the adhered leukocyte, 
allowing it to proceed to diapedesis (extravasation).   
Much is known about factors that down regulate L-selectin expression but less is 
known of factors that increase its expression and synthesis [144].  Steroids, such as 
dexamethasone or methylprednisone, modulate inflammation through effects on L-
selectin expression. Methylprednisone decreases the expression of L-selectin in 
circulating neutrophils [152].    Dexamethasone decreases the number of circulating 
leukocytes expressing L-selectin in animals [153]. Several studies have demonstrated 
that in vivo administration of dexamethasone caused nearly complete downregulation 
of  L-selectin on blood neutrophils [154, 155].  DeCoupade has shown that Annexin 1 
(ANXA1), a calcium binding protein which is upregulated by glucocorticoids, 
mediates some of their anti-inflammatory properties through L-selectin shedding 
[156].  Data obtained in this study using the immortalized monocytic cell line, U 937,  
have shown that, following dexamethasone treatment, endogenous ANXA1 translated 
on the membrane,  co-localized with L-selectin and possibly contributed to its 
shedding through protein/protein interaction [156].  Soluble L-selectin (sL-selectin), 
that which has been shed from the cell membrane, often retains functional activity, 
and may inhibit L-selectin mediated leukocyte binding to endothelium in-vivo [157].    
During the course of an inflammatory response, the cytokine TNF- α triggers 
leukocytes to increase expression levels of L-selectin [158].  Non-Steroidal anti-
inflammatory drugs (NSAID’s) such as aspirin, indomethacin, diclofenac and 
ketoprofen inhibit neutrophil adhesion to TNF-α activated endothelium in-vitro under 
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non-static conditions, down regulate leukocyte      L-selectin surface expression, and 
cause shedding [159].  As noted earlier (section 1.2.2 ),  TNF-α  is not considered to 
be a significant mediator in the implantation process, but is suspected to contribute to 
aetiology of many unexplained reproductive failures [160].  Thus, the role of TNF- α 
in the regulation L-selectin in the reproductive system may not be comparable to its 
role in the leukocyte adhesion process.  
Interferon- α, a cytokine with multiple postulated mechanisms that is used as anti-
tumor therapy in several diseases, upregulates L-selectin in lymphocytes, an effect 
which is partly dependent on inducing production of L-selectin mRNA [161].  
Though early investigations focused on L-selectin expression under conditions of 
stasis, it has also been shown that hydrodynamic shear forces (fluid flow) alone can 
increase expression of L-selectin [162].  This very important effect could also be a 
mediator in the upregulation of L-selectin on trophoblast cells.   
1.2.5.3 Effect of Fluid Flow on L-selectin Expression and Function 
It has been demonstrated that the capture of leukocytes and subsequent rolling 
requires critical thresholds of shear stresses to occur [162-165]. This effect is not 
shared by the other selectins, but is unique to L-selectin. Furthermore, it appears to be 
an intrinsic property of the L-selectin molecule, as this dependence has been shown in 
cell-free immobilized L-selectin interacting with cell based or bead-immobilized L-
selectin ligands [166, 167].  This effect is felt to be biologically important. Since L-
selectin is constitutively expressed on blood neutrophils, shear threshold requirement 
may prevent inappropriate interactions with the blood vessel walls. [162].  The 
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threshold shear stress range required to support rolling and attachment has been 
quantified at 0.4 to 1.9 dynes/cm2 [166, 168].   The rolling velocity can be controlled 
by two different mechanisms: intrinsic bond kinetics and the mechanical properties of 
the selectin-ligand bond [163].  Tethering is another feature that may occur as a result 
of interactions between selectins (or selectin ligands) with cytoskeletal proteins [139].  
L-selectin mediated leukocyte rolling has been shown to be regulated by the 
cytoplasmic domain of L-selectin [167].  L-selectin is constitutively associated with 
the actin-binding protein,   α-actinin [169] as well as with the regulatory cytoplasmic 
protein calmodulin [170]. Shortening or truncation of the 11 amino acid carboxyl 
terminal of the L-selectin cytoplasmic tail as well as disruption of the actin 
cytoskeleton led to the disruption of  L-selectin association with α -actinin and 
abolished L-selectin rolling on inflamed venules under physiological shear flow, 
without altering carbohydrate recognition by the selectin [147]. These observations 
support the hypothesis that cytoskeletal anchorage of the L-selectin molecule reduces 
the sensitivity of its dissociation rate to increasing shear forces, a critical feature for 
mediating leukocyte rolling under physiological shear stresses [167].   
In the presence of fluid flow, L-selectin has further been demonstrated to spatially 
redistribute, forming a “cap” or polarity of expression in the neutrophil membrane 
[171]. This group demonstrated that the capping of L-selectin, and PSGL-1, an L-
selectin ligand, is facilitated by fluid shear, and dependant on MAPK (Mitogen 
Activated Protein Kinase) regulated membrane transport processes. They proposed 
that recruitment and assembly occur within membrane rafts [172] which are 
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microdomains within the cell membrane that have recently attracted attention, as they 
can serve as platforms for signaling processes. The capping of the L-selectin in 
neutrophils is thought to provide an important role in the mechanics of adhesion 
while the cells are in a flow environment. In particular, L-selectin binding and 
clustering at a single site of membrane contact involving few microvilli provides for 
local and rapid recruitment of activated  β2- integrin and efficient conversion from 
neutrophil rolling to arrest in shear flow [171].   This same effect is not seen under 
static conditions, where L-selectin remains homogeneously distributed throughout the 
neutrophil cell membrane.  
 The effect of fluid flow on trophoblast L-selectin expression has not been previously 
described. The embryo does not have a self propelling mechanism (e.g., cilia or 
flagella), thus it is passively transported by intra-uterine fluid.  Fluid movements in 
the uterus may be induced by ciliary activity, myometrial contractions and mucin 
secretions by the endometrium [141].  Cilia-mediated flow has been shown to provide 
directional flow in the oviduct [173-175]. Accordingly, the characteristics of intra-
uterine fluid flow pattern in the uterus play an important role in the process of embryo 
transport to the implantation site [176], but whether or not this affects the expression 
of L-selectin remains to be determined.  
 
1.2.5.4  L-Selectin Shedding  
 
L-selectin shedding, i.e. cleavage of its ectodomain, plays an important role in the 
attachment of neutrophils to the endothelial cells of the capillary venules.  While 
neutrophil capture is mediated by L-selectin sulfated carbohydrate side chains, 
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breaking the bonds is generally thought to be achieved by proteolytic cleavage of the 
L-selectin ectodomain from the leukocyte surface. The soluble cleavage product has 
retained activity and can inhibit lymphocyte attachment to endothelium [157]. 
Cleavage of the molecule occurs in a region that links the consensus repeats with the 
transmembrane domain (see figure 3) [177] thereby generating a 62-110 kDa soluble 
and a 6 kDa transmembrane cleavage product depending on cell type and 
glycosylation state [177-179]. 
There are several metalloproteases known to function as sheddases, among them 
metalloprotease 17 (ADAM17, TACE) [180-182].  Inhibition of L-selectin shedding 
in neutrophils can occur through synthetic hydroxamic acid-based inhibitors of 
MMPs, such as Ro 31-9790 and TIMP-3 [183]. L-selectin has been shown to shed in 
the presence of high flow (high shear stresses) in neutrophils [171]. L-selectin 
shedding is also an anti-inflammatory mechanism in neutrophils to downregulate the 
molecule from the leukocyte surface. In the U-937 monocytic leukemia cell line, 
which constitutively overexpresses L-selectin, shedding can be induced by the 
glucocorticoid, dexamethasone [156]. DeCoupade demonstrated that the L-selectin 
shedding is mediated by  annexin 1, a protein which binds calcium and phospholipids 
and is abundantly found in granulocytes and monocytes [156].   Currently, little is 
understood about L-selectin shedding in trophoblasts.  However, equilibrium between 
L-selectin expression and shedding may influence primary attachment strength of the 
blastocyst to the endometrium.    
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1.2.5.5. L-Selectin Ligands  
Successful implantation is thought to depend on the initial interaction of the L-
selectin expressing trophoblast, , and the uterine endometrium, which expresses 
oligosaccharide-based selectin  ligands [184]. Thus, receptivity of the uterus may be 
critically influenced by the expression of L-selectin ligands. As with L-selectin, the 
discovery and characterization of the chemical and functional aspects of L-selectin 
ligands occurred within the realm of the vasculature, in particular, lymphocyte 
homing to secondary lymphoid organs. Early studies demonstrated that L-selectin 
recognizes a carbohydrate-based determinant, with an essential sialic acid moity 
[185].   These determinants are O-linked oligosaccharide side chains in a certain 
spatial conformation that seems to be an important feature for L-selectin ligand 
binding, and they  typically contain terminal components that include α2,3-linked 
sialic acid and α1,3-linked fucose, typified by the sialyl Lewis x (sLe
x
) determinant 
[139]. The dependence of L-selectin binding on sulfation of the ligand was first 
established by Imai in 1993 through the use of the metabolic inhibitors of sulfation: 
chlorate and brefeldin [186].  Subsequently, the recognition of the L-selectin ligands 
by MECA 79 antibody was shown to be sulfation dependent [187].   MECA-79 is an 
antibody which recognizes the  sulfated sialyl Lewis X (sLe
x
) epitope present in the 
ligands to which L-selectin binds. The structure of the sialyl Lewis x tetrasaccharide 
is shown in figure 10, with sites of sulfation [188].  
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Figure 10: Sulfated forms of Sialyl Lewis x Tetrasaccharide[188] 
 
MECA 79 has been shown to react with glycoproteins of several molecular weights. 
In human tonsil lysates, MECA 79 reactive proteins were seen at  MW 65, 105, 160 
and 200 kDa.[189].  In Peripheral lymph node HEV, seven major species were found 
to be reactive with MECA 79 in western blots, under both reducing and non-reducing 
conditions.  These were located at molecular weights of  200, 170, 115, 90, 75, ~60 
and 50 kDa [190].  The specific identification of these proteins remains to be fully 
elucidated, however, it has been proposed that the band at 160 may represent 
podocalyxin [185], the bands at 115, 105 and 90 may correspond to specific 
glycoforms of CD34 [185, 191, 192] the band at ~60 kDa may correspond to a subset 
of MadCAM-1 [187] and the band at 50 kDa may represent GlyCAM-1 [187, 192].  
The band at ~60 kDa was not expressed strongly, and this is thought to be due to its 
being obscured by stronger binding of MECA 79 to GlyCAM -1 at 50 kDa [187]. 
 
  45  
Sulfation is a post translational modification, requiring the mediation of 
sulfotransferase enzymes.  A major class of sulfotransferases which are involved in 
the post translational modification (sulfation) of L-selectin ligands is the 
“GlyNAc6ST” family which functions through 6-O- sulfation of N-Acetyl 
Glucosamine (GlyNAc) residues in glycoprotein bound oligosaccharides [193].           
This class of sulfotransferases  can be divided into two groups: those with broad 
distributions, and those with restricted distributions. Examples of the first group 
include:  N-acetylglucosamine (GlyNAc)- 6-O-sulfotransferase-1 (GlyNAc6ST-1) 
[194] which has been found in the bone marrow, peripheral blood leukocytes, spleen 
brain, spinal cord, ovary and placenta  [195] and GlyNAc6ST-4 which has been  
identified in the heart, spleen and ovary [193]. Examples of the latter group include: 
High Endothelial Cell-N-acetylglucosamine-6-Sulfotransferase (HEC-GlcNAc6ST ) 
found in High Endothelial Venules [196], I- GlyNAc6ST which  is preferentially 
expressed in the intestine [197], and  C-GlyNAc6ST which was named due to its 
exclusive expression in the cornea [198].  The essential nature of sulfotransferase 
enzymes was demonstrated by Uchimura whose group showed that a major class of 
L-selectin ligands is eliminated in mice deficient in GlyNAc6ST-1 and           
GlyNAc6ST-2 [199]. 
L-selectin interacts with several counter-receptors, and five have been well 
characterized:   Gly-CAM-1 (glycosylation-dependent cell adhesion molecule-1),         
a secreted molecule lacking transmembrane domain [140, 200],  CD-34 (a type I 
transmembrane glycoprotein) [201],  MadCAM-1  (mucosal addressin cell adhesion 
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molecule-1) which includes a mucin domain and Ig-like domains [190],  PSGL-1 (P-
selectin glycoprotein ligand-1) [202] and  podocalyxin [191].   
GlyCAM-1 (Sgp50) is a highly glycosylated serine and threonine rich protein, with a 
molecular weight of ~50 kDa.  Structural analyses of GlyCAM-1 have revealed that 
~70% of the MW of this glycoprotein is due to the carbohydrate component. 
GlyCAM-1 has been identified in lymphoid high endothelial venules, and in lactating 
mammary glands, where it is expressed in a hormone dependant manner [203].  
Additionally, this ligand contains no transmembrane domain, and  functions as a 
result of secretion directly into the blood [204]. It consists of a mucin–like scaffold, 
that presents a carbohydrate ligand(s) to the lectin domain of L-selectin [140, 205].  
As a result of a study focused on the regulation of murine GlyCAM-1 in response to 
an inflammatory stimulus, it was suggested that released plasma GlyCAM-1 may 
trap, at least in part, L-selectin shed from stimulated leukocytes and neutralize it. 
Furthermore, these results suggested that upregulation of GlyCAM-1 may be initiated 
by the inflammatory cytokine IL-6 [204].   
CD34, originally termed Sgp90,  is a sialomucin-like glycoprotein which contains a 
transmembrane domain, and has been shown to be stably associated with the cell 
surface. [201].  The molecular weight of CD34, a heavily glycosylated protein,  is 
~116 kDa.  As with GlyCAM-1, CD34 was originally detected in high endothelial 
venules (HEV) of peripheral lymph nodes (PLN), but its expression in human tissue 
is more extensive than GlyCAM-1.  CD34 is expressed in non-lymphoid sites in the 
vasculature, where it is involved in L-selectin mediated leukocyte rolling and has 
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long been a surface marker for the purification of pluripotent stem cells for bone 
marrow transplantations [201].  For high endothelial venules (HEV) CD34 serves as  
a ligand for L-selectin, whereas CD34 is not the ligand for L-selectin in 
hematopoietic stem/progenitor cells (HSPCs) and in fact, ligands for hematopoietic 
CD34 remain to be identified [206]  It has also been detected in capillaries of the 
human brain [207].  Two glycoforms of CD34 have been identified in both murine 
and human cells: a full length form and a truncated form. Their structures consist of 
identical extracellular regions, and differ only in their intracellular cytoplasmic 
domains [208]. The significance of this differentiation has not yet been established.  
The role of CD34 in the process of human implantation has not been explored to any 
significant extent. It is known that CD34 knockout mice have no detectable 
abnormality in leukocyte trafficking are viable and able to reproduce [208].    In 
2002,  Zhang, et al published the findings of a comprehensive study characterizing 
uterine endothelial cells throughout the menstrual cycle  for several protein 
biomarkers thought to be involved in the normal function of the human endometrium, 
including CD34 [209].  There appeared to be an upregulation of CD34 in the 
secretory phase of the menstrual cycle.   Though strong staining for CD34 was 
observed on small vessels and capillaries in the endometrium, as expected, an 
unexpected finding was the particularly strong staining seen in the stroma around the 
glands [209].  Since this work was performed before the discovery of the involvement 
of the L-selectin adhesion system in the process of implantation, the role of CD34 
was only examined with regard to its association with menstrual disorders. However, 
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given the unexpected finding in this study, it would be interesting to explore the 
temporal regulation of CD34 expression on the uterine epithelium.  
Podocalyxin (also called podocalyxin-like protein-1 or PCLP-1) is a protein that is 
expressed at high levels by podocytes (cells of the visceral epithelium in the kidneys), 
vascular endothelia, platelets and haemopoietic stem cells. It is a transmembrane 
mucin-like protein that possesses a structure very similar to CD34 and endoglycan.  
This protein, with a MW of 150-165 kDa  consists of a mucin domain, a disulfide 
bonded globular domain, a transmembrane region and a highly charged cytoplasmic 
tail with potential phosphorylation sites for protein kinase C and casein kinase II 
[210]. It has been shown to be an adhesive ligand for L-selectin expressed by 
leukocytes, one of its major roles in the body [201]. Based on a number of studies, 
however, it has been hypothesized that podocalyxin can also act as an “anti-adhesion” 
molecule, due to its negatively charged mucin domain. [211-213]. Thus, in HEV’s, 
podocalyxin, as well as CD34, is thought to serve two functions.  Initially, these 
ligands provide tethers for L-selectin expressing leukocytes, and later, they have been 
observed to relocate, in response to cell activation, to cell junctions and act to 
“spread”   the endothelial cells to facilitate leukocyte leukocyte transmigration. [210].  
Little is known of the role of potential in the process of human implantation. Weak 
immunostaining for  podocalyxin has been reported in the endometrial endothelium 
during the mid-secretory phase, and this has been associated with the selective 
recruitment of peripheral blood natural killer (NK) cells to the human endometrium as 
a normal function in the menstrual cycle. [214].  
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P-selectin glycoprotein ligand-1 (PSGL-1) is a dimeric mucin-like 120-kDa 
glycoprotein composed of 412 amino acids.    This glycoprotein, despite its name, 
may serve as a ligand for all three selectins.  PSGL-1 is a cell associated ligand,  with 
an extracellular domain (consisting of two subunits), a transmembrane domain, and a 
cytoplasmic domain [215].   Each subunit of the extracellular domain contains 70 
serine and threonine residues, which are potential sites for O-Glycosylation, as well 
as three potential sites for N-Glycosylation [215]. It has been shown that dimerization 
of the subunits (though not necessarily through covalent bonding) is essential for its 
high affinity binding to P-Selectin [215].  PSGL-1 displays appropriate sialyl Lewis x  
carbohydrate determinants required for L-selectin recognition [216].  The role of 
PSGL-1 as a ligand for P-Selectin has been widely studied [215, 217-219]. The role 
of PSGL-1 as an L-selectin ligand has been recognized more recently.  As such, it has 
been well characterized in its role in increasing leukocyte recruitment to 
inflammatory sites by mediating neutrophil attachment to adherent neutrophils [220, 
221].  During this process, activated neutrophils will shed their L-selectin, however, 
they will retain the PSGL-1 ligand [221].  
The three selectin cellular adhesion proteins each have distinct requirements for 
PSGL-1 ligand sulfation.  PSGL-1 contains  tyrosine sulfate and sulfated 
carbohydrate binding sites. Binding of PSGL-1 to both L-selectin and P-Selectin  is 
dependent on tyrosine sulfation of amino terminal residues 46, 48, and 51 and on α 
1,3 fucosylation of core-2 O-Glycans attached to Thr-57 [222, 223].  The binding of 
E-Selectin however, does not require tyrosine sulfate residues [222, 224].  Kanamori, 
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et al demonstrated that under shear flow, selectin mediated leukocyte rolling was 
highly influenced the specific binding sites. Whereas L-selectin “prefers” 
carbohydrate 6-sulfation much more than tyrosine sulfation, P-Selectin favors 
tyrosine sulfation in the PSGL-1 molecule [225].  
PSGL-1 expression has been shown to be regulated by granulocyte colony 
stimulating factor (G-CSF), dexamethasone, and Endotoxin [226, 227]. Endotoxin is 
a heat-stable polysaccharide like toxin bound to a bacterial cell membrane. It is 
responsible for many of the virulent effects of gram-negative bacteria. In healthy 
human volunteers, leukocyte activation by endotoxin challenge decreased the surface 
expression of PSGL-1 on monocytes and neutrophils and increased the level of 
soluble PSGL-1 (sPSGL-1) in plasma [227].  
In vitro, neutrophils rapidly down-regulated  PSGL-1 expression upon exposure to G-
CSF as well as dexamethasone, and induced  shedding of soluble PSGL-1. This 
finding supports the concept that the mechanism for down regulation of PSGL-1 is 
proteolytic cleavage [226]. As with the known effect of dexamethasone on L-selectin 
shedding [156], this effect may have implications with regard to the functioning of 
the L-selectin adhesion system in implantation, should PSGL-1 be identified as a 
specific L-selectin ligand in the uterine epithelium.  
Mucosal vascular addressin cellular adhesion molecule-1 (MadCAM-1) is a cell 
surface mucosal endothelial adhesion molecule with immunoglobin and mucin-like 
domains. [190].  It was first described in 1988 as “a tissue-specific endothelial cell 
molecule involved in lymphocyte homing” [228].  It has been identified on high 
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endothelial venules (HEV) of Peyer’s Patches, as well as the appendix, and 
mesenteric lymph nodes [228, 229]. MadCAM-1 is broadly expressed in the human 
embryo, starting from around week 7, and it gradually becomes localized to the 
mucosal vessels after birth  [230]. MadCAM-1 has also been found to be expressed 
outside the endothelial cell lineage on fibroblasts and melanoma cells [231] as well as 
(weakly) in the brain and pancreas [229].  Animal model studies have shown 
MadCAM-1 to be present in the genital mucosa during chlamydial infection [232].    
Generally, this molecule is expressed as a 55-66 kDa glycoprotein, however, a 40 
kDa  glycoform is also expressed by vascular endothelium [233].  The structure of 
MadCAM-1 consists of two extracellular amino terminal immunoglobin superfamily 
(IgSF) type domains that possess strong homology to the vascular adhesion receptors 
for leukocytes ICAM-1 (Intercellular Adhesion Molecule-1) and VCAM-1 (Vascular 
Cell Adhesion Molecule-1) [229].  Separating these domains from the cell surface is 
an extended mucin-like region of 115 amino acid residues followed by a 
transmembrane domain, and a 43 residue cytoplasmic domain  [234].   MadCAM-1 is 
post-translationally modified with extensive O-linked glycosylation [235].  Structural 
studies with synthetically glycosylated MadCAM-1 have suggested that the 
glycosylation can contribute to conformational aspect of the protein, which can effect 
its stability and chemoenzymatic reactivity [236].  
MadCAM-1 binds both the integrin α4β7, through its IgSF domains, as well as                    
L-selectin, through its O-glycosylated mucin like region [234].  As such, it plays a 
role in both the capture and retention of leukocytes.  The interaction of MadCAM -1 
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and α4β7 integrin has been shown to be the key step in lymphocyte homing to gut 
mucosa [237].    In the “adhesion cascade” in Peyer’s Patches, the interactions of 
MadCAM-1 with α4β7 integrin occur after MadCAM-1 interactions with L-selectin, 
and prior to it’s interactions another integrin, αLβ2 [238].  DeChâteau’s group also 
studied the kinetic and mechanical properties of cell-substrate tether bonds in a shear 
flow environment with a  focus on MadCAM-1 interactions with L-selectin and α4β7.  
“Stable” tethering was defined as the binding of cells in flow to substrates that was 
followed by rolling or firm adhesion that lasted for >3 seconds (s).  They discovered 
that stable tethering to MadCAM-1 was at a maximum under shear flow of 2 
dynes/cm2 or less, that the MadCAM-1-L-selectin bonds were slightly stronger and 
more stable than the MadCAM-1-integrin associations and that the rate of  bond 
dissociation per second (koffo (s-1)) was  greater for L-selectin interactions than  α4β7 
integrin interactions. This was explained by the fact that mechanically stable bonds 
are most important in early adhesive cascades, because a greater number of  receptor-
ligand bonds accumulate later in the adhesion cascade, and as such, the hydrodynamic 
shear force experienced by the cell is distributed over a larger number of bonds, 
therefore to be effective they may be less mechanically stable [238].  
The regulation of MadCAM-1 expression has been studied, particularly with a focus 
on treatments for acute and chronic inflammatory conditions of the intestine, such as 
Crohn’s Disease and ulcerative colitis [239, 240].   MadCAM-1 has been shown to be 
up-regulated in murine lymph node endothelium by the inflammatory cytokine, TNF-
α, [241] and inhibited by dexamethasone treatment [242]. The up-regulation by TNF-
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α is also blocked by IL-10 [242], and interferon-γ (IFN- γ) [241].  MadCAM-1 
expression has not been characterized with respect to the uterine epithelium, where it 
would likely be involved in the process of implantation, but in a recent study of the 
temporal expression of L-selectin ligands in the human endometrium, MadCAM-1 
was observed throughout the secretory phase, with the strongest staining seen in the 
late secretory phase [214]. This was associated with selective recruitment of natural 
killer (NK) cells to the endometrium as a normal function in the menstrual cycle.  
1.2.6 Summary: Molecular Aspects of Implantation 
The molecular aspects of human implantation are obviously very complex, and are 
likely to involve synchronized cross-communication between a receptive uterine 
endometrium and  an implantation competent blastocyst.  This process involves the 
hormonal  regulation of numerous proteins and signaling pathways. Many “markers 
of uterine receptivity”, that is, those which are present during the window of 
implantation, have been identified.  The major factors that indicate uterine receptivity 
are the ovarian steroids, progesterone and/or estrogens. Progesterone, which is the 
dominant sex hormone in the secretory phase of the menstrual cycle, upregulates 
other hormones such as calcitonin and prolactin.  Calcitonin mRNA was found to be 
expressed in the uterine mucosa during the mid-secretory phase of the menstrual 
cycle, with maximal expression occurring between days 19–21, which coincides with 
the implantation window. Calcitonin gene expression in human endometrium is 
induced by progesterone.   The coordinated temporal pattern of expression of 
endometrial prolactin  (e-PRL) and PRL-R in non-pregnant and pregnant 
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endometrium suggests that e-PRL may have an important role in the process of 
implantation and maintenance of pregnancy [45].     
The expression of various growth factors and their receptors in the uterus in a 
temporal and cell specific manner during the pre-implantation period suggests that 
these factors are also important for implantation [24].  Two important growth factors 
that are considered markers of receptivity are: heparin binding epidermal growth 
factor (HB-EGF) and transforming growth factor- β (TGFβ).   
Cytokines, normally play a major role in reparative and inflammatory-like processes 
which occur in the human endometrium every menstrual cycle, but they are also 
implicated in critical reproductive events such as ovulation and implantation [52]. 
The cytokines which have been identified as important to the implantation process, 
interleukin-1 (IL-1), and its receptors, IL-1R 1 and IL-1R 2, the  IL-6 family of 
cytokines which includes IL-6,  IL-11, and leukemia inhibitory factor (LIF), Colony 
Stimulating Factor- 1 (CSF-1) and the related protein, GM- CSF.   IL-1R 1 expression 
in the uterus may up-regulate the expression of αvβ3 integrins, IL-6 and LIF in the 
uterine epithelium. CSF-1 has been shown to be expressed by endometrial epithelial 
and stromal cells and by trophoblast cells, while its receptor, c-fms, is expressed on 
the embryo and placenta.  These processes are illustrated in figure 3.  
One of the first known hormonal signals of the embryo during implantation is human 
Chorionic Gonadotrophin (hCG), which has a dual role in the reproductive process. 
Its secretion begins no later than day 7 in the blastocyst stage which suggests a 
paracrine role of this hormone during the first steps of implantation.  Additionally, its 
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classical endocrine role is in rescuing the maternal corpus luteum at the onset of 
pregnancy [41].   
The initial mechanical interaction between the blastocyst and the uterine endometrial 
tissue, termed apposition, is thought to be mediated by the cellular adhesion protein 
L-selectin and it’s MECA-79 reactive ligands, which may include CD34, 
podocalyxin, GlyCAM-1 and MadCAM-1.  Fisher et al. demonstrated the presence of 
L-selectin on the blastocyst, as well as a significant upregulation of the expression of 
the sulfated oligosaccharides that function as high-affinity counter-receptors for L-
selectin on human uterine luminal and glandular epithelium during the window of 
receptivity [141]. L-selectin ligands are upregulated in the endometrium during the 
luteal phase coinciding with the high expression of L-selectin on trophoblastic cells.   
Finally, integrins, another classification of cellular adhesion molecules,  are thought 
to play a significant role in implantation. Several integrins, undergo cycle dependent 
expression during the menstrual cycle, and are therefore considered to be important as 
markers of receptivity.  In particular, the integrins which have been detected around 
the window of implantation are: α2β1, α4β1, and  ανβ3..   These integrins are receptors 
for collagen, fibronectin and vitronectin, respectively.   
With the discovery of the presence of the L-selectin on the human blastocyst and its 
ligands in the uterine epithelium at the time of implantation, parallel mechanisms, 
both mechanical and molecular,  have been suggested for the process of leukocyte 
rolling, attachment and  extravasation and the three stage process of implantation: 
apposition, attachment and invasion. The process of leukocyte extravasation is 
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                           Figure 11: Proposed molecular mechanism  of implantation 
A) Progesterone and estrogen  mediated  up-regulation of  other hormones,  
growth factors,  L-selectin and its ligands, and  primary attachment elicited 
through L-selectin mediated “tethering” of the blastocyst to the uterine 
epithelium, followed by signaling cascades of molecules (cytokines, 
MAPK’s) 
B) Integrin-ligand interactions facilitate stronger adhesion through secondary 
attachment mechanisms  




1.3  Attachment Strength Measurements   
Though the attachment strength values of the primary and secondary mechanisms 
have not been quantified in the blastocyst/uterine epithelial environment, the 
A B C 
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neutrophil/vascular endothelial system has been.  Approaches to attachment strength 
measurements vary considerably, depending on the cell-substrate system being 
characterized, the type of information desired, (quantitative or qualitative, etc), and 
the range of attachment strengths that are being measured. In vitro cell adhesion 
assays can be classified into static or dynamic models. Multiple examples exist in 
both categories, but those discussed in detail here are specifically applicable to the 
elucidation of adhesive interactions between L-selectin and its ligands, as well as 
integrin-mediated  adhesion processes. 
One of the simplest and most commonly used assays is the “static cell adhesion test” 
[243].   It consists of seeding a known number of  cells onto appropriately prepared 
substrates, incubating in a static environment for a specified period of time,  
removing non-adherent cells by washing with physiological buffers,  and quantifying 
the remaining adherent cells, through counting of a statistically significant sample 
[244-247].  The relative adhesion is determined as a percentage of the initial (seed) 
cell count.  This approach provides qualitative observation of cell-substrate 
interactions, but it is neither quantitative nor reproducible because the cells are 
exposed to uneven, unknown detachment forces [248]. Additionally, the requirement 
of physically counting the attached cells is cumbersome, time consuming, vulnerable 
to human error, and makes the assumption that all of the cells that adhered to the 
substrate were viable at the time of the experiment.  Modifications have been made to 
this assay have attempted to address some of these disadvantages.  For example, cells 
may be pre-labeled with a radioactive marker.  Following the incubation and removal 
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of non-adherent cells, the remaining cells are lysed. The percentage of adherent cells 
is inferred based on the relative radioactivity of the adherent cell lysate to the initial 
cell suspension, with each adjusted for background counts [249].  While this approach 
removes the requirement of physically counting the cells, the radioactive tag is 
typically expensive, and hazardous.  Since the radioactive material is metabolized 
into the cell, it does not give an accurate representation of cell-cell interactions [250].  
Alternatively, cells may be labeled with a fluorescent tag, and quantified by 
measuring the residual fluorescence intensity of the adhered cells with a fluorescent 
plate reader. Presently, many commercial static adhesion assay kits are available 
which offer molecular markers that can be chemically tailored to target many types of 
cell-cell interactions.  Most are based on the principle of quantifying the viable bound 
cells through fluorescence, or colorimetric  intensity,  generated through an enzymatic 
reaction with fluorogenic reagents or other organic chemicals which, upon 
undergoing an enzymatic reaction, form visibly colored by-products.   
Two main classes of fluorogenic reagents are generally used: the substrates of 
cytosolic (cytosol is the internal fluid of the cell, where a large part of cell 
metabolism occurs) esterases consist of a fluorochrome group esterified with an 
organic acid. (Ex. Calcein acetoxymethylester (Calcein-AM) and                                        
6 - Carboxyfluorescein diacetate  (6 CDFA) [250].  The substrates for alkaline and 
acid phosphatase, include 2-(5'-chloro-2'- phosphoryloxyphenyl)-6-chloro-4-(3H)-
quinazolinone (CPPCQ) [251] and 5-methylumbelliferyl-phosphate (MUP) [252].   
They contain a phosphate residue with an attached fluorogenic moity. The somewhat 
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lipophilic character of both groups of reagents allows for the selective passage of 
these reagents through the cell membrane of viable cells. Immediately afterward, they 
are hydrolyzed by intracellular enzymes, producing the hydrophilic, fluorescent 
reaction product. This remains within the cytoplasm and the cell now becomes 
detectable by measurement of a fluorescent signal that directly correlates with the cell 
number [253].  
Colored enzymatic reactions are generated by mitochondrial dehydrogenases, acid 
phosphatase, hexoamidase or NADPH oxidase [253]. One of the first methods for the 
measurement of cell-matrix adhesion in 96 micro-well plates utilized the reduction of 
a tetrazolium salt (for example:  3-(4,5 dimethylthiazole-2-yl)-2,5-
diphenyltetrazolium bromide or MTT) by mitochondrial dehydrogenases to colored 
formazan products [254].  MTT is converted into a blue reaction product which can 
be spectrometrically quantified by absorbance at 550 nm. The formazan product 
however,  is insoluble and requires extraction prior to measurement. The colorimetric 
determination of cell-matrix adhesion can also be made through phosphatase or 
hexosamidase dependent reactions [253].  
This approach to elucidating cellular adhesion characteristics can provide excellent 
insight into the relative adhesion strengths and adhesive regulatory mechanisms of 
cells to varied substrates, but truly quantitative information, is not possible. 
Quantitative detachment methods can be classified according to the type of force 
applied. Several categories exist: micromanipulation, centrifugation, and 
hydrodynamic shear force [248]. Micromanipulation quantifies adhesive forces 
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between a single cell, attached to a micropipette, and a (functionalized) surface or 
another cell. After a period of incubation, the cell is detached by pulling away the 
micropipette with a known applied force [255]. The forces applied with this method 
result in high local stresses, which are difficult to quantify, and are not necessarily 
representative of physiological environments, where cells are more often exposed to 
shear than normal forces [248].   Atomic Force Microscopy (AFM) is also used for 
characterizing the adhesive interactions of a single cell. This technique can provide 
very sensitive real-time force displacement measurements, but requires specialized, 
calibrated equipment, is a skill and time intensive technique [256].  AFM is well 
suited, however, to protein engineering, i.e. making dynamic measurements, 
including adhesive interactions and configurational changes, at the single molecule 
level [257]. 
Centrifugation adhesion assays are simpler by comparison, require only standard 
laboratory equipment (centrifuge) and allow the study of  large cell populations.  This 
assay was initially described in 1981[258]. A substrate containing adherent cells is 
spun at a known speed, applying controlled detachment forces (<10-3 dynes/cell) 
perpendicular to the cell adhesive area [256]. Only a single force can be applied per 
experiment, thus multiple runs at different speeds are needed to obtain mean adhesion 
strength values, typically defined as the centrifugal force that results in 50% 
detachment [256].  This assay has been applied  to the study of  mechanisms of 
implantation using the BeWo (cytotrophoblast) cell line, or freshly isolated murine 
blastocysts, co-cultured with the RL95 endometrial epithelial cell line (EEC) [259].  
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Effects of Ca2++ inhibitors as well as serum in co-culture on embryo attachment, were 
studied, and the authors put forth that the results supported this assay as an “efficient 
measure of embryonic attachment under various experimental conditions”[259].    
While the micromanipulation and centrifugal adhesion assays can provide 
quantitative  information of a cells’ adhesive qualities, in-vitro simulations  in a 
dynamic environment are not possible. For example, the process of leukocyte 
adhesion to the endothelial cell wall is highly influenced by its presence in an 
environment of hydrodynamic shear. Furthermore, the parallels which have been 
noted between this process and that of human blastocyst implantation [142]  have 
introduced the possibility that the initial steps in implantation also include L-selectin-
mediated “tethering” (referred to by Red-Horse et al. as low strength primary 
bonding) of the blastocyst to the wall of the uterus [260]. Thus, static cellular 
adhesion assays, alone, can neither  provide the insight required to completely 
elucidate all mechanisms which  influence the adhesion process, nor can it provide 
quantitative information on mechanical adhesion strengths.  
The differences between cellular adhesive phenomena in a dynamic versus a static 
environment have long been recognized, and adhesion studies which incorporate flow 
(hydrodynamic shear) have been reported since the mid 1900’s [261].  Today, several 
designs exist for the quantification of cellular adhesiveness through the use of 
hydrodynamic flow to produce shear (detachment) forces.  These include the parallel 
disc viscometer [262], radial flow chambers [263], the parallel plate flow apparatus 
[264], and the spinning disc detachment apparatus [248]. 
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Early designs for dynamic cellular adhesion measurements were adapted for use in a 
biological system from instruments developed for mechanical engineering 
applications, such as the parallel disc viscometer [262]. This instrument consisted of 
two parallel discs immersed in a fluid of known viscosity (η, poise), and separated by 
a known distance, (h, cm). From fundamental rheological considerations, Weiss 
modeled the forces involved in the attachment of an erythrocyte to a plasma clot. He 
then mathematically modeled the hydrodynamic shear forces that could  be applied 
with the parallel disc viscometer. When the upper disc rotates with a linear velocity, 
V cm/sec, over a circular strip of width dr cm, and radius r cm, the force acting on the 
strip is given by:     
         (V)(η)(2πr)(dr/h) dynes.      (1) 
Furthermore, if the angular velocity, ω, is defined by:  
                    V/r = ω        (2) 
Then the shear stress is given by : 
           (η) (ω) (r)   dynes/cm2                                               (3) 
            h 
 
Weiss hypothesized that if the bottom disc had cell uniformly dispersed over its 
surface, then, when the upper disc rotated, “a distractive force would be applied to the 
adherent cell which is directly proportional to the distance of that cell from the centre 
of the disc”. [262].  Thus the force would be at a maximum at the peripheral edge of 
the bottom plate, and at a minimum in the center of the plate.   Weiss used this 
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apparatus to demonstrate the temporal changes in adhesion strength of fibroblasts          
to  a glass substrate.  
More recently, a spinning disc cell detachment apparatus has been developed and 
validated by Garcia, which is based on the same design principle, and consists of a 
single bottom plate [248]. The shear forces are generated by the chamber fluid as it 
undergoes laminar flow, in a radial pattern over the disc. As the disc rotates, the fluid 
is drawn in axially from the surroundings, and as it approaches the surface of the  
disc, it acquires a rotational motion which forces it to exit radially [248]. 
In this design, the shear stress, τ, varies linearly with radial distance and is given by:      
  
                               τ = 0.800 r (ρμω3)1/2                                                         (4)  
 
Where ρ = fluid density, μ = fluid viscosity and ω = angular velocity.                                  
The instrument design and flow pattern [265] are shown in figure 12.  
 
 
Figure 12: Schematic of Spinning 
Disc Cell Detachment Apparatus 
(“flow pattern” adapted from [265]) 
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For a given rotational speed, the velocity and temperature of the fluid as well as the 
boundary layer thickness, δ, are constant, when the radius of the fluid chamber,  R,   
is infinite compared to the radius of the spinning disc, r.  The infinite disc 
approximation is valid when   R/ δ > 50.   This design, and in particular the fluid flow 
pattern,  has been validated for rotational speeds of  500 to 2500 RPM through an 
electrochemical technique known as current-voltage (CV) scanning and the 
ferric/ferrocyanide redox couple.   As the DC voltage in the system is varied, the 
transport of ions to the spinning disc was shown to be a diffusion/convection 
dependant process, with the resultant limiting current shown to be proportional to the 
rotational speed of the disc.   
When cells are seeded uniformly on the disc, they will undergo detachment forces 
which are proportional to the radial distance from the center of the disc. The value for 
50% detachment represents the average detachment shear stress for the cell 
population, and is used as the measure for detachment strength.[248]. 
Typical hydrodynamic shear detachment stresses that can be accurately generated 
with the (validated) spinning disc cell detachment apparatus (CDA) range from ~15 
to 350 dynes/cm2 .  The adhesion strengths associated with integrin-ligand 
interactions have been found to be in this range, and several studies have used this 
technique to quantify this adhesion system [248, 266-269].  Other reported 
applications of the spinning disc CDA include: red cell adhesion to Teflon®, glass 
and polyethylene [270],  adhesion of  3T3 cells (immortalized fibroblast cell line from 
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Swiss mouse embryo tissue) to a chemically homologous series of copolymers based 
on hydroxyethylmethacrylate (HEMA) and ethylmethacrylate (EMA) [265].   
The radial flow chamber (RFC) is another dynamic cell detachment technique which 
can generate a spatially dependant range of shear stresses simultaneously. Contrary to 
the spinning disc design, radial flow chambers utilize axisymmetric radial flow to 
produce a shear stress that decreases with increasing radial position [271].  The fluid 
is injected through a central port (usually from the bottom) into a chamber consisting 
of a transparent plate coated with the substrate of interest, and with cells attached. 
The fluid flows radially outward within a small gap, and the shear forces generated 
from the flow are exerted on the attached cells. A typical RFC design is shown in 
figure 13 [272].  
 
                 
Figure 13: Typical design of a Radial Flow Chamber (Adapted from [272]) 
 
  66  
RFC adhesion assays yield a critical radius from which the adhesive force can be 
simply determined [273].  The shear stress, S, at any radius is given by:  
                           S = 3Qμ                                                           (5)  
                                                        πh2 
 
where Q is the volumetric flow rate, μ is the fluid viscosity, and h is the gap in which 
the fluid is flowing.  The critical shear stress, Sc, (detachment strength)  is determined 
from the radius where the cells just begin to remain attached  [271].  However, to 
account for the inherent heterogeneity in adhesion strengths among the attached cell 
populations, some researchers have defined the critical shear stress for detachment, 
τwc, as the wall stress at which 50% of the adherent cells detach [274-276]. This 
design offers the advantage of microscopic observation of the detachment events in 
real time.   One disadvantage with this system, however, is the complexity of the 
hydrodynamic detachment forces at relatively small radial distances from the inlet.  
The assumption of “creeping flow”  (a condition  where the Reynolds number is very 
small, less than 1,  and inertia effects can be ignored in comparison to the viscous 
resistance)  is used to model the generation of detachment forces under laminar flow 
in this system and at this location, this assumption is not valid [277].  The range of 
shear detachment forces that can be generated is similar to the spinning disc CDA, 
~10 to 250 dynes/cm2 [275, 276].  As such, it has been used extensively to 
characterize cell detachment forces related to integrin-ligand adhesion processes [276, 
278, 279].   
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The parallel plate flow cell detachment apparatus has a defined flow profile that 
closely approximates the hydrodynamic features found in the vasculature. As such, it 
is often the cell adhesion assay of choice in immunological studies, in particular when 
simulating inflammatory ailments where leukocytes adhere to endothelium under 
flow conditions. [280].   This apparatus was first employed for leukocyte adhesion 
studies by Laurence over twenty years ago [164].  This apparatus is ideally suited for 
observing and quantifying the process of leukocyte rolling, tethering and attachment 
due to the very low attachment forces which it can generate. Studies with 
functionalized surfaces with induced shear stresses ranging from 0.3 to 35 dynes/cm2 
are the most common [166, 281, 282]. Microscopic experimental observations from 
the top-down, or sometimes, from a side view in real-time are possible, and often 
employed.  However, one disadvantage of this measurement technique, is that it 
allows measurements at only one shear force per experiment. The design and laminar 
flow pattern of a typical parallel plate flow apparatus is shown in figure 14.  
 
  
      Figure 14:  Schematic of a Parallel Plate Flow Chamber, showing laminar flow pattern 
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The configuration shown in figure 13 shows a functionalized bottom surface with 
cells attached, which will be detached under hydrodynamic shear, thus defining a     
cell detachment assay. In another variation of this assay, the cells are perfused in the 
chamber with the fluid, and their rolling and/or  subsequent attachment behavior can 
be observed and quantified, thus defining a cell attachment assay.  In both cases, 
either the bottom or the top plate may be functionalized for the adhesion assay.  
Laminar flow conditions are predicted when the Reynolds number < 2. (In fluid 
mechanics, this is the ratio of inertial forces to viscous forces).  The fluid velocity 
profile, as shown in figure 11 is parabolic. The wall shear stress, τ,  can be calculated 
from the momentum balance for a Newtonian fluid [283], and is given by:  
 
  τ = 3μQ               (6) 
            2a2b 
 
where μ= Coefficient of viscosity, Q = volumetric flow rate, 2a = channel height              
and b = channel width [164]. 
The process of leukocyte adhesion has been well characterized with the parallel plate 
flow apparatus. The surface expression of adhesion molecules such as ICAM-1 [284], 
VCAM-1 [285], E-Selectin [286], P-Selectin [287], L-selectin and PNAd [288], α4β1 
[289] and  PSGL-1 [290] and other L-selectin ligands expressing sialyl Lewis x 
epitope  [291] have all been characterized in this manner. Neutrophils have been 
shown to attach to L-selectin substrates with strengths of 1-3 dynes/cm2 [166].  
Studies in parallel plate flow chambers have allowed the observation and 
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quantification of the time constant of “rachet-like” steps involved in leukocyte rolling 
and tethering on selectin-ligand substrates as well as the estimation of a single bond 
force of 125 pN (pico-Newton) or below for all selectin-ligand bonds[288]. Under 
physiologic flow conditions, L-selectin in the neutrophil membrane has been 
demonstrated to redistribute, forming a “cap” or polarity of expression in the cells 
[171].  This interesting phenomenon was induced and characterized in a parallel plate 
flow chamber.  
Characterization of trophoblast cellular adhesive function or protein expression in a 
flow environment, with a focus on implantation events, has not been reported. 
However, one study has been reported using term human placental cytotrophoblast 
cells (HuPla),  alone and in co-culture with uterine endothelial cells [292]. The 
objective of this work was to elucidate some of the migratory aspects of trophoblast 
cells in the process of homing to the maternal vasculature after implantation, under 
conditions of shear stress, ranging from 1 to 30 dynes/cm2.  The parallel plate flow 
chamber was a critical tool in the discovery that the ability of trophoblasts to migrate 
against flow at physiological levels of shear stress is dependent on the presence of 
endothelial cells indicating that factors expressed on both trophoblast and endothelial 
cells play a role in this process [292].  For similar reasons, it is felt that this apparatus 
could also play a critical in understanding trophoblast/uterine epithelial interactions 
under conditions of hydrodynamic shear stress during implantation.   
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CHAPTER 2. HYPOTHESIS AND OBJECTIVE 
 
 
The ultimate objective of this thesis is to understand the biochemical and mechanical 
mechanisms responsible for the initial events which lead to the successful attachment 
of the blastocyst to the uterine epithelium, for pregnancy. From this insight, we would 
endeavor to develop clinically relevant treatment therapies which could affect the 
necessary conditions to support the formation of human life.  One of the biochemical 
mechanisms that has recently been identified as important in the initial attachment 
process is the L-selectin/L-selectin ligand adhesion system [141]. Furthermore, based 
on what is known about the protein adhesion molecules involved in the implantation 
process,  it has been noted that strong similarities with the leukocyte attachment and 
extravasation process, exist [142], whereby  L-selectin/L-selectin ligands interact to 
form a weak bond primary between the rolling leukocyte and the vascular 
endothelium, which results in the capture of the leukocyte. From this interaction, the 
integrin/ligand system is thought to be activated, mediating the formation of stronger 
bonds through the integrin/ligand adhesion system.  Yet, there is still very little 
understood about this process. In particular, it is not known how the hormonal 
environment mediates the expression of the cell adhesion molecules nor how the 
mechanical aspects of this process, both quantitative and qualitative, affect the 
outcome.   Our overall hypothesis is that the expression and retention of a critical 
level of L-selectin and L-selectin ligands are necessary to facilitate adequate initial 
attachment of the blastocyst to the uterine epithelium.  We specifically hypothesize 
the following:  
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- That the L-selectin adhesion system is modulated by the local environment of 
steroid hormones, cytokines and inflammatory mediators as well as mechanical 
shear forces due to flow.   
- That following the L-selectin mediated (low strength) attachment process, the 
trophectoderm will activate RDG containing adhesion proteins, such as 
fibronectin, vitronectin and fibrinogen which will be responsible for interacting 
with the integrins expressed by the uterine epithelial cells providing a higher 
strength secondary attachment.  
- That the attachment strengths in this system will be comparable to those reported 
for the leukocyte-vascular endothelial system.  
The objective of this project is to understand, and quantify where possible, the 
biochemical and mechanical mechanisms responsible for blastocyst attachment to the 
uterine epithelium, through the use of an optimized cell model, of established 
trophoblast-like and uterine epithelial cell lines. This will be accomplished through 
the following specific steps:  
a) The basal and temporal expression of the L-selectin adhesion system, in the presence 
of steroid hormones, will be quantified through Western Blot analysis, and flow 
cytometry. The specification of the optimized cell model will be based on appropriate 
responses of up or down regulation of L-selectin in the presence of normal  
hormonal influences.  
b) The optimized cell model will be characterized for L-selectin modulation and 
shedding in response to therapeutic hormones and fluid flow, with the use of 
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Western Blot analysis, and ELISA.    This will provide insight into the regulation 
of L-selectin in the presence of shear flow forces, as well as the effect of 
therapeutic hormones, which are used frequently in IVF protocol, on L-selectin 
expression.  
c) Systems for the measurement of the temporal attachment strengths of primary and 
secondary adhesion systems will be designed, constructed and validated.  A 
parallel plate flow apparatus will be employed to quantify low strength primary 
attachments, and a spinning disc cell detachment apparatus will be used to 
measure more robust secondary interactions between the Ishikawa uterine 
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CHAPTER 3:  ESTABLISHING A CELL MODEL 
 
 
 3.1 Introduction 
Embryo implantation in mammals varies somewhat with the species, with human 
implantation events being unique in many ways. Yet it is not possible, for a number 
of practical and ethical reasons, to study directly the physiology of implantation in 
statistically large numbers of human subjects. Therefore, animal and cell-based 
models are a necessary factor in unraveling the complexities of the molecular and 
mechanical events involved in human blastocyst implantation.  The animal models 
which are commonly used for such studies are: mice, rats, guinea pigs, pigs, rabbits, 
sheep, cows and primates such as the cynomolgus macaque, the marmoset monkey 
and the baboon [293].   In mammals, the processes between fertilization and the 
initiation of implantation  generally follows a well conserved autonomous process 
[294], through multiple steps of mitotic cell division until it becomes a multi-cellular 
ball of differentiated cells called the blastocyst. Upon shedding the zona pellucida, the 
blastocyst becomes implantation competent, and the diversity between the species is 
clearly seen at this point, even at the morphological level.  In humans, implantation 
usually occurs between days 7-9 post fertilization, in mice, it occurs at day 4 and in 
cows, it does not occur until 30 days after fertilization [294, 295].  Implantation in 
mammals has been divided into three broad categories: centric, eccentric and 
interstitial [296].  With centric implantation, the embryo expands to a large size 
before implantation, then remains in the center of the uterus. Examples include 
carnivores, ruminants, horses, and pigs.  In eccentric implantation the blastocyst  is  
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small at the time of implantation, and the site of implantation is within the 
endometrium on the side of the uterus, usually opposite to the mesometrium. 
Examples include rats and mice.  Interstitial implantation occurs when a small 
blastocyst erodes through endometrial epithelium into subepithelial connective tissue.  
This process is also called nidation (“nest making”) and is seen in primates, and 
guinea pigs.  Figure 15 schematically illustrates each of these processes [117].  
 
 
Figure 15:  The three different types of implantation:                                                   
interstitial implantation occurs in humans [117]  
 
 
It has been established that the primary factors that stipulate endometrial receptivity 
in humans are the ovarian steroids, estrogen (E2), and progesterone (P4).  The 
physiological effect of ovarian steroids in the uterus are best understood in the mouse 
model, where gene targeting experiments have elucidated the roles of these receptors 
in uterine function [297].  Biomedical research in murine models has been greatly 
facilitated by the use of “knock-out” mice, that is those which have been bred missing 
a single gene, and reproductive studies are no exception. In the case of implantation, 
however, the human process differs significantly and no suitable animal model has 
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been found. Even our closest species, the rhesus monkeys, are different (superficial 
implantation, limited decidualization, dual insertion at opposite poles etc. . . .). This 
uniqueness is perhaps best illustrated by the fact that extra-uterine pregnancies are not 
uncommon in humans whereas they are almost unknown in other mammals [53]. 
Although human blastocysts, produced in IVF programs, have undergone detailed 
observation by conventional and electron microscopy, neither the stage of adhesion to 
the uterine surface nor the penetration phase have been observed in the human. 
Consequently the nature of these crucial events must be deduced from in vitro models 
using cell models of human trophoblastic cells [53], and uterine epithelial model cell 
lines, or the human tissue itself.  
Several human trophoblast cell lines exist and have been studied as models for 
various aspects of human trophoblast function in the implantation and gestation 
process. In order to maximize the possibilities of replicating the protein expression 
signature of implantation ready trophoblast cells, it is important to use a cell line that 
has been established from fetal tissue harvested no later than first trimester. The cell 
line should possess the characteristic invasive properties of normal first-trimester 
trophoblast cells [298].  Three human tissue derived  cell lines meet these criteria: 
JAR [299] Jeg-3 [300] and BeWo [301].   All are choriocarcinoma cell lines.  
Interestingly,  many elements of trophoblast invasion are similar to events that occur 
during tumor cell invasion and these similarities suggest that that the two invasive 
properties may share certain common mechanisms [302].  These three cell lines have 
been used (many times in parallel) for reproductive studies of processes occurring in 
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the period ranging from pre-implantation  to the establishment of the fetal maternal 
vasculature.                                                                                                                                                    
JAR cells have been used to monitor adhesive forces, via atomic force microscopy 
(AFM)  between the trophoblast and uterine epithelium [303], an aspect of cellular 
interactions that would provide insight into implantation mechanisms.  They have 
been recognized for their “adhesiveness” and as such been utilized in studies with 
uterine epithelial cell lines (RL-95) to characterize certain signaling events during 
embryo implantation such as the Ca++ influx [304] or upregulation of RhoA [305] (a 
small GTPase protein known to regulate the actin cytoskeleton in the formation of 
stress fibers) that occurs in uterine epithelial cells as a result of trophoblast cell 
attachment.  Interestingly, both of these studies used multicellular JAR cell 
“spheroids”, a configuration that closely resembles a trophectoderm.   They have been 
also characterized as a potential model for studies of transepithelial transport in the 
placenta (a post-implantation process), and were found to be unsuitable[306].   
The hormone secreting properties of the trophoblast cell line, BeWo, have been 
shown to closely match those of normal trophoblast cells [307].   The levels of IL-8R 
mRNA and protein expression in BeWo cells is similar to those in first trimester 
primary trophoblast cells [308]. Epidermal growth factor (EGF) has been shown to 
dose-dependently stimulate the invasiveness of BeWo cells by inducing α2 integrin 
expression, as well as affect the upregulation of human chorionic gonadotrophin 
(hCG) [308].  Finally, BeWo spheroids were used in co-culture attachment studies 
with RL95-2 endometrial epithelial cells (EEC), and were found to cause  the 
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upregulation of p38 MAPK (mitogen activated protein kinase) and  ERK 
(extracellular signaling-related kinase) in the EEC’s [309].  These signaling pathways 
are felt to be critically important in the implantation process. 
Jeg-3 cells, have been utilized in several studies which focus primarily on hormonal 
expression and adhesion molecule modulation around the pre-implantation and initial 
implantation period. Jeg-3 cells, as well as normal trophoblast cell line (NPC),   have 
been used to investigate the signaling pathway which results in the inhibitory effect of 
TGF-β on the production of estrogen and progesterone [114].  Jeg-3 cells have been 
used to elucidate effect of LIF [310] and IL-17 [311] on the invasive properties of 
trophoblast cells.  The expression and regulation of matrix metalloproteinases 
(MMP’s) has been found to be up-regulated in Jeg-3 cells by fibronectin through the 
focal adhesion kinase (FAK)/p42MAPK  signaling pathway [280].  It was shown that 
cadherin-11 (a membrane protein that mediates intercellular adhesion) contributes to 
the morphological and functional differentiation of the Jeg-3 cells in a highly specific 
manner [312]. 
Several studies have included comparative evaluations of two or three of these cell 
lines.  RT-PCR was used to assess the presence of mRNA for the expression of 
cytokines known to be involved in the regulation of  critical implantation related 
events  in  JAR, Jeg-3 and BeWo cells.  All were found to express IL-6, IL-10, IFN-α, 
IFN-β, and GM-CSF [313].  High numbers of natural killer (NK) cells which are 
present in the uterine mucosa during the pre-implantation period and early pregnancy 
have been implicated in the regulation of trophoblast invasion. Both Jeg-3 and  BeWo 
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cells have been validated as appropriate trophoblast cell lines in a three-dimensional 
co culture in vitro cell model with uterine NK cells to study this process in detail 
[314].  Osteopontin has been shown to play an important role in embryo implantation 
by supporting the attachment of trophoblast cells to the uterine epithelium [315].  A 
recent study, using JAR, Jeg-3 and BeWo cells focused on the signaling pathways 
associated with osteopontin (OPN) mediated cell migration [316].  
 Hohn et al. showed, in a co culture model with RL95-2 cells, that the level of 
adhesive interactions of all three trophoblastic cell lines was inversely related to the 
level of differentiation of the trophoblast cells [317].  All three cell lines were 
pretreated with agents which are known to promote differentiation of cells such as 
methotrexate (MTX),  dibutyryl cyclic AMP (dbcAMP) and phorbol-12-myristate-13-
acetate (PMA).  In addition to increased secretion of hCG (human chorionic 
gonadotropin), a characteristic marker of early trophoblast differentiation, they found 
in every case that their adhesion to the uterine epithelial cell line was significantly 
reduced[317].  Though molecular aspects of the adhesive process were not the focus 
of this study in particular, the results support the appropriateness of JAR, Jeg-3 and 
BeWo cells for use in examining the implantation process.  
Two human uterine epithelial derived adenocarcinoma cell lines have been widely 
used for in-vitro studies of the early reproductive process: RL95 and Ishikawa. The 
RL95 cell line was established in 1983 by Way [318] and it has been used in 
numerous studies which focus on blastocyst-endometrial binding interactions[259, 
303-305, 309, 317, 319].  RL95 cells have been extensively used to investigate the 
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potential function of heparin sulfate proteoglycans (HSPGs) in human implantation 
[319, 320]. In one study, initial binding interactions between JAR and RL95 cells  
was shown to be mediated by cell surface glycosaminoglycans (GAGs) with heparin-
like properties, an observation consistent with an important role for HS and heparin-
like GAGs as well as their corresponding binding sites in early stages of human 
trophoblast-uterine epithelial cell binding  [319].   
Both the RL95 and Ishikawa cell line have been used in the study of progesterone-
dependent regulation of MUC1, a cell membrane associated polymorphic mucin 
[321]. This protein, expressed on the endometrial epithelium throughout the 
menstrual cycle, is characterized by anti-adhesive properties, and its function in the 
implantation process is poorly understood.  
The Ishikawa cell line was established in 1985 by Nashida [322].  This cell line has 
been proven to be stable, hormonally responsive, and has been shown to express 
endometrial proteins in a hormonally responsive manner [323].  Ishikawa cells 
possess both estrogen and progesterone receptors, which are regulated in a manner 
similar to that of the human endometrium [324].  They also express many of the same 
enzymes and structural proteins found in the normal endometrium [325]. The integrin 
expression characteristics in the Ishikawa cell line have been well characterized. As 
with normal endometrial epithelium, they maintain constitutive expression of α2β1, 
α3β1, and α6β4, and show cycle dependent expression of α1β1 [324] and αvβ3  [325] 
The similarities between normal uterine epithelial tissue and Ishikawa cells was 
further validated by the demonstration of comparable epidermal growth factor (EGF, 
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a biomarker of uterine receptivity)  regulation of  αvβ3 expression [326] and the leptin 
mediated regulation of LIF, LIF-R and IL-1 ligand [327]. 
 As an acceptable in vitro model for normal uterine epithelial tissue, Ishikawa cells 
have provided useful insight into the underlying mechanisms contributing to 
conditions of infertility, and the effectiveness of possible clinical treatments. The 
Ishikawa cell line has been used to investigate the role of androgen receptors (AR) in 
human endometrium. Endometrial AR have been shown to be biologically functional, 
inducing prolactin secretion in stromal cells in vitro [328] but elevated endometrial 
AR expression in women with poly cystic ovarian syndrome (PCOS) has been 
indicated as a contributing factor in poor reproductive performance of women with 
PCOS [131].  The up-regulation of AR in response to estrogen, and down regulation 
of AR by progestins in Ishikawa cells has been demonstrated [323].  Androgens were 
found to down regulate the expression of αvβ3 in Ishikawa cells, suggesting possibly 
one of many potential alterations in endometrial epithelial protein expression that 
may occur in response to elevated androgens in women with PCOS [131].  
One of the specific goals of this work is to establish and validate a cell model for 
studying the L-selectin/L-selectin ligand adhesion system using a human trophoblast 
derived cell line and a uterine epithelial cell line. Of the many implantation related 
studies using the three trophoblast cell lines, no one cell line emerges as an ideal 
candidate, so all three cell lines will be evaluated for normal hormonal regulation of 
L-selectin expression.  Conversely, since Ishikawa cells have been particularly well 
characterized with regard to the expression of protein biomarkers of uterine 
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receptivity, they are well suited for studies focused on the L-selectin mediated  
mechanisms of blastocyst implantation in humans, and will therefore be the uterine 
epithelial cell model of choice.   
3.2 Materials and Methods 
Cell Lines and Cell Culture 
JAR, Jeg-3, and BeWo trophoblast derived choriocarcinoma cell lines were obtained 
from American Type Culture Collection (ATCC, Rockland Md.).  The U-937 cell line, 
a non adherent monocytic leukemia cell line which has been shown to constitutively 
express L-selectin (deCoupade, 2003), was a generous gift from Dr. Monika Jost, 
(Drexel University College of Medicine). Ishikawa cells were purchased from 
European Collection of Cell Cultures (ECACC, Wiltshire, UK).   Cell lysates from the 
drosophila cell line, Deg-5r, (a generous gift from Dr. Noreen Robertson, Drexel 
University College of Medicine) were used as a negative control for L-selectin and L-
selectin ligands.  All cell lines, except for Deg-5r,  were routinely cultured at 37oC, in 
a humid atmosphere with 5% CO2.   U-937 and JAR cells were maintained in RPMI-
1640 culture medium (ATCC # 30-2001), BeWo Cells were maintained in ATCC 
formulated F-12K culture medium (ATCC # 30-2004) and Jeg-3 and Ishikawa cells 
were maintained in Eagle’s Minimum Essential Medium (MEM)  purchased from 
ATCC (#30-2003).   All culture media was supplemented with 10% Fetal Calf Serum 
(Fisher Scientific). All cells were routinely passaged every 5-7 days.  For adherent 
cells (JAR, Jeg-3, BeWo and Ishikawa) the culture medium was first removed, and 
cells were washed once with trypsin/EDTA (Cellgro) to remove all traces of serum 
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which contains trypsin inhibitor. Cells were then incubated at 37oC in fresh trypsin 
for 5-15 minutes, until the cell layer was dispersed. FCS supplemented culture 
medium was then added to the flask to inhibit the trypsin, and the cell suspension was 
then centrifuged, resuspended in fresh medium and seeded into new culture flasks.  
Non-adherent cells (U 937)  were passaged by simply aliquoting a predetermined 
portion (10-15%) of the cell suspension into a new flask and supplementing with 
fresh culture medium A detailed protocol for cell passaging can be found in  
Appendix A.  
Hormonal Conditioning  
Cells were first passaged and incubated for 24h under normal conditions in order to 
assure log-growth properties. Cells were then adapted for 24h in phenol red free 
culture medium: RPMI-1640 (Fisher Scientific #MT-17-105CV) for the U 937 and 
JAR cells, and D-MEM F-12 (Gibco/Invitrogen #21041)  supplemented with 10% 
charcoal stripped FBS to eliminate background stimulation by estrogen-mimetics or 





M progesterone), or a combination of both 
for 24h.  A detailed protocol for hormonal conditioning of the cells can be found in 
Appendix B.  Cells were then harvested and processed into cell lysates for analysis by 
Western Blotting.  
Cell Lysate Preparation 
  For the preparation of cell lysates, a modified form of a lysis buffer previously 
described [120] was used:  Into molecular grade water was placed 10 mM Tris-
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Acetate @ pH 8.0, 5 mM CaCl , 0.1% NP-40, 1 mM  Sodium Orthovanadate,  0.01 
mM NaF,   0.10 mg/ml Pepstatin, 1 “Complete Mini” tablet (Roche, Nutley, NJ),  0.5 
uM Chymostatin, and 10 ug/ml Benzamidine HCl. All lysates were prepared at 4oC.   
Cell cultures were washed 1X in cold PBS, followed by a 5 minute incubation in lysis 
buffer.  they were then removed from the culture flask by scraping,  and incubated on 
ice for 30 minutes with regular agitation.  Cells were lysed, centrifuged to concentrate 
the cellular debris, and the lysate solution was removed. Total cellular protein content 
was determined by a bicinchoninic acid (BCA) protein assay (Pierce, Rockford, IL). 
Lysates were prepared for Western Blotting by mixing the lysate in a 1:1 ratio with 
Laemmli sample buffer (Bio-Rad, Hercules, CA), with  β-mercaptoethanol added and 
boiling for 5 minutes. A detailed protocol for cell lysate preparation  can be found in 
Appendix C.  
Antibodies and Antigens 
Recombitant human L-selectin FC chimera was obtained from R & D Systems (San 
Diego, CA). In addition to the U 937 cells, this antigen was used as a positive control 
for the detection of L-selectin.  The primary antibodies used for Western Blot 
experiments were:  LEAF purified anti-human CD62L (L-selectin) (DREG-56) which 
was obtained from BioLegend (San Diego, CA),  MECA-79 rat anti-mouse 
monoclonal antibody which was obtained from BD Pharmingen (San Jose, CA), 
mouse anti-human mucosal addressin cell adhesion molecule 1 (MAdCAM-1) which 
was obtained from Serotec, Raleigh, NC (# MCA2096Z and MCA23). β-Actin rabbit 
polyclonal antibody was obtained from Cell Signaling Technology, Inc. (Danvers, 
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MA ). The quantification of actin in the cell lysates provided the internal loading 
control. The primary antibody for L-selectin detection used in flow cytometry was 
anti-human L-selectin (CD62L) monoclonal antibody #BBA24 (R&D Systems, 
Minneapolis, MN).  
 Isotype controls were used in immunohistochemistry and flow cytometry 
experiments. Affinity purified rat IgM isotype control antibody was obtained from 
eBioscience ( San Diego, CA). Affinity purified mouse IgG1 Isotype control 
eBioscience (San Diego, CA).  Secondary antibodies are used after incubation of the 
primary antibody to couple with the species-specific portion of the primary antibody 
and provide the chemically reactive label that allows direct detection. The secondary 
antibodies used in Western Blots were: peroxidase-conjugated AffiniPure goat anti-
rat IgM  which was obtained from Jackson ImmunoResearch Laboratories, Inc. (West 
Grove, PA)  HRP goat anti-mouse IgG polyclonal antibody which was obtained from 
BioLegend (San Diego, CA) and anti-rabbit IgG HRP-linked antibody which was 
obtained from Cell Signaling Technology, Inc. ( Danvers, MA).  The secondary 
antibody used for L-selectin detection in flow cytometry was Alexa-flor 488 goat 
anti-mouse IgG1  # A11001  (Molecular Probes/ Invitrogen, Carlsbad, CA).  At times, 
an intermediate antibody system is used to enhance the sensitivity of the detection 
and this was the case in the immunohistochemistry  experiments. Typically, this is a 
streptavidin/biotin coupling system. A Streptavidin/Biotin blocking Kit, #SP 2002, 
was obtained from Vector Labs.  (Burlingame, CA). The biotinylated secondary 
antibodies used in the immunohistochemistry protocol were: Biotinylated anti-mouse 
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IgG #BA-9200, Biotinylated anti-rabbit IgG # BA-1000 (both from Vector Labs) and 
Biotin Conjugated  Antibody to Rat IgM #16-16-03 (KPL, Gaithersburg, MD). 
Alkaline phosphatase Strep-Avidin, #SA-5100 and  the BCIP/ NPT reagent kit, #SK-
5400, were also obtained from Vector Labs.  
Western Blotting 
Sample lysates were run on 10 well 4-20% SDS-PAGE mini-gels (Bio-Rad,  #161-
1105) under reducing conditions.   Each well was loaded with the same amount of 
total protein. The protein mixture was electrophoretically separated by molecular 
weight at 100V for 1.5 hours.  The separated proteins were then transferred to 
nitrocellulose membranes at 100V for 1 hour.  The non-specific binding sites on the 
nitrocellulose membranes were blocked with 7% powdered milk in PBS plus .1% 
Tween-20 (PBS-T) for 1hour at room temperature.  The membranes were then 
incubated with the primary antibody in a solution of 5% powdered milk in PBS-T 
overnight at 4°C.  Membranes were washed in PBS-T, then incubated with the 
Horseradish Peroxidase (HRP) conjugated secondary antibody in a solution of 5% 
powdered milk in PBS-T  for 1 hour with agitation.  A final washing step in PBS-T 
was performed before incubating the membranes in ECL chemiluminescent  reagent 
(Amersham, Arlington Heights, IL) and developing  on x-ray film.   A detailed 
protocol for western blotting can be found in Appendix D.           
Immunohistochemistry 
Ishikawa cells were grown for 24 hrs. on 4-well Permanox chamber slides (Fisher 
Scientific #12-565-21).  All of the following steps were done at room temperature, 
  86  
unless otherwise noted. Cells were fixed with 4% paraformaldehyde for 30 min. This 
was followed by washing in PBS, a 1h blocking step in 10% normal goat serum 
(NGS), and a PBS with 0.05% Tween 20 (PBS-T) wash.  Cells were blocked with 
streptavidin D for 15 minutes, followed by a PBS-T wash and a 15 minute block with 
biotin solution.   Each chamber was incubated with a selected primary antibody, (anti-
actin, MECA-79 (for L-selectin ligands) or DREG-56 (for L-selectin) in 5% NGS in 
PBS-T, at 4oC overnight.  The cells were then washed in PBS-T, followed by a 1.5h 
incubation with the corresponding biotinylated secondary antibody. After washing in 
PBS-T, the samples were incubated for 1.5h with alkaline phosphatase Strep-Avidin 
diluted in 10% NGS in PBS-T, followed by  two washes in PBS-T and a final wash in 
PBS. An alkaline phosphatase system was used for visualization. BCIP/ 
NPT/levamisole reagents (Vector Labs) were prepared and used according to the 
instructions. This substrate forms a blue reaction product which can be easily 
observed microscopically.   Slides were washed in DI water air dried and preserved 
with coverslips and aqueous mounting media for future analysis.    A detailed 
protocol for immunohistochemistry of Ishikawa cells can be found in Appendix E.           
Flow Cytometry 
Adherent cells were detached by trypsinization, neutralized with fetal calf serum and 
washed in PBS. For staining, cells were resuspended in staining buffer (PBS with 
0.2% BSA) and incubated with either L-selectin primary antibody (clone 4G8), or 
isotype-matched control (clone MOPC-1, Beckman-Coulter, Fullerton, CA), for 20 
minutes at room temperature, followed by incubation with Alexa-Fluor 488 
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conjugated goat-anti mouse secondary antibody, (20ug/ml) in staining buffer for 15 
minutes at room temperature. Between antibody incubations, cells were washed with 
washing buffer (3% (v/v) FCS in PBS. Flow cytometry analysis was performed using 
a FACSORT flow cytometer (BD Biosciences, San Diego, CA) with 488 nm 
excitation from an argon ion laser at 15 mW. Forward scatter threshold was set to 
exclude small debris. Alexa Fluor 488 log fluorescence was captured on the FL1 
channel equipped with a 530nm wavelength filter with 30nm bandwidth. Data 
acquisition was done using Lysis II software (version 2.0, BD Biosciences, San Jose, 
CA).  At least ten thousand events were acquired per sample. Data analysis was 
performed using WinMDI software (Joseph Trotter, The Scripps Research Institute, 
La Jolla, CA, available online from http://facs.scripps.edu).   
Statistical Analysis 
Data were typically calculated as mean values with standard error of the mean from 
several experiments, performed on different days, with an n of ≥3, unless otherwise 
noted. Additionally, the significance of the differences was analyzed using Student’s 
two tailed t-test, comparing experimental groups with controls.  Limits of confidence 
are indicated for the 95% level, that is, error probability will be P≤ 0.05 when the 
limits of confidence do not overlap. 
3.3 Results 
Western Blot Detection of L-selectin Expression 
In figure 16 representative samples of a typical western blot for each cell type, 
showing the L-selectin expression of the cell line with the hormonal treatment, and 
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corresponding actin bands.  Cellular L-selectin is expressed at ~70 kDa; The L-
selectin  positive control, recombitant  human L-selectin/Fc Chimera, consists of the 
extracellular domain of human L-selectin (amino acid residues 1 - 332),  fused to the 
carboxy-terminal 6X histidine-tagged Fc region of human IgG1 via a polypeptide 
linker. The chimeric protein was expressed in a mouse myeloma cell line, NS0.  As a 
result of glycosylation, this protein is specified by the manufacturer to migrate under 
reducing conditions in SDS PAGE at 90-100 kDa.(R&D Systems, 2007)  Actin is 
expressed at 40 kDa.  For the negative control, only the actin band is seen.  The  blots 
are arranged in 3 sample sets, with each sample set consisting of 1 lysate of treated 








Figure 16: Representative western blots for each cell line, with hormone treatment. 
                  In each blot, a negative control, a positive control and a molecular weight   
standard was run in conjunction with the lysate sets (one control, and one 
treated) prepared from three duplicate runs for each cell line  and each 
treatment.  
 
A) Western Blot, fully labeled, showing bands for Jeg-3 cell lysates, where the   
treated cells were conditioned in progesterone for 24 hours.  
 
B) Western Blot showing bands for JAR cell lysates where the treated cells were 
conditioned in Progesterone + Estrogen for 24 hours. The six bands are 
divided into three sets, as shown in A.  
 
C) Western Blot showing bands for Ishikawa cell lysates where the treated cells 
were conditioned in Progesterone for 24 hours. The six bands are divided into 
three sets, as shown in A.  
 
D) Western Blot showing bands for BeWo cell lysates where the treated cells 
were conditioned in Estrogen for 24 hours. The six bands are divided into 
three sets, as shown in A.  
A 
B C D 
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For Western Blot analysis, all results are presented as relative protein expression.           
First, the intensity of all protein bands was quantified with the Kodak  “1D” image 
analyzer and associated software.  
The  Standardized Intensity (SI) of the protein band was calculated as the ratio of 
total protein loading, as indicated by the intensity of the corresponding actin band 
(IACTIN), to the intensity of the corresponding protein band ( ITREATED or ICONTROL). Thus:  
 
   ITREATED   =    SI TREATED,                               and                 ICONTROL   =    SICONTROL  
         IACTIN                                                                  IACTIN 
 
 
The Normalized Protein Expression of the cells was calculated as the ratio of the 
standardized intensity of the treated cells versus the standardized intensity of the 
controls:   
                                                   SI TREATED   =     Normalized Expression 
                                                   SICONTROL 
 
Thus the normalized expression of the control samples is always “1”.  
Figure 17 shows the modulation of L-selectin expression on all trophoblast cell lines 
(JAR, Jeg-3, BeWo) as well as the uterine epithelial cell line (Ishikawa).   
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Figure 17:  Normalized Expression of L-selectin in Trophoblast Cell lines (A)           
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Detection of L-selectin Expression through Flow Cytometry:  
In figure 18, the basal expression of L-selectin, as detected through flow cytometry,  
is shown for all trophoblast cell lines, as well as the monocytic leukemia cell line,        
U-937, which was used as a positive control.  
 
 
     Figure 18:  Determination of basal expression of L-selectin in all three trophoblast   
cell  lines by flow cytometry 
 
Detection of L-selectin Ligands 
The uterine epithelial derived Ishikawa cell line was probed for expression of L-
selectin ligands, at a basal level and under hormonal stimulation. Three antibodies 
(MECA-79, and two anti-MadCAM-1) were used in this work. Figure 19 shows a 
representative western blot in which MECA-79 antibody was used to detect the 
important class of  L-selectin ligands which contain  sulfate and carbohydrate 
epitopes.  Prominent bands were seen at 90, 80, 50 and 40 kDa.  Since one of the 
bands evaluated in the MECA-79 blot was at 40 kDa, the actin bands are shown 
separately.  
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             Figure 19:  Representative western blot for L-selectin Ligand detection in                          
Ishikawa cells with MECA-79 antibody.  
 
 
The expression of the MECA-79 associated L-selectin ligands was analyzed by the same 
procedure presented previously (3.3 Detection of L-selectin). The most prominent bands 
occurred at 90, 80, 50 and 40 kDa, and these, along with a “total intensity” reading were 
used to calculate the relative expression of L-selectin ligands.  The results are shown in 
figure 20.  
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Figure 20:  Normalized expression of L-selectin ligands, containing the sialyl              
Lewis x epitope, as detected by MECA-79 antibody. 
 
Figure 20 shows the results of immunohistochemical analysis of Ishikawa cells for 
MECA-79 reactivity.   
 
        
Figure 21:  Immunohistochemical analysis  of Ishikawa Cells shows membrane            
surface expression of sialyl Lewis x epitope 
 
L-selectin Ligand Expression    
in Ishikawa Cells 
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 Next, we sought to identify L-selectin ligands by probing cell lysates with antibodies 
against a specific ligand, MadCAM-1.  MadCAM-1 antibodies which detect two 
different glycoforms of this protein, one at 40 kDa and one at 60 kDa were used. In 
figure 22, representative Western Blot results for one test set are shown, for each anti-
body, as well as the actin (total protein) loading control.  
 
             
Figure 22: Representative western blot for 40 kDa and 60 kDa MadCAM-1               
detection in Estrogen Treated Ishikawa cells 
    
 
 In Figure 23, the relative expression of 40 kDa MadCAM-1 with hormonal treatment 
in Ishikawa cells is shown.  
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It has been established that the primary factors that stipulate endometrial receptivity 
in humans are the ovarian steroids, estrogen (E2), and progesterone (P4).  Biomedical 
research in animal models has provided great insight into the process of human 
reproduction, however, in the case of implantation, the human process differs 
significantly and no suitable animal model has been found.  The work reported herein 
has been performed with the intention of identifying a suitable cell model capable of 
being utilized for further detailed studies of the implantation process, with a specific 
focus on the function of the L-selectin, thought to be the initial cell adhesion protein 
involved in the attachment of the floating blastocyst to the uterine epithelium. We 
therefore identified possible candidates from existing trophoblast cell lines. The 
selection criteria required that these cells were derived from first trimester 
trophoblasts, since the protein expression profile of  trophoblast cells in vivo is known 
MadCAM-1 Expression         
in Ishikawa Cells 
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to change significantly as the pregnancy progresses, to the extent that by 17 weeks 
gestation, trophoblast staining for L-selectin is virtually absent [141].  The candidate 
cell lines were JAR, Jeg-3 and BeWo cells. Based on the work of Lessey [81] we 
established a protocol for preparation of cell lysates to be used in examining basal 
expression of  L-selectin in these cells through western blot analysis, as well as its 
modulation in a hormonal environment which simulated the temporal expression 
levels of the primary ovarian steroid hormones, estrogen and progesterone.  The 
presence of estrogen mimics the follicular phase of the menstrual cycle.  It was 
hypothesized that the cellular expression of L-selectin in this environment would be 
reduced as compared to an environment of progesterone, which is the hormone that 
dominates in the luteal phase. The window of implantation is a 2-3 day period of time 
when it is suspected that all conditions which constitute uterine receptivity towards an 
implantation competent blastocyst are present, and this includes known levels of both 
estrogen and progesterone. Thus, it was hypothesized that the expression of L-selectin 
would ideally be highest in a hormonal environment that mimicked the window of 
implantation.  Qualitatively, immunoblot analysis using the L-selectin-specific 
antibody Dreg-56 verified L-selectin expression in all three cell lines (15 and 16A).  
The monocytic leukemia cell line U-937, which has been described to express L-
selectin, was used as positive control [156].  Upon hormonal stimulation with 
progesterone, estrogen or a combination of both, JAR cells upregulated L-selectin 
under all conditions (figure 16A), however, this response was found to be significant 
(p<0.05) only in the environment of both hormones, which mimics the window of 
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implantation. BeWo cell L-selectin expression was only affected when stimulated 
with estrogen (downregulation of about 40%).  Jeg-3 cells responded with 30% 
downregulation of L-selectin to estrogen and upregulation of about 30% after 
combination treatment with progesterone and estrogen; however, these differences 
were not statistically significant (p>0.53).  
In addition to global L-selectin expression, we also determined cell surface 
expression of the molecule on each of these cell lines by flow cytometry, again using 
the U937 cell line as a positive control.  We were unable to detect L-selectin on the 
surface of BeWo or JAR cells.  Therefore, we concluded that it is unlikely that L-
selectin plays a role in initial uterine attachment of these cells and excluded them as a 
blastocyst model.  However, Jeg-3 cells were clearly positive for cell surface 
expression and therefore were selected for further studies.  Thus, although Jeg-3 cells 
are cancer cells, they have preserved responsiveness to endocrine regulators.  
Nevertheless, caution should be used in trying to extend these results to trophoblast 
cells. 
Since Ishikawa cells have been particularly well characterized with regard to the 
expression of protein biomarkers of uterine receptivity, they were used exclusively as 
the cell model for uterine epithelial tissue. An important characteristic of any 
candidate cell line in this study was that they maintain estrogen and progesterone 
receptors. Their presence has been demonstrated in the Ishikawa cells [325] and the 
results presented in this work for the candidate trophoblast cell lines would also 
support the presence of estrogen and progesterone receptors.   
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Though it is hypothesized that the Ishikawa cells, as an appropriate model for the 
uterine epithelial tissue, will express L-selectin ligands, the question remains as to 
whether or not these cells may also express L-selectin.  We felt that it was reasonable 
to explore this question for two reasons. First, a cell can secrete signal molecules that 
can bind back to its own receptors in a process called autocrine signaling [119]. 
Autocrine signaling has been reported in the implantation process with regard to the 
expression of  Fas/Fas Ligand (a type II transmembrane protein that belongs to the 
tumor necrosis factor (TNF) family) in the human endometrium [329].  Second, as is 
the case with the trophoblast cell lines, Ishikawa cells are carcinoma cells and as such 
they often use autocrine signaling to overcome the normal controls on cell 
proliferation and survival [119].  Thus, Ishikawa cells were evaluated for both basal 
L-selectin expression and its modulation in the presence of the ovarian steroid 
hormones.   We found basal expression of L-selectin, as well as its modulation by a 
combination treatment with progesterone and estrogen (slight upregulation of about 
30%).  This novel finding is interesting, and does support the hypothesis of an 
autocrine signaling process which may result in the expression of both L-selectin and 
its ligands on the same cell type.  Whether this interesting and novel finding is 
representative of events which occur in the actual process of implantation, or is an 
artifact of the fact that this is an adenocarcinoma cell line remains to be verified by 
further investigation.  
The MECA 79 antibody recognizes sulfate and carbohydrate epitopes on an important 
class of endothelial ligands.  It was a key component in the finding of L-selectin 
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ligand upregulation on uterine epithelial tissue during the window of implantation 
[141].  In this work, MECA-79 antibody recognized several proteins on western blots 
with molecular weights ranging from less than 10 to 100 kDa (Figure 19),  indicating 
that Ishikawa cells express several proteins with the sialyl-Lewis  x modification.  We 
also investigated the response of Ishikawa cells to hormonal stimulation with respect 
to expression of sialyl-Lewis-X proteins by quantitative western blots.  The total 
intensity of the bands, over the range of 10-100 kDa,  as well as four of the most 
prominent bands at MW 40, 50, 80 and 90 kDa,  were quantified by the image 
analysis technique earlier described (Section 3.3); the 90, 50 and 40 kDa were 
selected because they corresponded to the molecular weight of known L-selectin 
ligands (CD34, GlyCAM-1 and MadCAM-1), and the 80 kDa band was included 
because it was one of the most prominent bands (Figure 19).  Little response was 
observed for the 40 and 50 kDa proteins, regardless of the treatment.  The 80 and 90 
kDa proteins were significantly suppressed, with the combination treatment achieving 
the strongest effect. Thus, basal expression of non-specific MECA-79 reactive L-
selectin ligands in Ishikawa cells has been confirmed. Given the fact that the presence 
of estrogen and progesterone receptors in this cell line has been confirmed by other 
researchers [325], it would be reasonable to speculate that modulation of the ligand 
expression by  ovarian steroids would be present, however, it was not statistically 
significant.  This may be due to the limited number of experiments which were 
performed (n=3 for all conditions), or it may be a result of many passages in the 
maintenance of this cell line. Transformed cells such as the Ishikawa cells, that 
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become established in culture can undergo karyotypic changes, usually marked by an 
increase in chromosomes (polyploidy), with continual passage [330]. Furthermore,  
L-, P- and E-selectin ligand expression in carcinoma cells (typically those which are 
ready to metastasize) is sometimes seen, as this expression is thought to be a part of 
the mechanism of extravasation of the metastasizing cell, similar to the process of 
leukocyte extravasion in response to normal inflammatory processes [331-333].  The 
latter two conditions are unlikely, since Ishikawa cells have been well established as  
a stable immortalized cell line, with protein expression characteristics, particularly 
integrins, which mimic normal uterine tissue [325]. The constitutive expression of 
MECA 79 reactive  L-selectin ligands, which was also verified by 
immunohistochemistry  (Figure21),  is a novel and important finding which will allow 
this cell line to be utilized as a cell model in future experiments.  
We sought to further identify specific L-selectin ligands by probing cell lysates with 
antibodies against the known ligands, in particular, MadCAM-1.  Since trophoblast 
attachment and implantation into uterine epithelium has been proposed to mimic 
leukocyte attachment and extravasation through the vascular endothelium [142] we 
hypothesized that Ishikawa cells would only express the 40 kDa glycoform of 
MadCAM-1 in analogy to vascular endothelium.  Confirming this hypothesis, a 
strong signal was detected using an antibody to the 40 kDa glycoform of MadCAM-1 
by immunoblot analysis, while an antibody against the 60kDa glycoform did not react 
(Figure 22).  Estrogen treatment induced a downregulation of 40 kDa MadCAM-1 
expression of about 30% (Figure 23). Overall, these experiments support the 
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hypothesis that L-selectin ligand expression in Ishikawa cells is modulated by 
hormones.   
In summary, this work has resulted in the establishment and validation of an 
appropriate cell model for further studies of the process of initial human implantation. 
Jeg-3 and Ishikawa cell lines have shown protein expression characteristics which are 
consistent with those of human tissue, that is, L-selectin expression on the 
trophectoderm of an implantation ready blastocyst, and L-selectin ligand expression 
in uterine epithelial tissue, respectively. Furthermore, the novel findings of L-selectin 
expression in the Ishikawa cells, and the specific L-selectin ligand, MadCAM-1, has 
raised interesting new questions about protein adhesion mechanism in implantation 
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CHAPTER 4:  L-SELECTIN MODULATION                                                            
UNDER EXOGENOUS INFLUENCES OF GLUCOCORTICOIDS AND 
HYDRODYNAMIC SHEAR FLOW 
 
 
4.1 Introduction  
In the quest to improve outcomes in Assisted Reproductive Technology (ART), 
clinical interventions have focused on either the “embryo factor”, or the intra-uterine 
environment.  There have been few studies aimed at improving the “embryo factor” 
in implantation. These include the establishment of guidelines for “high quality 
embryo selection” [334],  pre-implantation genetic screening [335], optimizing 
techniques for embryo transfer [336], and assisted hatching (artificial disruption of 
the embryo’s outer coating), the latter of which has been most widely advocated [337, 
338].  However, in 2005, a review of the efficacy of this treatment concluded that 
there is little evidence to support its benefits in overcoming implantation failure 
[339].  Supplementation of the in-vitro fertilized embryo culture medium with 
physiologically occurring cytokines [15, 16] and exogenous steroids [14] has also 
been reported to improve the implantation success rate; however, no comprehensive 
review of this treatment genre has been done to determine its overall effectiveness.  In 
recent years, there has been much attention focused on the intra-uterine environment 
for therapies which will improve the rate of successful implantation and pregnancy 
[336]. Uterine receptivity is controlled by locally acting growth factors and cytokines 
[24] as well as natural killer (NK) cells, which have been shown to play an important 
role in early implantation [340].   Flaws in the integrity of the cytokine system, as 
well as an excess of NK cells, have been implicated in implantation failure [341, 
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342].  It has therefore been proposed that glucocorticoids (hormones with potent anti-
inflammatory and immunosuppressive properties)  may serve to improve the 
“receptive” uterine environment by acting as immuno-modulators to reduce the NK 
cell count, normalize the cytokine expression profile, and reduce endometrial 
inflammation [336]. Additionally, women with the condition of Poly Cystic Ovarian 
Syndrome (PCOS) are known to have a higher than normal level of androgens, and 
this is suspected to be detrimental to both oocyte quality and implantation success in 
IVF treatments. Glucocorticoid administration has been utilized in women with this 
condition to reduce androgen concentrations, but with limited success [343].   
Several different protocols for glucocorticoid administration have been used, where 
dosing and/or length of therapy have been varied. Treatments have been given in the 
luteal or follicular phase or both [344-346] and two IVF studies have reported 
administration of glucocorticoids from embryo transfer onwards [347, 348].  The 
glucocorticoids used for treatment of subfertile women have included: (methyl) 
prednisolone [345, 347-353],  hydrocortisone and (methyl) prednisolone in 
combination [346] dexamethasone [344] and hydrocortisone and dexamethasone in 
combination [354]. 
In a recent review, the results of several studies, focused  on peri-implantation 
glucocorticoid administration as a routine treatment in assisted reproductive 
technology (ART), were carefully analyzed [336].  The authors concluded that there 
was no clear evidence that routine administration of glucocorticoids in ART cycles 
improves the clinical outcome [336].  However, they cautioned that these conclusions 
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could not be extrapolated to women with unexplained infertility, endometriosis or 
those with high levels of uterine NK cells.  Thus, they recommended that, in order to 
clarify the role of glucocorticoids in aiding implantation, further trials focusing on 
women with these conditions (i.e. well defined subgroups) should be performed.          
The actions of glucocorticoids in the human organism are well characterized. 
Synthetic glucocorticoids possess the ability to bind with the cortisol receptor and 
trigger effects similar to their naturally occuring counterparts (eg, cortisol). 
Glucocorticoids are distinguished from mineralocorticoids and sex steroids by the 
specific receptors, target cells, and effects. Cortisol (or hydrocortisone) is the most 
important human glucocorticoid. It is essential for life, and it regulates or supports a 
variety of important cardiovascular, metabolic, immunologic, and homeostatic 
functions. Glucocorticoids influence all types of inflammatory events, no matter what 
their cause.                                                                                                                             
The most widely used synthetic glucocorticoids are prednisone, prednisolone, methyl 
prednisolone  and dexamethasone. Cortisol (hydrocortisone) is the standard of 
comparison for glucocorticoid potency, thus the potency of synthetic hormone is 
measured as a factor of its effectiveness with relation to cortisol.  Table 1 shows the 
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Name  Potency  Duration of action 




Prednisone 3.5 - 5 16- 36 
Prednisolone 4 16- 36 
Methyl prednisolone  5 – 7.5 18 - 40 
Dexamethasone 25 – 80  36 – 54  
 
The action of glucocorticoids is a function of their structure which facilitates their 
passage across the cell membrane, where they are recognized by cytosolic 
glucocorticoid receptors. Glucocorticoid receptors are found in the cells of almost all 
vertebrate tissues. The structure of dexamethasone is based on the cortisol structure 
but differs in three positions (extra double bond in the A-ring between carbons 1 and 
2 and addition of a 9-α-fluoro group and a 16-α-methyl substituent).  Figure 23 shows 
the structure of cortisol, and two glucocorticoids of  importantance in reproductive 
therapies, dexamethasone and prednisolone.  
 
Figure 24:  Chemical Structures of Cortisol, Dexamethasone and Prednisolone [355] 
Table 1:  Relative potencies of important synthetic glucocorticoid compounds  
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The inhibition of leukocyte accumulation in inflamed tissues is one result of the anti-
inflammatory effect of glucocorticoids. One mechanism that has been suggested is 
that glucocorticoids, at clinically relevant concentrations, exert specific actions on 
expression of adhesion molecules on activated neutrophils, which are mediated 
through ligation of glucocorticoid receptors [356].  Another mechanism  is that 
glucocorticoids, specifically dexamethasone, can act to up regulate and externalize  
annexin, a calcium binding protein typically found in granulocytes and monocytes,  
which can then co-localize with L-selectin, and facilitate its shedding through calcium 
dependant interaction, thereby interfering with leukocyte tethering to vascular 
endothelium and subsequent extravasation [156]. Given the many similarities 
between leukocyte attachment/extravasion and blastocyst attachment/implantation,  in 
particular the initiation of these events with L-selectin/L-selectin ligand interactions, 
it would be useful to investigate the effect of glucocorticoids on L-selectin in a 
trophoblast cell model. The observations could provide insight into the underlying 
reasons for the apparent failure of glucocorticoid administration in ART cycles to 
positively affect the clinical outcome. 
Neutrophils have been shown to increase L-selectin expression in the presence of 
fluid flow [162] Further, in the presence of fluid flow, L-selectin in the neutrophil 
membrane has been demonstrated to redistribute and localize, forming a “cap” or 
polarity of expression in the cells [171]. This  group suggests that the capping of L-
selectin and it’s ligand, PSGL-1,  is accomplished by an active transport process, a 
hypothesis which  is supported by the fact that the speed of redistribution of receptors 
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to form a cap would require a 10-100 fold greater speed than previously reported for 
passive diffusion of integral membrane proteins [357]. The membrane capping of          
L-selectin in neutrophils is thought to provide an important role in the mechanics of 
adhesion while the cells are in a flow environment.  This same effect is not seen under 
static conditions, where L-selectin remains homogeneously distributed throughout the 
neutrophil cell membrane [171]. 
Similarly, while the specific fluid mechanics of the uterine cavity have not been fully 
described, it can be assumed that there is at least a mixing flow provided by 
asynchronous contractions [176] and mucin secretions by the endometrium  [141].   
There may also be a more oriented flow resulting from beating of cilia on the 
endometrial ciliated cells.  Cilia-mediated flow has been shown to provide directional 
flow in the oviduct [173, 174].   The effect of fluid flow on trophoblast L-selectin 
expression has not been previously described.  However, because of the possible 
clinical treatments that could be implemented with the use of flow to stimulate L-
selectin expression, it would be of great interest to explore the modulation of L-
selectin in trophoblast-like cells, under conditions of  flow.    
The effect of dexamethasone or fluid flow on L-selectin ligand expression in the 
uterine epithelium has not been studied. In fact, few studies exist which focus on      
L-selectin ligand modulation with dexamethasone.  It has been reported that 
dexamethasone can inhibit the TNF-α induced up-regulation of MadCAM-1 [242], 
but it has no effect on the regulation or expression of PSGL-1 on neutrophils [226].  
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Thus, in addition to modulation of the L-selectin adhesion system by the local 
environment of sex steroid hormones and cytokines, we hypothesize that this system 
is further modulated by inflammatory mediators as well as mechanical shear forces 
due to flow.  The work reported in Chapter 3 has resulted in the characterization and 
validation of an optimized cell model consisting of  trophoblast-like Jeg-3 cells and 
uterine epithelial-like Ishikawa cells.  This cell model has been shown to be 
responsive to the primary sex steroid hormones, estrogen and progesterone. The work 
reported in Chapter 4 will focus on the quantification, through western blot analysis, 
of expression and modulation of L-selectin and L-selectin ligands in the presence of 
the powerful anti-inflammatory agent, dexamethasone, and as a response to 
hydrodynamic shear forces.  Furthermore, L-selectin shedding in response to these 
two conditions will be quantified with the use of ELISA.     
4.2 Materials and Methods 
 
 Hormonal Conditioning of Cells 
 
Jeg-3 and Ishikawa cells were selected as the optimum cell model, as a result of the 
work reported in Chapter 3.  The culture conditions, and passaging protocol are 
reported in section 3.2., Cell Lines and Cell Culture.  Hormonal treatment of the cells 
was initiated after the cells were passaged and incubated for 24h under normal 
conditions, to assure log-growth properties. Cells were then placed in phenol red free 
culture medium: D-MEM F-12, #21041 (Gibco/Invitrogen) supplemented with 10% 
charcoal stripped FBS to eliminate background stimulation by estrogen-mimetics or 
FBS-derived hormones.  Additionally, cells were treated with physiological 
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concentrations of dexamethasone, 10-7
 
M (Thermo Fisher Scientific, Pittsburgh, PA) 
for 24 or 48h.   
Exposure of Cells to Hydrodynamic Shear Forces 
Jeg-3 cells were first passaged and incubated for 24h with normal culture medium, 
and under static conditions in order to assure log-growth properties. Cells were then 
washed and the culture medium replaced with phenol red free culture medium:  D-
MEM F-12 supplemented with 10% charcoal stripped FBS. At this point, the test 
samples were subjected to random fluid flow by placing the culture flasks on a 
standard laboratory rocker, cycling at 3.25 cycles/min. Test cultures on the rocker, 
along with static control cultures, were incubated at 37oC for 24 hours.  Figure 24 
shows the experimental setup.  Cells and supernatant were collected for analysis of 
cellular as well as shed L-selectin.  
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Antibodies and Antigens 
For western blot analysis of L-selectin modulation, as well as  the preparation of 
standards for ELISA,  both recombitant human L-selectin FC chimera #728-LS (R & 
D Systems (San Diego, CA), and U 937 cells were used as  positive controls.  The 
primary antibodies used for western blot experiments were:  LEAF purified anti-
human CD62L (L-selectin) (DREG-56) from BioLegend (San Diego, CA),  MECA-79 
rat anti-mouse monoclonal antibody from BD Pharmingen (San Jose, CA), mouse 
anti-human mucosal addressin cell adhesion molecule-1 (MAdCAM-1) obtained from 
Serotec, Raleigh, NC (# MCA2096Z), and  β-Actin rabbit polyclonal antibody from 
Figure 25:  Experimental setup for conditioning Jeg-3 cells        
in random hydrodynamic shear flow. 
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Cell Signaling Technology, Inc. (Danvers, MA ). The quantification of actin in the 
cell lysates provided the internal loading control.  
The ELISA antibodies and reagents were: N-18 L-selectin polyclonal antibody (Santa 
Cruz Biotechnology, Santa Cruz, CA),   DREG-56 (BioLegend), biotinylated goat-anti 
mouse secondary antibody #BA-9200 (Vector Labs, Burlingame, CA), HRP 
conjugated Streptavidin, #21126 and TMB (tetramethyl benzidine) Substrate Kit, 
#1854050,  ( both from Pierce, Rockford, IL).   
Supernatant and Cell Lysate Preparation 
For quantification of cellular L-selectin modulation through western blot, cells were 
harvested and processed into lysates using the same protocols described in section 
3.2, “Cell Lysate Preparation and Western Blotting”.   
The supernatant was processed for quantification of shed L-selectin as follows.  
Cellular debris was removed by centrifugation at 1000 rpm for 10 minutes, followed 
by syringe filtration through a 0.2 uM filter. Media were concentrated in a two step 
process:  Centriplus centrifugal protein concentrators #YM-30 with a molecular 
weight cutoff of 30, 000, were first used for 15-20 fold concentration, followed by 
Microcon #YM-30 for concentration to a final range of 40-65 X (both from Millipore 
Corp., Bedford MA).  All supernatants were kept at 4oC or lower (when possible) 
during this process. Concentrated supernatants were stored at -80oC. .     
 
ELISA for Shed L-selectin 
 
Plates were coated overnight at 4oC with 3 ug/ml N-18 polyclonal L-selectin 
antibody.  All subsequent  steps were done at room temperature. Coated wells were 
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blocked for 2h with 3% BSA in PBS. Samples and standards, prepared in phenol red 
free culture medium with 10% charcoal stripped FBS, were incubated for 2h.  The 
captured  L-selectin was detected with DREG-56 monoclonal antibody (1:500), 
incubated for 1 hour followed by biotinylated goat anti-mouse antibody (4ug/ml) 
incubated for 1 hour.  Staining was performed with HRP conjugated streptavidin (0.5 
ug/ml) and TMB substrate system, and stopped in 3 M HCl.  For quantification, 
absorbance measurements were made at 450 nm on a microplate reader. A detailed 
protocol for supernatant (culture medium) concentration and ELISA can be found in 
Appendix F.           
 
 4.3 Results   
 
Western Blot Detection of Cellular L-selectin 
 
 Figure 26 shows representative western blots for treated Jeg-3 (A) and Ishikawa 
(B) cells at 24 and 48 hours of dexamethasone exposure.  The blots were quantified 
for L-selectin expression and modulation, using corresponding actin bands as total 
protein loading controls.  Cellular L-selectin is expressed at ~70 kDa. Actin is 
expressed at 40 kDa.  Positive and negative controls were used for all western blots, 
as previously described (Chapter 3).   The blots show single sample sets, with each 
set consisting of 1 lysate of  treated cells, and 1 lysate of non-treated cells.  In all 
cases n=3, unless noted otherwise.   






   
 
 
The procedure and calculations used to quantify relative expression of L-selectin have 
been presented in Section 3.3.  Cellular L-selectin expression in Jeg-3 and Ishikawa 
cells, as well as the temporal modulation of L-selectin expression with 
dexamethasone is shown in Figure 27. For the 48 hour dexamethasone treatment of 
Jeg-3 cells, n = 6.   
A
B
Figure 26: Representative Western Blots showing L-selectin expression and          
modulation in the presence of dexamethasone in Jeg-3 (A) and Ishikawa (B) cells  




Therefore, the temporal expression of sialyl Lewis X oligosaccharide containing L-
selectin ligands (A), and MadCAM-1 (B) with 24 and 48 hour exposure to 





Figure 27: Normalized Cellular L-selectin expression in Jeg-3 and Ishikawa 
cells after treatment with dexamethasone for 24 and 48 hours. U 937 cells were 
used as a positive control, at 48 hrs only. Quantification by western blot. 





Expression of the sialyl Lewis x oligosaccharide containing L-selectin ligands was 
quantified  by the same procedure presented previously (3.3 Detection of L-selectin). 
With MECA-79 antibody, the intensity of the protein bands at  90, 80, 50 and 40 kDa, 
along with the  “total intensity” readings were used to determine  the relative 
expression of L-selectin ligands.  “Total intensity” is defined as the intensity of all the 
bands, over the range of 10-100 kDa.   The relative expression of the proteins at these 
molecular weights, as well as that for 40 kDa MadCAM-1 are presented below   
(Figure 29)    
       Figure 28: Western Blots showing sialyl Lewis x oligosaccharide containing L- 
selectin ligands (A) and MadCAM-1 (B) expression in Ishikawa cells. For 
clarity, tubulin (50 kDa) was used as the loading control in place of actin 
(40kDa).  
B








The results of ELISA analysis of the supernatant, to quantify the amount of shed            
L-selectin with dexamethasone treatment, are shown in Figure 30.  
Figure 29: Temporal modulation of sialyl Lewis x oligosaccharide 
containing L-selectin ligands, with dexamethasone treatment,             
as detected by MECA 79 antibody (A) and anti-MadCAM-1 (B) 
A
B





In figure 30 the modulation of L-selectin in the presence of fluid flow are shown.  We 
quantified both the levels of cellular expression through western blot, and shed                




      Figure 30:  Effect of Fluid flow on cellular L-selectin expression in Jeg-3 cells (A),  
as well as L-selectin shedding (B) 
 
Figure 30:  Quantification of shed L-selectin in the supernatant of             
U 937(positive control), Jeg-3 and Ishikawa cells through 
ELISA Analysis 
BA 
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4.4 Discussion 
Effect of Dexamethasone on L-selectin Expression 
Dexamethasone is a potent synthetic member of the glucocorticoid class of steroid 
hormones which acts as an anti-inflammatory mediator and immunosuppressant.  
Dexamethasone and other glucocorticoids such as prednisone, prednisolone and 
methyl prednisolone have been used to treat infertility as a routine step in IVF 
treatment protocols, and in the context of inflammatory disease, such as PCOS [358, 
359] but with unproven  success. The glucocorticoid  effect on expression of 
components of the L-selectin adhesion system in the reproductive process is not well-
understood.  With L-selectin, two mechanisms of down regulation have been 
proposed. The first is that glucocorticoids, at exert specific actions on expression of 
adhesion molecules on activated neutrophils, which are mediated through ligation of 
glucocorticoid receptors [356]. The second is that glucocorticoids, specifically 
dexamethasone, can act to upregulate and externalize  annexin, a calcium binding 
protein in granulocytes and monocytes,  which can then co-localize with L-selectin, 
and facilitate its shedding through calcium dependant interaction, thereby interfering 
with leukocyte tethering to vascular endothelium and extravasion [156].  The latter 
mechanism seems to be the most widely accepted.  
Since dexamethasone is the most potent of the commonly used glucocorticoids  
(Table 1), and it was used to elicit both of the proposed mechanisms of down 
regulation,  we analyzed the effect of physiological levels of dexamethasone on Jeg-3 
and Ishikawa cells by quantitative western blot, and  quantified  the levels of                
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sL-selectin in the corresponding cell supernatant.  U 937 cells were used as a positive 
control. From figure 23,  it appears as if the relative expression of cellular L-selectin 
in  U 937and  Jeg-3 cells is only slightly affected, even after 48 hours, but Ishikawa 
cells show a much higher level of upregulation; almost 50% after 24 hours. If the 
proposed  mechanism of dexamethasone induced shedding [156] is accurate, then the 
ELISA results for the dexamethasone treated cells should reflect this by showing a 
correspondingly higher level of shed L-selectin in the supernatant than the untreated 
cells.  Indeed this is true for the  U 937 cells (which were evaluated only at 48 hours) 
as well as the Jeg-3 cells at both 24  and 48 hours which  raises the question of 
whether dexamethasone, by inducing ectodomain shedding, has any effect, positive or 
negative, on initial blastocyst attachment.  Increased shedding may also lead to 
altered rolling velocity of the blastocyst, which is controlled by shedding activity in 
leukocytes.  However, the effect of dexamethasone on L-selectin expression and 
shedding should be further investigated in the presence of fluid flow and other 
hormonal conditioning. 
 The Ishikawa cells not only show virtually no difference in the level of shed                    
L-selectin but on an absolute basis, very little shed L-selectin is seen at all. This can 
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Table 2:  Amount of s L-selectin in cell supernatant as determined by ELISA 
             
 
 
                     
                              
For both U 937 and Jeg-3 cells, the relative increase in sL-selectin with 
dexamethasone treatment is over 100%, while in the case of the Ishikawa cells, the 
sL-selectin  level is one order of magnitude lower than the lowest level seen in the 
Jeg-3 cell line, and more than 2 orders of magnitude lower than that of the U 937 
positive control. In considering both the upregulation of L-selectin in the Ishikawa 
cells, as determined by western blot, and the apparent lack of shedding, it is 
consistent to conclude that the cellular L-selectin in Ishikawa cells may be primarily 
found within the cell, and not as a trans-membrane type protein, as with the Jeg-3 
cells. However it must also be considered, that the L-selectin may be expressed on the 
cell membrane, but in such a configuration that it was not accessible to the antibodies 
used in flow cytometry, nor to the proteases that promote L-selectin shedding.    
Furthermore, Ishikawa cells do express L-selectin ligands (Chapter 3). It has been 
suggested by Khan, et al [177] that one anti-inflammatory mechanism in lymphocytes 
is the binding of sL-selectin to presenting ligands preventing  further interaction with 
membrane bound L-selectin. This would also be consistent with an apparent 
Cell line  Control (No Treatment) 
 
 Dexamethasone (10-7 M)   
U 937  125 259 
Jeg-3 56 134 
Ishikawa 5.02 5.11 
Shed L-selectin after 48 hrs. (pg/ml)  
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upregulation of cellular L-selectin. Further testing would need to be done in order to 
fully characterize the function of L-selectin in Ishikawa cells.  
Effect of Dexamethasone on L-selectin Ligands 
Though many studies have been reported regarding the effect of dexamethasone on         
L-selectin, little is known of its effect on L-selectin ligand expression and 
modulation. It has been shown that L-selectin is shed from the membrane surface as a 
result of dexamethasone exposure[156] , and that soluble (shed) L-selectin can retain 
its functional activity [157].   It has been suggested that soluble L-selectin (sL-
selectin) can regulate lymphocyte migration into the peripheral lymph nodes with 
increased levels (of sL-selectin)  resulting in more profound inhibition of this process 
[177]. The presumed mechanism is one in which sL-selectin binds to the presenting 
ligands and prevents further interaction with membrane bound L-selectin on 
lymphocytes. With the finding of L-selectin expression in Ishikawa cells, it is 
reasonable to hypothesize that, under the influence of dexamethasone, a mechanism 
might exist in which shed L-selectin might effect L-selectin ligand expression in the 
same cells.  
The effect of glucocorticoid treatment on temporal expression of L-selectin ligands in 
Ishikawa cells was therefore examined by quantitative immunoblot in a similar 
manner to the protocol given in Chapter 3. In quantifying the MECA 79 reactive 
ligands, the bands at 90, 50 and 40 kDa were selected because they correspond to the 
molecular weight of known L-selectin ligands (CD34, GlyCAM-1 and MadCAM-1), 
and the 80 kDa band was included because it was one of the most prominent bands, 
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though no specific L-selectin ligand has been reported to correspond to this MW.  
After 24 hours of exposure, cells responded with a moderate but insignificant 
upregulation of L-selectin ligands, with the exception of the 80 kDa protein.  Cells 
responded to prolonged (48 hr) dexamethasone exposure with a reduction of 
expression of all four proteins examined, in particular, the reduction in the 80kDa 
band (about 25%), was statistically significant (p=0.03) (Figure 29A).  Very little is 
known of the modulation of L-selectin ligand expression with dexamethasone.  Only 
one study has been reported, where the regulation of PSGL-1 on monocytes by 
dexamethasone was examined, and it was unaffected by the dexamethasone treatment 
[226]. In contrast, Genbacev et al., have shown that the attachment of the blastocyst 
to the uterine wall is mediated, at least in part, by (MECA 79 reactive) selectin 
oligosaccharide-based ligands.  L-selectin ligands are upregulated in the endometrium 
during the luteal phase coinciding with the high expression of L-selectin on 
trophoblastic cells thus promoting the initial step of implantation.  Our finding may 
therefore  be significant  in that a downregulation of the MECA 79 reactive ligands in 
the presence of dexamethasone could impair uterine receptivity to blastocyst 
attachment during the initial stages of the implantation process. This observation is 
also consistent with the recent review which concluded that there was no clear 
evidence that routine administration of glucocorticoids in ART cycles improves the 
clinical outcome[336]. It may in fact be detrimental to primary implantation 
mechanisms, however, further examination of hEEC’s will be necessary to confirm 
this observation.  
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The effect of dexamethasone on cellular MadCAM-1 expression in Ishikawa cells 
was also evaluated by western blot. Figure 25 shows that dexamethasone has very 
little effect on the expression of this ligand.  MadCAM-1 expression has not been 
characterized with respect to the uterine epithelium, where it would likely be involved 
in the process of implantation, but it has been observed throughout the secretory 
phase in the uterine endometrium[214].  Its presence was associated with selective 
recruitment of natural killer (NK) cells to the endometrium as a normal function in 
the menstrual cycle. The regulation of MadCAM-1 expression has been studied, 
particularly with a focus on treatments for acute and chronic inflammatory conditions 
of the intestine, such as Crohn’s Disease and ulcerative colitis [239, 240].  MadCAM-
1 has been shown to be up-regulated in murine lymph node endothelium by the 
inflammatory cytokine, TNF-α, [241].  Furthermore, in the human intestinal tract, 
TNF-α mediated upregulation of MadCAM-1 (due to inflammatory bowel disease) is  
inhibited by dexamethasone treatment [242].  Thus, it is consistent that 
dexamethasone would have little effect on the expression of MadCAM-1 in Ishikawa 
cells, particularly in an environment lacking in pro-inflammatory cytokines like TNF-
α . Furthermore, since TNF-α  is not considered to be a significant mediator in the 
implantation process, there would probably not be a need to investigate its influence 
in this process.   Presently, MadCAM-1 has not been confirmed to be present on 
human uterine epithelial tissue, though it is one of the aims for further studies in this 
project. The results of this work suggests, however, that if MadCAM-1 is found, it 
would probably not be negatively affected by the presence of glucocorticoids.  
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Effect of Fluid Flow on L-selectin 
It was hypothesized that when subjected to hydrodynamic shear flow, the Jeg-3 cells 
might respond by upregulating L-selectin, in a similar manner as has been observed 
on leukocytes [162, 171]. Earlier observations by flow cytometry have demonstrated 
that the L-selectin expressed by Jeg-3 cells is, in part, functional as a membrane 
bound extracellular protein. Due to experimental configuration of this test, Jeg-3 cells 
would not be able to “shed” L-selectin due to interactions with membrane bound 
ligands, as with blood leukocytes, however, we wanted to determine if the 
hydrodynamic shear forces alone may contribute to the shedding process. Thus, 
cellular L-selectin was quantified through western blotting, and the cell supernatant 
was quantified for sL-selectin through ELISA (Figure 31). Expression of L-selectin 
on the trophectoderm of an implantation competent blastocyst (after shedding of the 
zona pellucida) has also been demonstrated [141], however, in this environment, 
modulation of L-selectin due to fluid flow has not been investigated, and this study 
did not specify the conditions of the environment (static or dynamic) in which the L-
selectin expressing trophoblast cells were maintained. Many of the experimental 
designs in which the effect of fluid flow is investigated correctly include interactions 
with L-selectin ligands [171, 225, 360-362]. However, the suggestion has been made 
that “hydrodynamic shear forces alone may increase expression of L-selectin” [144].  
In this experiment, we attempted to qualitatively investigate the effect of 
hydrodynamic shear forces by culturing cells on a rocker plate, as shown in Figure 
25. The culture medium, flowing over attached trophoblast-like Jeg-3 cells as the 
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rocker cycled back and forth, was meant to mimic the effect of uterine fluid on the 
blastocyst, although this fluid flow has not been well defined.  Based on immunoblot 
analysis, random fluid flow induced a 30% increase in cell associated L-selectin 
expression (Figure 31A).  When the cell supernatant was analyzed for sL-selectin by 
ELISA, there was a slight increase compared to the (static) control samples, however, 
as with the Ishikawa cells, the absolute amount of shed L-selectin was insignificant 
(<0.1x) when evaluated in the context of the dexamethasone treated cells,  where 
shedding of the L-selectin has been demonstrated.  This is illustrated in figure 32.   
 
Figure 32: Comparison of shed L-selectin levels with dexamethasone treatment, and 
after exposure to hydrodynamic shear forces.  
 
 L-selectin shedding can occur as a result of glucocorticoid exposure [156], as a result 
mechanical forces between L-selectin and its oligosaccharide based ligands which 
induce the cleavage of L-selectin from the neutrophil surface during rolling and 
tethering to L-selectin ligands [363].  Since neither of these conditions existed in this 
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experiment, it is not likely that shedding of L-selectin occurred as a result of 
hydrodynamic shear forces that the Jeg-3 cells experienced.    
 This finding leads us to hypothesize that exposure of an in vitro fertilized blastocyst, 
to fluid flow of a carefully determined  range of magnitude,  may enhance L-selectin 
expression (among other molecules) and, consequently, enhance the attachment 
potential of the embryo to uterine epithelium.  In addition, the fluid flow in the uterus 
may stimulate the blastocyst to prepare for primary attachment through the L-selectin 
adhesion system.  It is worth noting that the geometrical configuration of the 
trophoblasts of the blastocyst, as well as the size of the blastocyst may provide 
interesting differences between L-selectin shedding and potentially with L-selectin 
capping or spatial distribution in the presence of fluid flow.  Further, definition of the 
intra-uterine fluid flow characteristics may be important in understanding blastocyst 
“mechanical” conditioning.  
In conclusion, working with an optimized cell model for blastocyst/uterine epithelium 
interactions, consisting of  trophoblast like Jeg-3 cells and uterine epithelial like 
Ishikawa cells,   we have explored the effect of two exogenous influences on the             
L-selectin adhesion system which are of importance in the process of human 
implantation. These are the effect of the powerful glucocorticoid, dexamethasone, and 
that of hydrodynamic shear forces.  Our results support the hypothesis that 
dexamethasone induces shedding of L-selectin in trophoblast like cells, however, an 
unexpected finding was the significant down regulation of MECA 79 reactive L-
selectin ligands in the Ishikawa uterine epithelial cell line  Both of these observations 
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would indicate that the use of dexamethasone in IVF protocols might in fact have a 
detrimental effect on the outcome.  
Hydrodynamic shear forces generated by random fluid flow resulted in an ~30% 
upregulation of L-selectin on the Jeg-3 cells, but L-selectin shedding was negligible.  
Thus, treatment of an in vitro fertilized blastocyst with fluid flow, of a carefully 
determined  range of magnitude,  may enhance L-selectin expression (among other 
molecules) and, consequently, enhance the attachment potential of the embryo to 
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Implantation begins with apposition, which involves low bond strength interactions 
between the blastocyst and the uterine surface epithelium [260].  In order for structural 
attachment to occur, that is, one which can resist shear forces due to fluid flow and other 
motions, there must first be an initial interaction that will slow the moving blastocyst and 
provide primary attachment.  Recently, the presence of L-selectin on the human 
blastocyst, as well as a significant upregulation of the expression of the sulfated 
oligosaccharides that function as high-affinity counter-receptors for L-selectin on human 
uterine luminal and glandular epithelium during the window of receptivity has been 
demonstrated [141]. These initial interactions are thought to be mediated by L-selectin 
and its associated ligands. Secondary attachment is mediated at least in part by 
integrin/ligand interactions.  The presence of integrin subunits on the human uterine 
endometrium throughout the menstrual cycle has been characterized through 
immunohistochemistry [120-122], and integrins have been known to be critical to the 
adhesion process in implantation since they were characterized by Lessey in the human 
endometrium in 1992.  Of all the integrins which have been characterized, αν β3   clearly 
stands out as the integrin most likely to be critical in the blastocyst attachment process, 
and it  has been proposed as a potential receptor for embryonic attachment [364]. The αν 
β3 dimer is simultaneously present in the uterine epithelium and in the trophoblast.  It is 
thought that the anchorage of the embryo is made possible through “loop interactions”:  
thus, αν β3 expressed on the trophoblast cells  recognizes endometrial osteopontin, and 
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endometrial αν β3 interacts with vitronectin and fibronectin expressed by the 
trophectoderm [132]. The ανβ3 integrin interacts specifically with the tripeptide sequence 
Arg-Gly-Asp (RGD), and this sequence has been implicated in trophoblast adhesion to 
extracellular matrix [13]. Thus, after initial interactions through the L-Selectin adhesion 
system,  activation of the  integrins and their ligands, through signaling cascades of 
molecules such as MAPK’s and cytokines,  results in secondary adhesive interactions 
which strengthen the primary bonds and provide firm attachment of the blastocyst to the 
uterine epithelium.  
 A parallel mechanism has been proposed between the steps involved in the human 
blastocyst implantation: embryo-endometrial apposition, attachment and invasion, and 
the leukocyte extravasation process: rolling/adhesion and invasion of the vascular 
endothelium [142].  These similarities introduced the possibility that the initial steps in 
implantation may include a rolling blastocyst which, in a manner similar to blood 
leukocytes,  is slowed through the mechanism of low strength L-selectin-mediated 
primary bonding to the posterior wall of the uterus.    
It has been demonstrated that the capture of leukocytes and subsequent rolling requires 
critical thresholds of shear stresses to occur  [162-164].  The threshold shear stress range 
required to support rolling and attachment has been quantified at 0.4 to 1.9 dynes/cm2 
[166, 168].   This effect is not shared by the other selectins, but is unique to L-selectin. 
Furthermore, it appears to be an intrinsic property of the L-selectin molecule, as this 
dependence has been shown in cell-free immobilized L-selectin interacting with cell 
based or bead-immobilized L-selectin ligands [166, 167, 365]. 
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Integrin-ligand interactions are known to have much stronger bonds. Depending on the 
concentration of the ligand (eg, fibronectin), bonding strengths ranging from 50 – 200 
dynes/cm2 have been measured in in-vitro systems [266, 269].  
Many cellular adhesion measurement techniques exist, however, the differences between 
cellular adhesive phenomena in a dynamic versus a static environment have long been 
recognized, and for studying the initial processes involved in the capture and attachment  
of the blastocyst to the uterine epithelium, methods which incorporate flow 
(hydrodynamic shear) are the most appropriate type. Such techniques have been reported 
since the mid 1900’s [261].  Today, several designs exist for the quantification of cellular 
adhesiveness through the use of hydrodynamic flow to produce shear (detachment) 
forces.  These include the parallel plate flow apparatus [264],   parallel disc viscometer 
[262], radial flow chambers [275], and the spinning disc detachment apparatus [366-368]. 
Each is described more fully in Chapter 1. 
The parallel plate flow apparatus is ideally suited for observing and quantifying the 
process of leukocyte rolling, tethering and attachment due to the very low attachment 
forces which it can generate. Studies with induced shear stresses ranging from 0.3 to 35 
dynes/cm2 are the most common.  Neutrophils have been shown to attach to L-selectin 
substrates with strengths of 1-3 dynes/cm2 [166].  The surface expression of adhesion 
molecules such as ICAM-1 [284], VCAM-1 [285], E-selectin[286], P-selectin [287],         
L-selectin and PNAd [288], α4β1 [289] and  PSGL-1 [290] and other L-selectin ligands 
expressing sialyl Lewis x epitope  [291] have all been characterized in this manner.   
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Typical parallel plate designs allow studies of cellular interactions under laminar flow on 
functionalized surfaces from the top-down, or sometimes, a side view with microscopic 
observation and analysis.  A novel modification of typical parallel plate flow chamber 
designs that has been incorporated in the apparatus used in this work is a Quartz Crystal 
Microbalance (QCM) sensor which responds to changes in the mass of a coating on its 
surface with a well defined resonant frequency shift [369, 370], thus allowing real time 
monitoring of cell detachment kinetics. The shift in frequency can be correlated with 
quantitative changes in cell population on the QCM surface allowing the generation of  
detachment strengths profiles of L-selectin/ligand binding.  This sensor [369], and its 
response characteristics [371] are shown in figure 33.  
 
 
Figure 33: (A) QCM Sensor [371];                                                                                   
(B) Typical frequency response of a quartz crystal resonator  [369]. 
 
 
Radial flow chambers, and the spinning disc detachment apparatus  have been used 
extensively to quantify adhesion interactions with integrin and their ligands.  The radial 
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flow chamber (RFC) is a dynamic cell detachment technique which can generate a 
spatially dependant range of shear stresses simultaneously. Radial flow chambers utilize 
axisymmetric radial flow to produce a shear stress that decreases with increasing radial 
position [271], however, a significant disadvantage with this system, is the complexity of 
the hydrodynamic detachment forces at relatively small radial distances from the inlet.  
The spinning disc cell detachment apparatus,  based on the same design principle as the 
parallel disc viscometer [262], is a more recently developed instrument [366].   The 
parallel disc viscometer was one of the very early designs for cellular adhesion 
measurements, adapted for use in a biological system from instruments developed for 
mechanical engineering applications[262].  The spinning disc design consists of a single 
bottom plate where, similarly to the radial flow chamber, a range of  shear forces are 
generated simultaneously by the chamber fluid as it undergoes laminar flow, in a radial 
pattern over the disc. Of these three hydrodynamic systems, the spinning disc is the only 
configuration that applies a linear range of detachment forces under uniform and constant 
chemical conditions at the surface [256].  Applications of the spinning disc CDA include: 
red cell adhesion to Teflon®, glass and polyethylene [270], adhesion of  3T3 cells 
(immortalized fibroblast cell line from Swiss mouse embryo tissue) to a chemically 
homologous series of copolymers based on hydroxyethylmethacrylate (HEMA) and 
ethylmethacrylate (EMA) [265], and initial integrin-fibronectin interactions using K562 
cells [266].     
Substrates for studies of the interactions of cells with protein ligands or components of 
the extracellular matrix are often prepared by allowing a protein to adsorb from solution 
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onto a glass or polymer surface. This method is effective for many studies, however, it 
can fall short in cases where reproducible, well defined and carefully controlled protein 
coating is required. When the material to be functionalized is gold, this requirement can 
be particularly challenging. Self assembled monolayers, formed by the spontaneous 
ordering of terminally functionalized alkanethiols onto the gold provide a convenient  
method for tailoring substrates with ligands, proteins and other groups in a highly 
controlled manner [372].   
The structure of thiol terminated SAM’s on gold is well established [373].  The sulfur 
atoms coordinate to the threefold sites of the gold (111) surface to give a closed packed 
array of alkyl chains, which is particularly efficient where n >10 for the n-alkanethiols 
used.  The strong interactions between the sulfur and the gold substrate contributes 
substantially to the overall adsorption energy, which is typically in the range of 35-45 
kcal/mole.  The thiols are believed to attach primarily to the threefold hollow sites of the 
gold surface, losing the proton in the process,  and forming a slightly tilted,                       
highly crystalline overlayer configuration as shown in figure 34 [374].    
 
 
 Figure 34: Structure of n-alkanethiol self assembled monolayer adsorbed on gold: 
molecules assemble in slightly tilted, all trans configuration in order to optimize 
lateral interactions between molecules within the monolayer (adapted from[374]).  
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Proteins may then be adsorbed onto the SAM, or they may be covalently attached.  
Furthermore, when precise control of the protein density, is desired, mixed monolayers 
may be utilized. Mixed monolayers, consist of only a percentage of the terminal groups 
which are reactive, and may serve to maximize accessibility and minimize steric 
hindrance for the receptor. They are highly effective for this application, since it  has 
been shown that multicomponent monolayers do not segregate into discrete single-
component domains [375].    Mixed SAM’s are produced on gold substrates from 
solutions of two or more alkanethiols, where one component (X) contains an inert 
terminal group (eg, CH3) and a second component (Y) contains a reactive terminal 
functional group (eg, COOH), which determines the reactivity of the SAM.  To preserve 
crystallinity, and maximize accessibility, the relative chain lengths of X and Y should be 
close, with X < Y.  An ideal mixed monolayer system would thus consist of                     
(HS-(CH2)16-OH) /(HS-(CH2)n-CH3) where n = 11-15 [374, 375].   
It is possible to covalently attach a biomolecule (such as a ligand binding protein) onto a 
SAM modified gold surface.  Several immobilization strategies are available, however,  
carboxyl terminated (-COOH) alkanethiols are recommended, as this approach avoids the 
possibility of protein-protein cross linking [374].  The carboxyl group can then be 
activated in a carbodiimide (N=C=N) reaction where it will undergo nucleophilic 
substitution in the presence of a primary amine, as shown below.   In protein molecules, 
the primary amine may be a surface exposed lysine, which is common due to the 
hydrophilic nature of lysines, which insures that they predominate on protein surfaces. 
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Figure 35: Covalent coupling of protein molecule to carboxyl terminated                                            
SAM through carbodiimide reaction [376] 
 
Attachment strengths for both the L-selectin and integrin adhesion systems have not been 
quantified with regard to trophoblast-uterine epithelial interactions. It is the ultimate goal 
of project to quantify the attachment strengths of the protein/ligand interactions as a 
function of expression which may provide compelling evidence toward critical levels of 
L-selectin/L-selectin ligand, as well as integrin/ligand expression which would be 
necessary to achieve  primary attachment, and strengthen this attachment through 
secondary interactions which ultimately facilitate implantation.  The first step toward this 
goal is the work reported herein. That is, evaluation attachment strengths of the primary 
and secondary adhesion mechanisms in the optimized trophoblast-uterine epithelial cell 
model consisting of Jeg-3 and Ishikawa cell lines through the use of appropriate cell 
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5.2 Materials and Methods 
Antibodies and Antigens 
For deposition of the SAM on all gold substrates, 11-Mercaptoundecanoic Acid (MUA), 
1-Decanethiol (NDt), (N-3- Dimethylaminopropyl)-3-ethylcarbodiimide (EDC),  N-
Hydroxysuccinimide (NHS), and ethanolamine were all obtained from Sigma Aldrich (St. 
Louis, MO).  All organic compounds were of the highest purity available, and were used 
without further purification. ).  Fibronectin was also purchased from Sigma Aldrich, and 
was used for coating the spinning disc at a concentration of 5 ug/ml in PBS.  L-Selectin 
Fc Chimera was obtained from R&D Systems,(San Diego, CA), and was used at a 
concentration of 25 ug/ml in PBS when used in the coating for the spinning disc.              
LEAF purified anti-human CD62L (L-Selectin) (DREG-56) was obtained from 
BioLegend (San Diego, CA).  Phenol red free culture medium, D-MEM F-12 was 
purchased from Gibco/Invitrogen #2104 (Carlsbad, CA). 
 
Preparation of Ishikawa Cells for Detachment Assays 
Ishikawa cells were passaged and incubated for at least 24h under normal conditions in 
order to assure log-growth properties. Cells were harvested for testing during the log-
growth period; ~24 to 72 hours after passaging. Cells were first rinsed in PBS, 
trypsinized for 7-10 minutes at 37oC, then centrifuged and resuspended in serum free 
phenol red free culture medium at a concentration of 6 x 105 cells/ml. Cells were 
incubated at 37oC in suspension until used.  
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Parallel Plate Flow Apparatus 
The parallel plate flow cell detachment apparatus has a defined flow profile that closely 
approximates the hydrodynamic features found in the vasculature [377].  This apparatus 
is ideally suited for observing and quantifying the process of leukocyte rolling, tethering 
and attachment due to the very low attachment forces which it can generate. Studies with 
functionalized surfaces with induced shear stresses ranging from 0.3 to 35 dynes/cm2  are 
the most common. [166, 281, 282].  The apparatus used in this work was designed, 
manufactured, and validated in our lab [378] and  is similar in design and function to 
many of the commercially available parallel plate flow chambers on the market today.  It 
is capable of generating hydrodynamic shear forces in the range of 0 – 10 dynes/cm2,  
through laminar flow generated by a peristaltic pump (Harvard Apparatus - Peristaltic 
Pump 77) selected for its accuracy (+/- 1%; similar to that of a syringe pump)  and ability 
to pump very high volumes of fluid.  A reservoir system was implemented to achieve 
precision control of flow rate and induced shear rates with minimal pulsation. Figure 11 
(Chapter 1) shows an exploded schematic of the flow chamber, with the laminar flow 
profile that occurs over the functionalized surface.  The laminar flow rate and applied 
wall shear stress are linearly proportional through equation (7):  
The wall shear stress, τ wall, can be calculated from the momentum balance for a 
Newtonian fluid [283], and is given by:  
 
  τwall  =   3μQ               (7) 
                   2h2b 
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where μ= Coefficient of viscosity, Q = volumetric flow rate, 2h = channel height              
and b = channel width [164].   The flow chamber is shown in figure 36 A. For calculating 








Figure 36:  (A) Parallel Plate Flow Apparatus for Ishikawa Cell Detachment Assay 
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A unique modification to the typical flow chamber design, which was validated in this 
work, is the addition of a quartz crystal microbalance (QCM) as a detection device 
(figure 32A).  A QCM is a piezoelectric sensor which works by deforming at a resonant 
frequency when a voltage is applied. Mass deposited on or removed from the surface will 
cause a change in the frequency at which the crystal resonates [369]. Background 
stability of the sensor output in the presence of temperature and flow variations was 
monitored, however, absolute quantification of the cell detachment levels was made by 
microscopic observation.  
The gold surface of the QCM was functionalized with L-selectin, covalently bound to the 
substrate through a mixed-alkane thiol SAM “linker”, as described in the following 
section.    PBS at 37 oC was first flowed through the system for a period of approximately 
10 minutes to achieve a baseline reading. Ishikawa cells were prepared for testing by brief 
trypsinization to detach them from the culture flask, after which they were placed in a 
suspension of serum-free culture medium and incubated at 37oC during the baseline 
equilibration.    They were then added to the system and allowed to adhere, under static 
conditions, for approximately 5 minutes, at 37oC. The cell density was observed 
microscopically, and recorded.  Flow was then applied to the system at known shear force for 
5 minutes and the cell density was recorded again.  `The shear force which resulted in a 50% 
detachment of the cells was that which was taken to represent the cell detachment strength 
related to L-selectin/L-selectin ligand bonds [256].  For the control experiment, an L-selectin 
antibody (DREG-56) was applied to the L-selectin coated  sensor to block binding sites.  
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Deposition of Mixed SAM on Gold  
Gold substrates were first cleaned in a solution of 30% H2O2, 25% NH3, H2O (1:15) at 
80oC for 5-10 minutes. Cleaned substrates were immersed in a binary mixture of 2.5 mM 
MUA and 7.5 mM NDt in absolute ethanol for three (3) hours at RT, followed by a 
thorough rinse in absolute ethanol, after which they were allowed to dry in a flow of 
clean dry air. A monolayer coating of 90Ǻ  thickness was measured by elipsometry.  
 
Covalent Attachment of Protein to SAM 
The SAM coated gold substrate was immersed in a solution of 20mM NHS and 10 mM 
EDC in ultrapure water for 2 hours at room temperature (RT) for “activation”, followed 
by immersion in a solution of  25 ug/ml L-selectin Fc Chimera in 10 mM PBS at pH 7.4 
for 2 hours at RT.  Remaining active binding sites were then blocked with 1M 
ethanolamine at pH 9.0 at RT for 20 minutes.  Following a thorough rinsing of  the  
substrate in ultrapure water,  all remaining binding sites are blocked with 1% BSA in         
10 mM PBS  for two hours at RT.   A detailed protocol for SAM deposition and the 
covalent attachment of L-selectin can be found in Appendix G.           
 
Spinning Disc Apparatus  
    Figure 37 shows the spinning disc apparatus used in this experimentation.  




The hydrodynamic shear detachment stresses that can be accurately generated with this 
(validated) spinning disc cell detachment apparatus range from ~15 to 350 dynes/cm2 .  
The apparatus was built with specifications which would assure the achievement of 
laminar flow. For a given rotational speed, the velocity and temperature of the fluid as 
well as the boundary layer thickness, δ, are constant, when the radius of the fluid 
chamber,  R,  is infinite compared to the radius of the spinning disc, r.  The infinite disc 
approximation is valid when   R/ δ > 50.   
Electrochemical Validation 
To test this criterion an electrochemical method described by Garcia [248] was conducted 
utilizing the redox couple ferrocyanide/ferricyanide . The electrochemical solution was 
prepared by dissolving 1.0 M KCl, 0.01 M K4Fe(CN)6, and 0.01 M K3Fe(CN)6 (generous 
         Figure 37: Spinning Disc Cell Detachment Apparatus( SDCDA) 
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gifts of Drexel University Chemistry Department), in DI water. KCl was used as the 
common ion to suppress electrical migration effects. Electrochemical measurements were 
performed with a l5 mm diameter disc of platinum foil glued onto the sample holder. The 
electrical circuit was established with an insulated wire soldered to the underside of the 
platinum disc, inserted through the shaft and connected to a slip ring assembly, which 
was  then connected to a potentiostat (model #283, EG&G, Princeton, NJ). The counter-
electrodes consisted of two strips of platinum foil (each 2”L x 0.5”W) placed against the 
interior chamber wall on opposite sides of the chamber. A saturated calomel electrode 
(SCE) (Drexel University, Chemistry Department) was used as the reference electrode 
(figure 38). It was placed centrally in the chamber, at a small vertical distance from the 
platinum disc to minimize IR drop.  At several disc speeds, single voltage sweeps over a 
potential range of   + 0.4V to -1.0V were made, and the resulting current was recorded 
 
Figure 38: Electrode configuration for spinning disc electrochemical 
validation of flow characteristics [379] 
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Experimental Protocol 
The Ishikawa cells were prepared for testing by detaching them from the culture flask by 
brief  trypsinization, after which the cell suspension was centrifuged, and the cells were 
re-suspended in serum free culture medium, and counted. The functionalized disc was 
masked with a custom cut silicone rubber sheet containing a centrally located              
3.5cm x 1cm opening .  The cells were seeded onto the disc at a concentration 6 x 105 
cells/ml and allowed to adhere, under static conditions, for 15 minutes, at 37oC. The 
silicone rubber mask was removed, the disc was placed on the sample holder in the 
chamber, and the chamber was carefully filled with 37oC PBS, while shielding them           
from any turbulence.  Each spinning disc experiment was 5 minutes in duration. The 
2320D Smart Motor (Animatics, CA) was controlled by LabView software which 
enabled input of a desired velocity (rpm) and rate of acceleration and deceleration.   
At the conclusion of the test, the PBS was drained, the mask was precisely replaced over 
the functionalized area with the remaining attached cells, and the cells were counted as a 
function of distance from the center. Images of the cell population were taken in 2mm 
increments across the diameter of the disc, and the cells were manually counted in each 
image. Figure 39 shows the experimental setup for quantification of the results.   
 








Parallel Plate Flow Apparatus 
The parallel plate flow apparatus was used to measure (low) detachment strengths 
associated with the L-selectin adhesion system. Validation of the QCM sensor, for use in 
the parallel plate flow apparatus, first required the evaluation of signal stability in the 




Figure 39: Experimental setup for microscopic imaging of the disc with 
attached cells, and the modified micrometer used to move the disc in          
precise 2 mm increments. 
 
Figure 40: QCM response to flow, over the hydrodynamic 
shear range of 0 to 10 dynes/cm2 
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The parallel plate flow apparatus was then  used to examine the detachment strength of 
Ishikawa cells to substrate functionalized with  L-selectin covalently bonded to an SAM.  
The detachment strength is determined by the shear force which is required to detach 
50% of the cells. Figure 41 shows the results of this test. Cells were counted at seeding 





During the cell detachment assay, the frequency response of the QCM sensor was 
monitored as well (figure 42)  
  Figure 41: Parallel Plate cell detachment assay using Ishikawa cells:  
(A) Ishikawa cells on L-selectin functionalized gold surface                           
(B) Ishikawa cells on DREG 56 antibody blocked L-selectin            
functionalized gold surface 
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Spinning Disc Cell Detachment Apparatus 
The spinning disc cell detachment apparatus was used to evaluate (stronger, secondary ) 
detachment strengths associated with the integrin/ligand adhesion system.  Prior to the 
experimental work the theoretical flow pattern of the system was validated through an 
electrochemical validation protocol using the ferrocyanide/ferricyanide redox couple, as 
shown in Figure 43.  
 
Figure 42: QCM frequency response in parallel plate cell detachment assays 
using Ishikawa cells on L-selectin functionalized sensor 
 





The spinning disc rotational speeds used for this testing ranged from 1500 to 2000 RPM. 
The detachment profile for cells at these two different angular velocities was evaluated 
for consistency.  Figure 44 shows the Ishikawa cell detachment profile on a 100% 
fibronectin coated substrate for 1500 and 2000 RPM, and the resultant adhesion strength. 
Cell counts were normalized to the number of adherent cells at the disc center.  
 
 
Figure 43:  (A) Current-Voltage curves showing limiting current for the spinning 
disc electrode as a function of disc speed.   
                   (B) The values for the limiting current obtained from the polarization 
curves, versus disc speed. 





Attachment strengths attributed to integrin/ligand interactions, were investigated with the 
spinning disc apparatus.  The potential modulating effect combining L-selectin  and 
fibronectin was also explored by quantifying attachment strengths of Ishikawa cells on 
coatings of various ratios of fibronectin (FN) and L-Selectin (LS). Figure 45 shows the 
detachment profile for Ishikawa cells on various substrates, as well as the relationship of 
these values to the % of fibronectin.  
Figure 44: Determination of detachment strength for Ishikawa cells on  
a fibronectin substrate at two different angular velocities.  






5.4 Discussion  
Parallel Plate Flow Apparatus 
While parallel plate flow chambers are useful for monitoring “low strength” primary 
cellular interactions, one disadvantage is that most flow chamber designs must utilize 
A 
B 
Figure 45: (A) Cell detachment profile for Ishikawa cells on mixtures of 
fibronectin and L-selectin of varying ratios  
                  (B) Relationship of cell detachment strength to  fibronectin 
concentration 
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costly high-speed cameras to observe cell motion and velocity, however typically this is 
not done in real-time.  Experimentation with high-speed cameras requires the user to 
review collected data and conduct secondary analysis to characterize cellular interactions. 
Computer programs do exist to calculate cell numbers when recorded through a 
microscope however, they are cumbersome to use, and can be inaccurate especially when 
high density cell populations are used.  The parallel plate flow chamber with a QCM 
sensor incorporated is a novel configuration that will allow the monitoring of cell 
detachment kinetics in real time. The work reported in this thesis is the first step towards 
the goal of real time monitoring, without microscopic observation and cell counting. The 
QCM sensor was first evaluated for its suitability in this application by examining 
background sensitivities, such as frequency shifts in the presence of hydrodynamic flow.  
The high level of signal stability that was seen with the QCM sensor (Figure 40), over all 
flow rates that are used in this apparatus, verifies that this sensor has little to no 
sensitivity to hydrodynamic flow, and thus is suitable for use in this application.    
Preliminary work to determine the optimum incubation period for the cells to attach to 
the L-Selectin surface showed that it should not exceed 6 minutes. After this, the 
detachment strength of the cells exceeded the maximum shear forces (10 dynes/cm2) that 
could be generated by this apparatus [378]. This increase in detachment strength is 
thought to be associated with cell spreading, which occurs after the strength is thought to 
be associated with cell spreading, which occurs after the preliminary attachment 
processes associated with the L-selectin adhesion system .  
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When the Ishikawa cells were added and incubated statically for 6 minutes, the shear 
stress that resulted in the detachment of 50 % of the cells was 0.5 dynes/cm2 (flow rate = 
63 ml/min).  The threshold shear stress range required to support rolling and attachment 
in neutrophils through L-selectin/L-selectin ligand interactions has been quantified at 0.4 
to 1.9 dynes/cm2 [166, 168]. The detachment strength determined here correlates very 
well with these values.  When the L-selectin coating was blocked by DREG-56, an L-
selectin antibody, virtually all of the Ishikawa cells detached under the same shear stress. 
This supports the conclusion that the detachment forces being measured are due to L-
selectin/L-selectin ligand interactions.    
Though these tests relied greatly on cell counting for final quantification, the output of 
the QCM sensor correlated well with the temporal detachment process. In figure 42,  
QCM signals are shown for two samples. In one  test, represented by a blue line, the 
adhesive interactions of Ishikawa cells on an L-selectin functionalized surface were 
monitored (normal adhesion), and in the other test, represented by a red line, the adhesive 
interactions of Ishikawa cells on a surface,  functionalized with L-selectin, but blocked by 
an L-selectin antibody,  were monitored (anti-body control). For the first 10 minutes, 
baseline stability readings were taken. This is followed by the perfusion of Ishikawa cells 
into the chamber and a 6 minute static incubation period.  The third section represents the 
sensor signals while the hydrodynamic shear forces are being applied.  
The baseline readings for both sensors, while somewhat noisy, do not show any 
significant level of net drift in the signal.  However, the static incubation period shows 
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considerable between the “control” and the “normal adhesion” samples.  The steady 
downward drift of the “normal adhesion” signal can be interpreted as the cells adhering to 
the L-selectin as they contact functionalized surface, thus adding mass to the sensor, and 
dampening the frequency of the crystal resonator. In the control sensor, even though a 
slight change in the signal is seen, there is no downward drift indicating that adhesion to 
the surface probably not occurring. Upon the initiation of the flow, the signal for each 
sensor increases however, by different amounts. Whereas the control sensor returns to its 
original signal at the end of the stability period, the test sensor (normal adhesion) returns 
to a signal that is ~50 db lower than its value at the end of the stability testing. Both of 
these observations are consistent with the microscopically determined results. That is, 
~50% of the cells remained attached to  the L-selectin functionalized surface, after the 
hydrodynamic shear stresses were introduced, thus the remaining cell mass was indicated 
by the sensor signal. However, with the antibody blocked control sensor, virtually all 
cells were removed from the surface under hydrodynamic forces, so the sensor signal 
returned to its original signal before cells were added. In conclusion, though the data are 
not quantitative, we have obtained positive results to support the feasibility of 
incorporating a QCM sensor into this device as a means to monitor in real time, the 
cellular adhesion events associated with “low strength” primary attachment mechanisms 
such as those which occur between L-selectin and its ligands. However, further validation 
of this modified apparatus is required to obtain direct quantitative information. 
Furthermore, by visually quantifying the cellular attachment characteristics, we have, for 
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the first time, determined an attachment strength value for the L-selectin/L-selectin ligand 
adhesion system in a cell model for the process of blastocyst implantation.     
 
Spinning Disc Cell Detachment Apparatus (CDA) 
The spinning disc apparatus generates shear forces through laminar flow, in a  radial 
pattern over the disc. As the disc rotates, the fluid is drawn in axially from the 
surroundings, and as it approaches the surface of the disc, it acquires a rotational motion 
which forces it to exit radially [248].  A schematic of the idealized flow pattern for the 
spinning disc apparatus is shown in figure 11: Chapter 1 [265].  To achieve laminar flow, 
the surface must be uniformly accessible, and the diffusive field must be uniform across 
the surface of the disc [248].  
The spinning disc cell detachment  apparatus was built with specifications so that laminar 
flow could be achieved (e.g. no head space in the  filled chamber, chamber dimensions 
infinitely large compared to the disc size). For steady laminar flow, the velocity, 
temperature and concentration boundary layer thicknesses are constant for a given 
rotational speed and independent of radial distance [248].  Under these conditions, the 
disc is a uniformly accessible surface and the diffusive field is uniform over the surface 
of the disc. In this design, the shear stress, τ, varies linearly with radial distance and is 
given by:       
                           τ = 0.800 r (ρμω3)1/2                                                            (4)  
Where ρ = fluid density, μ = fluid viscosity and ω = angular velocity.  
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Electrochemical validation of the spinning disc CDA flow pattern was performed in 
accordance with the protocol outlined by Garcia [248].   On a platinum electrode, the 
reduction of ferricyanide to ferrocyanide is a rapid charge transfer reaction. The overall 
reaction rate is therefore dependent only on the transport of ions. This transport is  
limited by diffusion, which is influenced by three factors: migration due to  an electrical 
gradient, diffusion due to a concentration gradient, and convection as a result of  bulk 
fluid movement. The effects of the electrical gradient (IR drop) are negated with the use 
of a common ion (KCl) at a high concentration, (1M). Therefore for an instantaneous 
reaction  at the electrode, the  reaction rate is dependent on diffusion and convection. The 
flow of ions to the platinum working electrode increases as the potential applied to the 
system increases, and this is seen by an increase in current, until a diffusion limited 
current density is obtained [248, 380, 381].  The limiting current then remains constant 
with further increases in potential, unless another cathodic reaction (such as the reduction 
of water) is activated. If a uniform diffusive field exists across the disc surface then the 
current density achieved at a given voltage and angular velocity should be according to 
the equation: 
 
                                                   iL =   nFci D 2 / 3 ω1/ 2                                                                (7) 
                                                                1.61 υ1/6 
where iL = limiting current density, n = number of  electrons in the charge transfer 
reaction, F = Faraday’s constant, ci = ion concentration, D = diffusivity, ω = angular 
velocity and υ = kinematic viscosity [248].  Figure 42 (A) shows the current- voltage 
  156  
curves obtained with this spinning disc apparatus, where the limiting current is directly 
influenced by the angular velocity of the rotating disc. Figure 43(B) shows that this 
relationship is linear, in agreement with the theory presented, thus for the speeds 
examined, the transport patterns generated correlate well with those for an infinite 
spinning disc.    
In exploring integrin/ligand interactions, with the spinning disc, the Ishikawa uterine 
epithelial cell line was used, with substrates functionalized with the integrin receptor, 
fibronectin.  Fibronectin is a ligand which can bind to several integrin receptors, 
including α3β1, α8β1and αvβ3 [382].  There is substantial evidence that the integrin ανβ3 is 
directly involved in the blastocyst/uterine epithelial adhesion process. This integrin binds 
to the RGD motif in fibronectin, osteopontin, vitronectin and laminin, among others [125, 
126]. It is also expressed in Ishikawa cells [81].    
Prior  to more in-depth probing of  the integrin/ligand interactions with Ishikawa cells, 
we wished to answer one additional question with regard the spinning disc validation 
regarding the consistency of the range of forces generated at different angular velocities. 
Theoretically, the detachment strengths for the same cell line adhering to the same 
substrate under the same conditions should be the same regardless of the angular velocity 
at which it was tested, with the radial distance at which 50% of the cells detach being the 
only variable.   In figure 44 the results of the detachment experiments at different angular 
speeds for Ishikawa cells on 100 % fibronectin are shown, where the normalized fraction 
of adherent cells is plotted versus the shear stress. For a cell population with normally 
distributed adhesion properties, the detachment profile is predicted to fit a symmetrical 
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logistic equation [248].   The detachment strength values (τ50 ) were determined using the 
following relationship:   
f =                f0                                                                                    
        1  + exp [b (τ - τ50)]                                         (8)  
 
where f is the experimental adherent cell fraction,  τ  is the shear stress on the disc 
surface,  f0   is the cell fraction  at “0” stress (typically near 1), b is the decay slope, and τ50 
is the inflection point, ideally where f =0.5  The τ50  values for obtained (144 and 168 
dynes/cm2 for 2000 and 1500 RPM, respectively) are in good agreement with each 
other(σ = 17), Though no data has been reported regarding quantification of 
integrin/ligand  interactions  with Ishikawa cells, the values obtained here are within the 
range of normal adhesive strengths for  these systems i.e. 50-200 dynes/cm2 [266, 269].  
Though optimum experimental protocol would specify all tests at the same speed, the 
results of this examination support direct comparison of test data obtained at different 
speeds. The small variations seen are hypothesized to be a result in heterogeneities in the 
cell populations, cell size and possibly receptor numbers, since the cells used in a series 
of tests were detached and counted at the same time, but incubated in a centrifuge tube 
(where they could not reattach) for varying amounts of time prior to seeding on the 
functionalized disc. These could be minimized by protocol revisions for cell preparation.  
After the initial low strength binding interactions mediated through the L-selectin 
adhesion system, integrins are thought to play an important role in affecting secondary 
  158  
strengthening interactions. In parallel to the temporal adhesion interactions demonstrated 
in neutrophils, primary low strength L-selectin mediated interactions in the process of 
blastocyst implantation are thought to initiate the up-regulation and/or activation of 
integrins through MAPK signaling cascades. We questioned whether or not the presence 
of L-selectin in the substrate would facilitate this sequential series of interactions, and 
therefore influence the resulting detachment strength values.  Thus, attachment strengths 
of Ishikawa cells on coatings of various ratios of fibronectin (FN) and L-Selectin (LS) 
were evaluated. The ratios used were 25% fibronectin/75% L-selectin (1:3 FN/LS), 50% 
of each component (1:1 FN/LS), 75% fibronectin/25% L-selectin (3:1 FN/LS), and 100 
% fibronectin (1:0 FN/LS).  In figure 45A, the fraction of adhered cells is plotted versus 
shear stress, and radial distance from the center for each of these conditions. The 
progressive increase in τ50  with fibronectin concentration  is  evident, however, this linear 
relationship is clearly seen in figure 45B.   
Garcia, et al. has used the spinning disc apparatus to elucidate cooperative binding effects 
with integrin/ligand  adhesion interactions [266, 269]) in untreated IMR-90 (human 
fibroblast) cells.  However, it was found that, with short incubation times (15 minutes) 
these effects were absent. Instead, it was determined that a linear relationship existed 
between the adhesion strength and fibronectin density.   The results obtained with 
Ishikawa cells would also support this conclusion. The optimum incubation time in this 
testing was determined to be 15 minutes.  At longer incubation times, the cells were 
observed to be spreading, and had attachment strength increased beyond values which 
could be generated by the spinning apparatus.   Both of these observations would indicate 
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that more complex interactions between the cells and substrate were occurring after 15 
minutes.  
In conclusion, adhesive interactions between Ishikawa cells and L-selectin have been 
quantified through the use of a parallel plate flow chamber, and found to be in the range 
of values obtained for similar interactions with neutrophils.  Furthermore, integrin/ligand 
interactions with Ishikawa cells have been quantified with a spinning disc cell 
detachment apparatus, and been found to be within the range of normal adhesive 
strengths for these systems i.e. 50-200 dynes/cm2.  Experimental results with the mixed 
L-selectin/fibronectin substrates support the hypothesis that within the 15 minute 
incubation time, L-Selectin mediated integrin activation is probably not occurring, and 
the various adhesion strengths seen are most likely due to the range of fibronectin 
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CHAPTER 6: SUMMARY AND CONCLUSIONS 
 
 
This project has focused on furthering the understanding of biochemical and mechanical 
mechanisms involved in the human blastocyst implantation process, with the long term 
goal of developing strategies for enhancing the initial embryonic attachment event in 
women undergoing fertility treatments.  This occurrence is thought to be mediated by the 
L-selectin adhesion system.  Further secondary events, namely strengthening of the 
adhesive bond, are thought to occur through integrin/ligand interactions. Little  
information exists, however, as to the effects of cytokines, exogenous hormones, and 
other endocrine mediators on these critical events. Further, no information exists with 
regard to the mechanical aspects of the attachment process.  
Toward that end, a cell model, consisting of trophoblast-like Jeg-3 cells and uterine 
epithelial like Ishikawa cells has been established. The Jeg-3 cell line has been shown to 
constituitively express L-selectin, and undergo modulation of the expression levels in 
response to progesterone and estrogen hormonal influences. Most importantly, the L-
selectin is expressed on the cell membrane, a required condition to facilitate adhesive 
interactions with L-selectin ligands. The other trophoblast like cell lines (JAR and  
BeWo)  which were evaluated did not appear to express this protein on the cell 
membrane.  
Ishikawa (uterine epithelial) cells have been well characterized with regard to the 
expression of protein biomarkers of uterine receptivity, however, they have not been 
evaluated for expression of L-selectin ligands.   We found that Ishikawa cells do express 
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MECA 79 reactive L-selectin ligands, which contain the requisite sulfated sialyl Lewis x 
oligosaccharide. Further, we found that ligands expressed at MW 80 and 90 kDa are 
responsive to hormonal conditioning by progesterone and estrogen.  One specific L-
selectin ligand, MadCAM was also identified.  Since trophoblast attachment and 
implantation into uterine epithelium has been proposed to mimic leukocyte attachment 
and extravasation through the vascular endothelium [142] we hypothesized that Ishikawa 
cells would only express the 40 kDa glycoform of MadCAM-1 analogous to that found in 
vascular endothelium.  Confirming this hypothesis, a strong signal was detected using an 
antibody to the 40 kDa glycoform of MadCAM-1 by immunoblot analysis, while an 
antibody against the 60kDa glycoform did not react.  In this work, the constitutive 
expression, and hormonal regulation  of the class of  MECA 79 reactive L-selectin 
ligands, as well as MadCAM-1,  is a novel and important finding which will allow this 
cell line to be utilized as a cell model in future experiments. 
Dexamethasone and other glucocorticoids such as prednisone, prednisolone and methyl 
prednisolone have been used to treat infertility as a routine step in IVF treatment 
protocols, and in the context of inflammatory disease, such as PCOS. The modulation of 
L-selectin/ligand system by glucocorticoids in the reproductive process is not well-
understood. The Jeg-3/Ishikawa trophoblast/uterine epithelial cell model was used to 
explore the effect of physiological levels of dexamethasone on the L-selectin adhesion 
system. When we evaluated the effect of dexamethasone on cellular L-selectin expression 
by western blot, we found a slight  upregulation after 48 hours.  When the culture 
medium was analyzed for soluble L-selectin by ELISA, it was determined that 
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dexamethasone induces shedding of L-selectin in trophoblast like cells, an effect which 
has been characterized in neutrophils. However, an unexpected finding was the 
significant down regulation of MECA 79 reactive L-selectin ligands in the Ishikawa 
uterine epithelial cell line, as determined by western blot.   Both of these observations are 
novel and important findings which indicate that the use of dexamethasone in IVF 
protocols might in fact have a detrimental effect on the outcome.  
Intra-uterine fluid flow characteristics are not well understood, however, it can be 
assumed that there is at least a mixing flow provided by asynchronous contractions [176] 
and mucin secretions by the endometrium [141].   Fluid flow has been shown to increase 
L-selectin expression in neutrophils [162]. We tested the condition of hydrodynamic fluid 
flow on the Jeg-3 trophoblast-like cell line to determine its potential modulating effect on 
the expression of L-selectin, and found an increase in L-selectin expression of around 
30%. Though L-selectin can be shed from a rolling leukocyte through tethering 
interactions with ligands expressed on the vasculature, shedding as a result of 
hydrodynamic shear forces alone has not been investigated. The culture medium of Jeg-3 
cells exposed to hydrodynamic shear forces was evaluated for shed L-selectin, and an 
insignificant amount was found.  This is a significant and novel finding because of the 
possible clinical treatments that could be implemented with the use of flow, in vitro, to 
stimulate L-selectin expression in a developing blastocyst prior to transfer.  
It has been demonstrated that the initial capture of leukocytes and subsequent rolling 
requires critical thresholds of shear stresses to occur [162-164]. The threshold shear 
stress range required to support rolling and attachment through L-selectin mediated 
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interactions has been quantified at 0.4 to 1.9 dynes/cm2 [166, 168].  Integrin/ligand 
interactions facilitate secondary, higher strength bond formation. Depending on the 
concentration of the ligand (eg, fibronectin), bonding strengths ranging from 50 – 200 
dynes/cm2 have been measured in in-vitro systems [266, 269]. The mechanical aspects of 
L-Selectin and integrin mediated interactions in implantation events have not been 
quantified. In this project, two cell detachment measurement systems were built and 
validated for the purpose of evaluating detachment bond strengths associated with both 
primary and secondary adhesion events in the implantation process, which are thought to 
parallel those of leukocyte attachment. A parallel plate flow apparatus was used to 
quantify bond strengths between L-selectin ligand expressing Ishikawa cells, and an L-
selectin functionalized substrate, which are thought to correspond to bond strengths of the 
initial or primary adhesion events in the implantation process. The forces measured (0.5 
dynes/cm2) closely paralleled those seen for primary low strength binding of leukocytes 
to vascular endothelium. This information has provided, for the first time, some insight 
into the functional mechanics of the L-selectin adhesion system associated with initial  
reproductive events. The parallel plate flow apparatus was also modified to include a 
QCM sensor, which is a novel addition that will allow the monitoring of cell detachment 
kinetics in real time.  
A spinning disc cell detachment apparatus was built in our lab and validated with an 
electrochemical technique following a protocol first introduced by Garcia [248].  Bond 
strengths were measured between integrin expressing Ishikawa cells and a substrate 
functionalized with an integrin ligand (fibronectin). The spinning disc apparatus was 
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further validated for consistency of the range of forces generated at different angular 
velocities, and found to have acceptable reproducibility. Tests were also conducted on a 
substrates functionalized with a combination of fibronectin and L-selectin.  Experimental 
results with the mixed L-selectin/fibronectin substrates support the hypothesis that within 
the 15 minute incubation time, L-selectin mediated integrin activation is probably not 
occurring, and the various adhesion strengths seen are most likely due to the range of 
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CHAPTER 7: FUTURE WORK 
 
This project has laid the groundwork for continuing research in two key areas which will 
provide further insight into the critical mediators of initial attachment mechanisms 
involved in blastocyst implantation.  The biochemical aspects of this process have been 
characterized to a small extent, with the identification of the L-selectin adhesion system, 
and the integrin/ligand adhesion system, however, critical modulators for the expression 
of these proteins have not been explored. Furthermore, the mechanical aspects of the 
attachment process have not, to our knowledge, been characterized, by any other group. 
The suggestions listed below are focused on these two areas.  
 
7.1 Understanding the biochemistry of implantation 
The effect of other key biomarkers of implantation, such as the IL-6 family of 
interleukins, IL-1, LIF and CSF on the temporal expression of L-selectin and its ligands 
is not known.  Using the same techniques and protocols as those used in this project, as 
well as the cell model established for the study of L-selectin/ligand adhesion system, the 
effects of these important  proteins on the L-selectin/ligand adhesion system could be 
elucidated. Additionally, the effects of endogenous and exogenous molecules, thought to 
be relevant factors in infertility, such as testosterone, leptin, and the inflammatory 
cytokine, TNF-α  could be elucidated, in a manner similar to the work reported in 
Chapter 4 with dexamethasone.  
There are five well characterized ligands for L-selectin:  GlyCAM-1, PSGL-1, CD34, 
MadCAM-1 and podocalyxin. The first four contain sulfated sialyl Lewis x 
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oligosaccharide moieties, and may be detected by the MECA 79 antibody, however, this 
antibody is still non-specific in that it detects only a class of ligands with this definitive 
property.  MECA 79 reactive ligands as well as one specific ligand, MadCAM-1, have 
been found on the Ishikawa uterine epithelial cell line.  MECA 79 reactive ligands have 
also been seen on uterine epithelial tissue by other researchers [141], and has been 
detected by immunohistochemistry in our lab [383]. In order to further validate the 
Ishikawa cell line as an appropriate cell model for the implantation process, it is 
necessary to continue to correlate its expression characteristics those of actual the human 
tissue. Thus, verifying the presence or absence of MadCAM-1 on uterine tissue would be 
important. Furthermore, the known L-selectin ligands have somewhat varying functions in 
the body.  By identifying the specific L-selectin ligands present on uterine epithelial tissue, 
the mechanism of the ligand function could be further defined.  
It is believed that, L-selectin binding is dependant on sulfation of the ligand [186]. 
Sulfation is a post translational modification, requiring the mediation of sulfotransferase 
enzymes.  The essential nature of sulfotransferase enzymes was demonstrated by 
Uchimura whose group showed that a major class of L-selectin ligands is eliminated in 
mice deficient in GlyNAc6ST-1 and GlyNAc6ST-2 [199].  Thus, a more complete 
understanding of the mechanism of L-selectin ligand expression in uterine epithelial 
tissue would be gained by studying the function of the sulfotransferase enzymes in the 
Ishikawa cell line.  
In this project, an IRB protocol for the collection of human uterine tissue was established 
and approved (Protocol #15822).  To date the human biopsy tissue collected has been 
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preserved and evaluated immunohistologically.  However, the storage protocol for the 
retrieved tissue could be modified such that 3D epithelial culture systems, consisting of 
both stromal and epithelial cells could be established.  This system would allow cells to 
organize into structures recapitulating their in vivo geometry and provide a cell-based 
model to study the interactions of endometrial epithelium and trophoblast cells in a more 
biologically relevant context. Briefly, the protocol for the establishment of the primary 
cell culture would follows that which has been established by Satyaswaroop [384].  
Primary cells are cultured in phenol red free media under estrogen-free conditions and 
evaluated by immunofluorescence to confirm maintenance of cell specific markers. For 
co-cultures, Matrigel coated gold surfaces are seeded first with human primary 
endometrial stromal cells which are allowed to attach. After attachment of the stromal 
cells, endometrial epithelial cells are seeded over the stromal cells. For analysis of 
biological and morphological changes, fluorescence and confocal microscopy can be 
used.  This 3-D endometrial epithelium culture system offers a powerful system to model 
early events in implantation, identify molecular pathways regulating changes in tissue 
architecture, and evaluate therapeutic agents in a more physiological setting.  
 
7.2 Quantifying the mechanical aspects of implantation 
In this project, equipment has been developed and validated, and protocols have been 
established to quantify the attachment forces related to the L-selectin and integrin  
adhesion systems in an implantation cell model consisting of trophoblast-like Jeg-3 cells 
and uterine epithelial-like Ishikawa cells. Attachment/detachment strengths of Ishikawa 
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cells on L-selectin as well as integrin ligand substrates have been quantified. These 
studies can be greatly expanded to facilitate a functional understanding of expression 
levels in the L-selectin and integrin adhesion systems and their regulation by endogenous 
or exogenous hormones, and allow further investigation into regulation by cytokines and  
inflammatory mediators.   Additionally, the upregulation of L-selectin on Jeg-3 cells in 
response to fluid flow has been shown.  
For the spinning disc cell detachment apparatus, integrin/ligand interactions could be 
temporally quantified with a focus on the integrin biomarkers of implantation, αν β3  and , 
α4β1.   Further, the effects of endogenous or exogenous hormones, cytokines and  
inflammatory mediators could be quantified, for the first time.    
The parallel plate flow apparatus, offers a powerful system for quantifying the critical 
attachment strength necessary to stabilize a blastocyst in an environment of fluid flow 
through L-selectin mediated adhesion interactions.  With the addition of the QCM sensor, 
these interactions can be monitored in real time, an advantage which significantly reduces 
the time required for post experimental analysis. The first task to facilitate the full use of 
this sensor is to quantitatively characterize the cell detachment process in terms of the 
sensor signal output.  With the Jeg-3 trophoblast-like cells, the effects of endocrine 
mediators (progesterone and estrogen) and steroid hormones  (eg, dexamethasone) on L-
selectin  shedding, capping and attachment mechanics under static and shear force 
conditions could be quantified using functionalized substrates of varying complexity from 
the sialy Lewis x tetrasaccharide molecule, to cultured Ishikawa cells, and finally to the 
optimized 3D endometrial epithelial cultures. Trophoblast cells could be tested individually, 
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or in a spherical blastocyst-like configuration, produced in accordance with the protocol 
used by Tinel, et al. [304].    In figure  46, a schematic of the proposed experimental 




Figure 46: Schematic design of Ishikawa cell or EEC surface on a Matrigel-coated gold      
substrate will provide a model of the endometrial epithelium. Jeg-3 cells will either be 
flowed over the substrate and attachment strength will be quantified or attached to the 
Ishikawa or EECs and sheared off, thus quantifying detachment strength.  
 
Conditioned or control Jeg-3 cells, collected after exposure to hydrodynamic shear 
(attached cells from the substrate or un-attached cells from the collection chamber) could 
be analyzed for L-selectin expression and capping. Cell-surface exposed L-selectin could 
be detected and quantified by flow cytometry. Capping and spatial and temporal 
redistribution of L-selectin on the cell surface of Jeg-3 cells could be imaged through 
confocal microscopy.  Retained fluid could also be tested for L-selectin shedding using 
the specific ELISA established in our laboratory. Protein expression of L-selectin post 
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treatment could be quantified by immunoblot and by immunohistochemistry as described 
in Chapter 3, using the Dreg-56 L-selectin-specific antibody.  
While the cell models and experimental techniques employed here are extremely useful 
in characterizing L-selectin and integrin mediated interactions, they are limited in the 
extrapolation of this data to the human implantation condition. Future research will build 
on this work to advance strategies for enhancing the initial embryonic attachment event 
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APPENDIX A 




A.  Adherent Cell Lines 
1.    Equipment and Materials 
i.          Ishikawa (uterine epithelial) cells 
ii.    Jeg-3 (trophoblast) cells 
iii.    BeWo (trophoblast) cells  
iv.    JAR (trophoblast) cells 
v.         75 cm2 cell culture flasks with vented caps 
vi.    Sterile pipettes  
vii.    Sterile 15 ml centrifuge tubes 
viii.    Phosphate buffered saline solution (PBS) 
ix.    Sanitizing disposal solution (betadine or bleach)  
x. Culture medium for Jeg-3 and Ishikawa cell lines: Eagle’s 
Minimum Essential Media (MEM), #30-2003 (ATCC) with 10% 
Fetal Bovine Serum (FBS)  
xi. Culture medium for BeWo cell line: Kaighn's Modification of 
Ham's F-12 Medium (F-12K) #30-2004 (ATCC) with 10% Fetal 
Bovine Serum (FBS) 
xii. Culture medium for JAR cell line: RPMI-1640 Medium,            
#30-2001 (ATCC) with 10% Fetal Bovine Serum (FBS) 
xiii. Centrifuge  
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xiv.    Incubator maintained at 37oC, with 5% CO2 
 
2.  Cell cultures  of JAR, Jeg-3 and Ishikawa cells are ready to be passaged 
(split)  when they are 70-100% confluent.   
3.  For BeWo cells, passaging should be done when cultures reach 60-80%        
confluency. 
4.  With a sterile pipette, remove culture medium and discard in sanitizing 
disposal solution  
5.  For BeWo, JAR and Jeg-3 cell lines, briefly rinse the cell layer with 0.25% 
(w/v) Trypsin-0.03% (w/v) EDTA solution to remove all traces of serum 
(which contains trypsin inhibitor).  
6.   For Ishikawa cells, briefly rinse the cell layer with PBS 
7. Add 2.0 to 3.0 ml of Trypsin-EDTA solution to the  flask and incubate at 37oC   
for 5-15 minutes. (Periodically observe cells under an inverted microscope. 
When  cell layer is separated into small aggregates, proceed to step 8.             
DO NOT agitate  cells during this incubation period)  
8. Add 9.0 ml of  FBS supplemented culture medium and separate cells by   
gently pipetting, and lightly tapping the flask to provide aggitation.  
9. Remove all culture medium with inactivated trypsin and  cell suspension by    
pipette, and transfer to a sterile 15 ml centrifuge tube.   
10.  Pellet the cells by centrifuging at 1000 RPM for 5 minutes. 
11.  Pour off supernatant, and resuspend the cells in 10 mls of fresh FBS   
supplemented culture medium.  
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12.  Add appropriate aliquots  of the cell suspension to new culture vessels:   
i.       Split ratio for Ishikawa and Jeg-3 cell lines ~ 1:10 
ii. Split ratio for JAR cell line ~ 1:20 
iii. Split ratio for BeWo cell line ~ 1:5 
13.  Add enough fresh FBS supplemented culture medium to the flask to achieve     
a  total volume of 15 mls.  
14.  Incubate cultures at 37oC to  recommended confluency levels before splitting. 
B. Non-adherent  Cell Line 
1. Equipment and Materials  
 i.          U-937 cell line  
ii. Sterile pipettes  
    iv.        Sanitizing disposal solution (Betadine or bleach)  
v. Culture medium for U-937 cell line: RPMI-1640 Medium,            
#30-2001 (ATCC) supplemented with 10% Fetal Bovine Serum 
(FBS) 
vi. Incubator maintained at 37oC, with 5% CO2 
2 .   Cells should be split when they reach an ~ concentration of  1 – 2 x 106   
cells/ml 
3.    Remove 13. 5 mls of the cell suspension and discard in sanitizing disposal 
solution.   
4.     Add 13.5 mls of  fresh  culture medium supplemented with 10% Fetal 
Bovine  Serum (FBS).  
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5.    Incubate at 37oC in 5% CO2 until cells reach a concentration of                         
1 – 2 x 106 cells/ml. 
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APPENDIX B 




A.  Equipment and Materials 
1.   Estradiol (10-5 M)  in ethanol (stock) 
2. Progesterone (10-3 M) in ethanol (stock) 
3. Dexamethasone (10-4 M)  in ethanol (stock)   
4. Sterile phosphate buffered saline solution (PBS)  
5. Sterile pipettes  
6. Sterile phosphate buffered saline solution (PBS) 
7. Sterile centrifuge tubes 
8. Sanitizing disposal solution (Betadine or bleach)  
9. Phenol red free culture medium, supplemented with 10% charcoal stripped 
fetal bovine serum (FBS): 
i.          JAR and U-937 cell lines:  RPMI-1640,  #MT-17-105CV (Fisher 
Scientific) 
ii.  Ishikawa, Jeg-3 and BeWo cell lines: D-MEM F-12, 
#21041(Gibco)  
B. Conditioning Protocol 
1. Passage cells according to standard protocol, and allow to incubate for 24  hrs. 
to assure that cells are in log growth phase. 
2. For adherent cell lines, remove culture medium by pipette, and discard. 
Follow steps 3-6.  
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3. Wash adherent cells with 5-10 mls of PBS 1X, remove PBS by pipette, and 
discard.  
4. Replace original culture medium with similar amount of FBS supplemented 
phenol red free culture medium. 
5. Add desired stock hormone solution to test flask in 1:1000 concentration 
6. Incubate conditioned cultures at 37oC (5% CO2) for 24 hours before collection 
and cell lysate preparation.  
7. For non-adherent cell line, follow steps 8-14.    
8. Remove cell suspension and place in appropriately sized centrifuge tube.  
9. Pelletize the cells by centrifuging for 5 minutes at 1000 RPM.  
10.  Pour off supernatant 
11.  Resuspend cells in 10-20 mls of PBS, aspirating gently to assure complete  
washing.  
12.  Pelletize the cells by centrifuging for 5 minutes at 1000 RPM.  
13.  Pour off supernatant. 
14.  Resuspend cells in an amount of FBS supplemented phenol red free culture 
medium similar to the original amount of culture medium. 
15.  Add desired (stock) hormone solution to test flask in 1:1000 concentration 
16.   Incubate conditioned cultures at 37oC (5% CO2) for 24 hours before 
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This protocol was developed for the preparation of cell lysates from Ishikawa, JAR, 
Jeg-3 and BeWo cells. The lysates were intended to be analyzed for L-selectin and     
L-selectin ligands.  
A.   Lysis Buffer  
1.  Equipment and Materials 
i.   Molecular grade water 
ii.   Tris-acetate (1M) solution in water (stock) 
iii. Calcium chloride (CaCl) (0.5M) solution in water (stock) 
iv. 10% NP-40 solution in water (stock)  
v. Sodium orthovanadate (100 mM) in water (stock)  
vi. Pepstatin (1g/ml) in water (stock)   
vii. Sodium fluoride (NaF) (1M) in water (stock)  
viii. Chymostatin (10 mM) in Dimethyl sulfoxide (stock)  
ix. Benzamidine HCl (10mg/ml) in water (stock)  
x. “Complete Mini” protease inhibitor cocktail tablets (Roche) 
xi. Ice 
2.  Add 9.6 mls of molecular grade water to a 15 ml conical centrifuge tube (or  
similar container)  
3.  Add 100 uL of stock Tris-acetate to the water 
4.  Add 100 uL of stock CaCl to the water 
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5.  Add 100 uL of stock NP-40 to the water 
6.  Mix well and place the solution on ice to cool for ~15 minutes 
7.  Add 100 uL of stock sodium orthovanadate to the solution  
8.  Add 10 uL of stock NaF to the solution  
9.  Add 10 uL of stock pepstatin to the solution 
10.  Add 1 “complete mini” tablet to the solution  
11.  Mix the solution to dissolve the tablet: keep cold 
12.  Add 50 uL of stock chymostatin to the solution 
13.  Add 10 uL of stock benzamidine HCl to the solution 
14.  MIX WELL and keep cold: store at 4oC for no longer than one week 
B. Collection of Cells and Lysate Preparation 
1. Equipment and  Materials  
i. Microcentrifuge tubes 
ii. Lysis buffer 
iii. Ice 
iv. Syringes with 22 gauge needle or higher 
v. Cell scrapers  
2.  NOTE: All steps should be performed at 4oC, or as close as possible to   this 
temperature 
3.  Remove culture/conditioning medium from culture flask 
4. Wash the adherent cells 1X with sterile PBS (2 – 10)  mls depending on the 
flask size)  
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5.  Remove PBS by suction; allow all PBS to drain to the bottom of the flask, 
and maintain suction until all is removed before adding the lysis buffer. 
6. Add sufficient  lysis buffer to the flask to assure a complete layer of  coverage 
(200-500 uL, depending on the flask size 
7.  After 5 minutes, begin scraping the cells from the flask surface.  
8.  Transfer cells in lysis buffer to a microcentrifuge tube, keep cold. 
9.     Incubate cells in lysis buffer for 30 minutes; vortex the solution about  every 
10 minutes. 
10.  Lyse cells by drawing the solution into a syringe then pushing the solution 
out forcibly.  
11.  Repeat step 9 at least 10X. 
12.  Centrifuge cell/lysate solution for 5 minutes at 14, 000 ppm, in a refrigerated  
centrifuge at 0oC, if possible.  
13.  Transfer lysate to a new container, discard pelleted cellular debris. 
14.   Measure total protein content of the lysate via BCA (bicinchoninic acid)    
protein assay, following manufacturers instructions.  










  214  
APPENDIX D 
Protocol for Western Blot (reducing conditions) for                                                       




A. Gel Electrophoresis 
 
1. Equipment and Materials: 
i. Gel Electrophoresis Apparatus,  #170-3836 Mini-PROTEAN 
Trans-Blot cell (Bio-Rad) 
ii. Running Buffer:  25 mM Tris, pH 8.3, 192 mM glycine, 0.1% 
SDS, # 161-0772, 10X (Bio-Rad)   
iii.   SDS-PAGE Gels,  #161-1105 (Bio-Rad) 
iv. Protein Standard #161-0374 (Bio-Rad) 
v. Cell Lysates 
vi. Laemmli buffer #161-0737 (Bio-Rad) 
vii. Power supply 
 
2. Prepare cell lysates, and determine total protein content 
 
3.   Mix cell lysates in a 1:1 ratio with laemmli buffer(with β-mercaptoethanol 
added per instructions)  
4. Heat @ 90-100 oC for 5 minutes 
5. Allow lysate/laemmli buffer mixture to cool to room temperature. 
6. Prepare the running buffer according to instructions. 
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7. Assemble the SDS-PAGE gels into the Gel Electrophoresis Apparatus per 
instructions. Add enough running buffer to the internal compartment to just 
cover the gel completely.  Add a similar amount to the external compartment.  
8. Determine the amount of protein lysate mixture (uL) that must be added to 
each well such that all wells contain the same amount of total protein sample.  
9. Load the wells with lysate sample, controls and standards, and add additional 
running buffer to both compartments to fill the container.   
10. Hook the electrodes to the power supply and set the voltage to 100V for 1 to  
1.5 hrs, depending on the separation efficiency.  (Note: A good connection 
has been made when small bubbles are observed rising from the bottom of 
the chamber). 
11.  After the separation is complete remove the gels from the chamber and  
assemble them  into the cassette for the (Western Blot)  transfer process          
(Step B). 
B. Western Blot 
 1.   Equipment and Materials: 
 
i.       Mini Trans Blot Module, #170-3935 (Bio Rad) 
 
   ii.       Hybond ECL nitrocellulose sheets, # NC9228451 (ThermoFisher  
Scientific)          
iii      Thick blot filter paper, #170-3932 (Bio Rad) (4 pieces) 
 iv       Transfer buffer: Tris, glycine, methanol,  water,  #161-0771                                          
(Bio Rad, 10X) 
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v.  Power supply 
vi.       Phosphate buffer solution (PBS) 
vii.       Tween 20  
viii.      Primary antibody: DREG 56,  # 304811 (Biolegend) MECA-79,    
#553863 (BD Pharmingen) or anti-MadCAM-1, # MCA2096Z 
and # MCA23 (AbD Serotec) 
ix.        Secondary antibody: HRP conjugated 
x.         Non-fat powdered milk 
xi.        Laboratory rocker or orbital platform shaker 
xii.       ECL+ Western Blot Detection system #32106 (Pierce 
Chemicals) 
xiii.      Chemiluminescence film,  #RPN3114K (GE Amersham) 
 
2.   Prepare transfer buffer according to instructions, and place some in a soaking 
dish  
3.   Cut two nitrocellulose membranes approximately the same size as the gels.  
4.   Soak the nitrocellulose membranes, filter paper, and gauze in transfer buffer  
at least 10 minutes before assembling into the module.  
5.   Remove the gel from its glass housing and place on top of the wetted         
nitrocellulose membrane, in the transfer buffer.  
 6.  Stack the gel, nitrocellulose sheet, filter papers and gauze pads as shown in   
Figure 1, taking care not to trap bubbles between the layers.  
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 7.  Place the stack (from step 6)  in the holder as shown in Figure 1.  Make sure 
that the SDS-PAGE gel is closest to the black side of the holder, and the 








8.   Place the holder in the western blot transfer cassette, oriented such that the   
black side of the \holder is towards the black side of the cassette.  
9.   Place the cassette into the tank, along with a stirring bar and the ice pack.   
10.  Fill the tank with transfer buffer, place the top on the tank and hook the   
electrodes into the power supply.  
11.  Set the power to 100 V for 1 hour, agitate the solution with the stirring bar. 
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12.  At the end of one hour, disassemble the transfer cassette, and remove the       
nitrocellulose sheets (These now have the separated proteins on the surface).   
13.   Block non-specific binding sites on the nitrocellulose sheets with 7% (w/v)  
non-fat powdered milk in PBS+0.1% Tween (PBST) for 1 hour at room 
temperature, or overnight at 4oC. Be sure to agitate. 
14.   Incubate the nitrocellulose sheets in the primary antibody diluted as 
recommended in 5% (w/v) non-fat powdered milk in PBST for 1 hour at 
room temperature, or overnight at 4oC.  Be sure to agitate. 
15.  Rinse the nitrocellulose sheets briefly 2x with PBST, then wash for 15   
minutes  in PBST with agitation.  
16.  Wash 2x in PBST for 5 minutes each.  
17.  Incubate the nitrocellulose sheets in the secondary antibody diluted as 
recommended in 5% (w/v) non-fat powdered milk in PBST for 1 hour at 
room temperature, or overnight at 4oC.  Be sure to agitate. 
 18.  Rinse the nitrocellulose sheets briefly 2x with PBST, then wash for 15 
minutes in PBST with agitation. 
 19. Wash 1x in PBST for 5 minutes, followed by 1x in PBS for 5 minutes. 
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APPENDIX E 




A   Materials 
1. 4% Paraformaldehyde solution 
2. 4-well Permanox chamber slides #12-565-21 (Fisher Scientific) 
3. Phosphate buffered saline solution (PBS) 
4. Phosphate buffered saline solution + 0.05% Tween 20 (PBS-T) 
5. Blocking Solution: 10 % Normal Goat Serum (NGS) in PBS  
6. Diluent: 5 % Normal Goat Serum (NGS) in PBS 
7. Streptavidin/Biotin blocking Kit, #SP 2002, (Vector Labs). 
8. β-Actin rabbit polyclonal anti-actin antibody (Cell Signaling Technology, 
Inc.): 5uL /250 uL of diluent 
9. Biotinylated anti-rabbit IgG # BA-1000 (Vector Labs): 5uL /250 uL of diluent 
10. MECA-79 rat anti-mouse monoclonal antibody (BD Pharmingen): 5uL /250 
uL of diluent 
11. Rat IgM isotype control #14-4341 (eBioscience) : 5uL /250 uL of diluent 
12. Biotinylated anti-rat IgM Antibody,  #16-16-03 (KPL) (~700 uL, 0.5 mg/ml) 
13. Alkaline phosphatase streptavidin, #SA-5100 (Vector Labs) 
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B.  Protocol 
1.   Seed Ishikawa cells in 4-well Permanox chamber slides and incubate in 
normal  culture medium for 24 hrs. at 37oC, in 5% CO2  
 2.   Remove culture medium and wash 1X with PBS. 
3.   Fix cells with 4% paraformaldehyde solution for 30 minutes at room  
temperature. 
4.   Remove paraformaldehyde and wash 1X with PBS. 
5.   Block for 1 hour at room temperature in 10% NGS in PBS. 
6.   Wash 1X with PBS-T 
7.   Block for 15 minutes with streptavidin D solution  
8.   Wash 1X with PBS-T 
9.   Block for 15 minutes with biotin solution 
10. Wash 1X with PBS-T 
11. Add primary antibody (MECA-79, anti-actin, or rat IgM isotype), and 
incubate at 4oC overnight.  
12. Wash 3X with PBS-T 
13. Incubate in corresponding biotinylated secondary antibody at room 
temperature for 1.5 hrs.  
14. Wash 1X with PBS-T 
15.  Incubate at room temperature for 1.5 hrs. in alkaline phosphatase streptavidin 
diluted in 10% NGS in PBS-T.  
16.  Wash 2X with PBS-T 
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17.  Wash 1X with PBS 
 18.  Prepare BCIP solution per directions. Add to each well, followed by 1 drop of  
levamisole.  
19.  Incubate at room temperature until a color change is observed.  
20.  Wash 2X with DI water and allow slides to dry.  
      21.  Add 1-2 drops of aqueous mounting solution and a coverslip to seal slide 
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APPENDIX F 
Protocol for Enzyme-Linked ImmunoSorbent Assay                                                  




This protocol was developed for ELISA analysis of L-Selectin shed into culture 
medium of conditioned Jeg-3 and Ishikawa cells.  
 
A.  Concentration of culture medium  
1.   Equipment and materials 
i.          Protein media concentrators:  Microcon YM-30 and Centriplus 
YM-30 (Millipore Corp)    
ii.         Syringes with 0.2 μm  low-protein binding syringe filter  
2.   NOTE: For all steps,  the temperature of the culture medium should be kept at 
-4oC as much as is practically possible.  
3.   Collect culture medium from cell culture flask, cool on ice. 
4.   Centrifuge at 1000 g for 10 minutes 
5.   Filter cooled culture medium through syringe filters  
6.   Place up to 15 ml of  filtered culture medium in Centriplus protein 
concentrator (measure volume precisely, and note as initial volume).  
7.   Centrifuge according to manufacturers recommendations to a volume of  ~ 
1000 – 500 uL.  
8.   Transfer concentrated culture medium (500 uL max) to YM-30 Microcon 
protein concentrator, and centrifuge according to manufacturers 
recommendations, to a final volume of ~200-300 uL.  
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9.   Carefully measure final volume, and calculate concentration factor.  
10.  Store concentrated culture medium at -80oC until use.  
 
B.  ELISA 
1.  Equipment and materials 
i.          Coating buffer - 100 mN Bicarbonate/carbonate buffer:  3.03 g  
Na2CO3,  6.0 g NaHCO3 in 1L of distilled water, adjusted to    
pH 9.6.  
ii.         Blocking buffer - 3% (w/v) BSA in PBS 
iii.        Wash buffer – PBS + 0.1% (v/v) Tween-20 (PBS-T) 
iv. Stopping buffer – 3 M HCl 
v. ELISA 96-well plates 
vi. Polyclonal L-selectin (capture) antibody #N-18, (Santa Cruz 
Biotechnology) 
vii. DREG 56 L-selectin (primary) antibody, #304811 (BioLegend)  
viii. Biotinylated goat anti-mouse (secondary) antibody #BA-9200 
(Vector Labs) 
ix. HRP conjugated streptavidin #21126 (Pierce) 
x. TMB (tetramethylbenzidine) substrate reagent set, #1854050 
(Pierce Chemicals)  
2.  Coat 96-well ELISA plates with 100 μL/well of  3 μg/ml polyclonal  L- 
selectin (capture) antibody (N-18) in coating buffer at 4oC overnight 
3.  Wash the plate 2X in PBS  
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4.  NOTE: firmly blot the plate against clean paper towels at the end of  
each washing step. 
 
5.  Add 200 μL/well of blocking buffer and incubate for 2 hours at room  
 
temperature with shaking. 
 
6.   Wash the plate 3X in PBS-T 
 
7.   Prepare L-selectin standards in culture medium 
 
8.   Add 100 μL/well of  concentrated culture medium, standards and     
 
 blank to the plate 
 
9.   Incubate for 2 hours at room temperature with shaking. 
10. Wash the plate 5X in PBS-T 
11. Add 100 μL/well of DREG 56 antibody (1:500 in blocking buffer) to the 
plate. 
12. Incubate for 1 hour with shaking at room temperature 
13. Wash the plate 5X in PBS-T 
14. Add 100 μL/well of biotinylated goat anti-mouse secondary antibody  
(4 μg/ml in blocking buffer) to the plate  
15. Incubate for 1 hour with shaking at room temperature 
16. Wash the plate 5X in PBS-T 
17. Add 100 μL/well of streptavidin-HRP (0.5 μg/ml in blocking buffer)     to the 
plate  
 18.  Incubate for ½  hour with shaking at room temperature 
 19.  Wash the plate 5X in PBS-T 
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 20.  Mix TMB reagents (1:1) and add 100 μL/well to the plate 
 21.  Cover the plate with a material impervious to light (eg, aluminum foil).  
22.  Incubate for ½  hour with shaking at room temperature 
23.  Add 100 μL/well of stopping buffer to the plate to stop the reaction (DO 
NOT REMOVE TMB REAGENTS) 































  226  
APPENDIX G 
Protocol for L-selectin Attachment to Gold via                                                              




A.  Cleaning of Gold Surface 
 
 1.  Materials  
 
i. 30 % Hydrogen peroxide (H2O2) solution 
 
ii.        25% Ammonia (NH3) solution 
 
2. Prepare a solution of hydrogen peroxide:ammonia:water in a ratio of 1:1:5 
 
3. Heat the solution to 80oC 
 
4. Immerse the gold substrates in the solution for 5-10 minutes.  
   
B.  Deposition of Mixed  SAM 
 
 1.   Materials  
 
i.      Absolute ethanol 
 




iii.     1-Decanethiol (NDt): HS(CH2)9CH3  F.W. 174.35 
 
2.  Prepare a binary mixture of  2.5 mM MUA and 7.5 mM NDt in absolute 
 
      ethanol 
 
3.    Immerse the clean gold surface in the mixture for three (3) hours at RT 
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 C.   Covalent immobilization of L-selectin 
 
1.   Materials: 
 
i. Ultrapure water 
 
ii.        N-3-Dimethylaminopropyl)-3-ethylcarbodiimide (EDC): 
C8H17N3    F.W. 155.24 
  
iii.       N-Hydroxysuccinimide (NHS): C4H5NO3   F.W. 115.09 
 
iv.        L-selectin Fc Chimera (R&D Systems)  25 ug/ml in 10 mM PBS 
@ pH 7.4 
v.        ethanolamine (1M) @ pH 9.0 
vi.       1% (w/v) BSA in 10 mM PBS @ pH 7.4 
2.   Prepare a solution of 20mM NHS and 10 mM EDC in ultrapure water. 
3.   Immerse the SAM coated gold  substrate in the above  solution for 2 hours at     
RT to “activate”  the SAM 
4.   Prepare a solution of  L-selectin Fc Chimera at a concentration of  25 ug/ml    
in 10 mM PBS @ pH 7.4 
5.   Immerse the “activated” SAM coated substrate in the L-selectin  solution for 2 
hours at R.T 
             6.  Block any  remaining active sites by immersion in the ethanolamine solution 
for 20 minutes at R.T 
7.   Wash the coated  gold substrate  thoroughly with ultrapure water (~ 4-5     
rinses)  
            8.   Immerse the gold substrate in BSA solution for 2 hours.  
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